{"numRecords":"808","DataElementQueryResults":[{"publicId":"2008493","version":"1","preferredName":"Follow-up Visit Schedule Interval","preferredDefinition":"Response indicating the schedule of follow-up.","longName":"CHSSCHE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"A1A779A2-98D7-19DF-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-05-23","endDate":null,"createdBy":"DWARZEL","dateCreated":"2002-05-23","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"10.16.20 TL changed WFS from RETIRED DELETED to RETIRED ARCHIVED and added an End Date in preparation of OneData.; Workflow status set to \"Retired Deleted\" in 3.0 deployment, was previously Deleted using the Admin Tool \"Delete\" function key. This function is no longer available.","administrativeNotes":"12.29.22_Unretired for AMC use_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2590851","version":"1","preferredName":"Alcohol Use Indicator","preferredDefinition":"Indicator of whether alcohol was used (consumed).","longName":"BASALCHL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2842CB1E-B7BA-5F13-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-30","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-01-30","modifiedBy":"TSESU","dateModified":"2022-12-27","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2919108","version":"1","preferredName":"Chemotherapy Planned Indicator","preferredDefinition":"Indicator of whether chemotherapy is planned.","longName":"CCTNCHEM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"ASCO:American Society of Clinical Oncology","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EAE3776-A79C-6030-E040-BB89AD432E08","latestVersionIndicator":"Yes","beginDate":"2009-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-14","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"2020-10-16 ak Move RETIRED WITHDRAWN content to RETIRED ARCHIVED for MDR.; Curated to support ASCO Chemotherapy Administration report by D. Reeves 6/2009. Retired due to lack of use. 11.20.2014.dmr","administrativeNotes":"12/21/2022_UN-RETIRED for AMC reuse_smt.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6592220","version":"1","preferredName":"Neurologic Disease or Disorder Present Indicator","preferredDefinition":"Coded indicator of whether neurologic disease or disorder is present.","longName":"BASNEURO_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D385F03-9957-5F31-E053-F662850A63FA","latestVersionIndicator":"Yes","beginDate":"2018-12-17","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-12-17","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"10.16.20 TL changed WFS from RETIRED DELETED to RETIRED ARCHIVED in preparation of OneData.; 3/11/2020: CM retired deleted, created in error","administrativeNotes":"12.27.22_Unretired to reuse for AMC_smt; 07.05.22_Set RS to Retired to reflect WFS of Retired_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7125285","version":"1","preferredName":"Participant Lymphoma Negation Treating Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response that indicates the participant meets the eligibility requirements for participation in a clinical trial with regards to untreated lymphoma.","longName":"LYMP_NEG_TRT_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA61CC7-4625-0D1B-E053-F662850A57E7","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-01-08","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated in support of protocol AMC-101 DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7125287","version":"1","preferredName":"Leptomeningeal Neoplasm Present Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response that indicates the participant meets the eligibility requirements for participation in a clinical trial with regards to known or suspected leptomeningeal disease.","longName":"LEP_NEO_PRES_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA5E5B6-0298-4714-E053-F662850A445E","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-01-08","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated in support of protocol AMC-101 DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7215584","version":"1","preferredName":"ECOG Performance Status Greater Than One Score Indicator","preferredDefinition":"Indicator of whether or not the ECOG Performance Status is greater than one.","longName":"KS1ECOG","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A139AAB2-867C-5E1E-E053-F662850AA495","latestVersionIndicator":"Yes","beginDate":"2020-03-19","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-19","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Created for AMC-107 Protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7218999","version":"1","preferredName":"Gingiva Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the gingiva/gums.","longName":"GINGIVA_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1EED1-B3F1-2CB8-E053-F662850A9862","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219010","version":"1","preferredName":"Hard Palate Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the hard palate.","longName":"KS1HPALA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1D81B-EA7E-2CA0-E053-F662850A4F1F","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219011","version":"1","preferredName":"Soft Palate Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the soft palate.","longName":"KS1SPALA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1EED1-B417-2CB8-E053-F662850A9862","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219012","version":"1","preferredName":"Buccal Mucosa Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the buccal mucosa.","longName":"KS1BMUCO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1D81B-EAA4-2CA0-E053-F662850A4F1F","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curate for AMC-107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219013","version":"1","preferredName":"Tongue Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the tongue.","longName":"KS1TONGU","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C32C77-3033-2CB2-E053-F662850ADBDF","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219014","version":"1","preferredName":"Oral Cavity Floor Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the floor of the mouth.","longName":"KS1FMOUT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1DBE0-64E4-2CA6-E053-F662850A9BBB","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219015","version":"1","preferredName":"Tonsil Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the tonsils.","longName":"KS1TONSI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1DBE0-650A-2CA6-E053-F662850A9BBB","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219016","version":"1","preferredName":"Uvula Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the uvula.","longName":"KS1UVULA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C3635C-B668-2CC4-E053-F662850A0AF2","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curate for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219017","version":"1","preferredName":"Posterior Pharynx Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the posterior pharynx.","longName":"KS1PPHAR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1EED1-B43D-2CB8-E053-F662850A9862","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curate for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219069","version":"1","preferredName":"Lip Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the lips.","longName":"KS1LIPS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C37F4B-7161-2CAE-E053-F662850AD611","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219070","version":"1","preferredName":"Labial Mucosa Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the labial mucosa.","longName":"KS1LMUCO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1B63011-8728-2CAA-E053-F662850AA059","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7219084","version":"1","preferredName":"Vestibule of Mouth Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the vestibule of the mouth.","longName":"KS1VESTI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C1EED1-B463-2CB8-E053-F662850A9862","latestVersionIndicator":"Yes","beginDate":"2020-03-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-03-26","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7239218","version":"1","preferredName":"Patient Kaposi Sarcoma Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response that indicates the participant meets the eligibility requirements for participation in a clinical trial with regards to histologically or cytologically confirmed cutaneous Kaposi sarcoma.","longName":"ECCONFKS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A26395B9-3234-67CF-E053-F662850A7D7C","latestVersionIndicator":"Yes","beginDate":"2020-04-03","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-04-03","modifiedBy":"COLLIED","dateModified":"2021-02-25","changeNote":"Curated for the AMC-107 protocol DC  Revised context from NCIP to AMC - smt 9/8/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7332446","version":"1","preferredName":"Eligibility Determination Checklist Complete Indicator","preferredDefinition":"Indicator of whether or not the eligibility checklist been completed per protocol.","longName":"ECPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A834EA13-2160-4DEA-E053-4EBD850A4532","latestVersionIndicator":"Yes","beginDate":"2020-06-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-16","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7332452","version":"1","preferredName":"Person Blood Tissue Donor Consent Indicator","preferredDefinition":"Indicator of whether or not the participant consents to donate samples of blood for future research.","longName":"FTRUSBL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A837923B-1014-2583-E053-4EBD850A1BE6","latestVersionIndicator":"Yes","beginDate":"2020-06-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-16","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added proper Alt short name with rep term_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7332453","version":"1","preferredName":"Patient Future Research Cancer Biobank Storage Consent Indicator","preferredDefinition":"The indicator of whether or not the participant consents to sample donation to a biobank for future research to learn about, prevent, diagnose, or treat cancer or other diseases.","longName":"FTRUSLBT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A834BCDC-1F5B-1878-E053-4EBD850AFA3D","latestVersionIndicator":"Yes","beginDate":"2020-06-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-16","modifiedBy":"TSESU","dateModified":"2023-11-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7332454","version":"1","preferredName":"Specimen Related Genetic Future Research Consent Indicator","preferredDefinition":"The indicator of whether or not the participant consents genetic testing on samples donated to a biobank for future research.","longName":"FTRUSGEN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A837D118-53EC-2DB1-E053-4EBD850ACB60","latestVersionIndicator":"Yes","beginDate":"2020-06-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-16","modifiedBy":"SHEIKHM","dateModified":"2022-02-18","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334303","version":"1","preferredName":"Kaposi Sarcoma Related Edema Limb Anatomic Site","preferredDefinition":"information relating to the anatomic location of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues)._A body region referring to an upper or lower extremity._Named locations of or within the body.","longName":"KS_R/T_ED_LIM_ANAT_SITE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A84111DF-D30B-42FB-E053-4EBD850A26A0","latestVersionIndicator":"Yes","beginDate":"2020-06-16","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-06-17","modifiedBy":"ALAIS","dateModified":"2020-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334304","version":"1","preferredName":"Kaposi Sarcoma Related Limb Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A84293C0-6F0F-3FF2-E053-4EBD850AAD10","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-06-17","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334352","version":"1","preferredName":"Kaposi Sarcoma Stage Oral Candidiasis Opportunistic Infection Grouping Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of opportunistic infection and/or thrush.","longName":"OI_ SYS_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A849F27D-6E6F-232D-E053-4EBD850A6D02","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334376","version":"1","preferredName":"Kaposi Sarcoma Stage Immune System Grouping Status","preferredDefinition":"Text terms that represent the status of the Kaposi sarcoma stage immune system grouping.","longName":"IMM_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84A7CD7-82CD-6B6D-E053-4EBD850AD475","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334381","version":"1","preferredName":"Kaposi Sarcoma Stage B-Symptoms Grouping Indicator","preferredDefinition":"The indicator that asks whether there are B-symptoms present (fever above 38 degrees C, drenching night sweats, and weight loss of more than 10% of body mass in the previous 6 months).","longName":"BSYMP_ SYS_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84A90E6-9B07-6D49-E053-4EBD850A8AF6","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334384","version":"1","preferredName":"ECOG Performance Status Greater Than One Score Indicator","preferredDefinition":"Indicator of whether or not the ECOG Performance Status is greater than one.","longName":"ECOG_ SYS_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84A7CD7-82F3-6B6D-E053-4EBD850AD475","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curate for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334409","version":"1","preferredName":"Kaposi Sarcoma Stage Other Human Immunodeficiency Virus Disease Grouping Indicator","preferredDefinition":"The indicator that asks whether there is other HIV-related illness.","longName":"OTHHIV_ SYS_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84A90E6-9B2D-6D49-E053-4EBD850A8AF6","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334418","version":"1","preferredName":"Patient Malignant Neoplasm Related Pain Personal Medical History Indicator","preferredDefinition":"The indicator of whether or not the participant is experiencing tumor-related pain.","longName":"PAIN_RSPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84B1BE4-29C5-606B-E053-4EBD850AFDBD","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curate for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334424","version":"1","preferredName":"Patient Cancer Pain Analgesic Use Opioid Analgesic Agent Indicator","preferredDefinition":"The indicator of whether or not the participant is on analgesics for tumor-related pain.","longName":"PAIN_RSTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84B13FD-8BCA-6087-E053-4EBD850AADD8","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335588","version":"1","preferredName":"Average Pain Past 24 Hours Occurrence Average Pain Scale","preferredDefinition":"A participant's stated observation rating their average pain over the past 24 hours, using a 11 point Likert scale.","longName":"PNSCORE_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84B13FD-8BF0-6087-E053-4EBD850AADD8","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curate for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with Rep Term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335648","version":"1","preferredName":"Oral Cavity Disorder Assessment Indicator","preferredDefinition":"The indicator of whether or not there are any Kaposi sarcoma oral lesions present at this evaluation.","longName":"ORAL_RSPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C0BEC-8ACC-3607-E053-4EBD850A74A7","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335670","version":"1","preferredName":"Hard Palate Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the hard palate.","longName":"HPALATE_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C672F-C597-0A2B-E053-4EBD850A5683","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curate for AMC 107 protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335674","version":"1","preferredName":"Soft Palate Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the soft palate.","longName":"SPALATE_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C5D44-8C02-365E-E053-4EBD850ABCBB","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curate for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335675","version":"1","preferredName":"Buccal Mucosa Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the buccal mucosa.","longName":"BUCMUCOS_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C4D74-1953-7A87-E053-4EBD850ADFFB","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curate for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335676","version":"1","preferredName":"Tongue Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the tongue.","longName":"TONGUE_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C13E7-D3C4-35BA-E053-4EBD850AD225","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335686","version":"1","preferredName":"Oral Cavity Floor Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the floor of the mouth.","longName":"FLMOUTH_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C9680-523B-358C-E053-4EBD850A5C9F","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335687","version":"1","preferredName":"Tonsil Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the tonsils.","longName":"TONSILS_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C72C6-DA84-0DE2-E053-4EBD850AEFD2","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335688","version":"1","preferredName":"Uvula Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the uvula.","longName":"UVULA_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84CAD79-2C10-09F5-E053-4EBD850A1E9A","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335689","version":"1","preferredName":"Posterior Pharynx Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the posterior pharynx.","longName":"POSPHRNX_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C72C6-DAAA-0DE2-E053-4EBD850AEFD2","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335695","version":"1","preferredName":"Lip Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the lips.","longName":"LIPS_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C9680-5261-358C-E053-4EBD850A5C9F","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335696","version":"1","preferredName":"Labial Mucosa Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present on the labial mucosa.","longName":"LABMUCOS_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C2E36-FC4C-405A-E053-4EBD850AADEC","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335697","version":"1","preferredName":"Vestibule of Mouth Kaposi Sarcoma Present Indicator","preferredDefinition":"Indicator of whether or not Kaposi Sarcoma oral lesions are present in the vestibule of the mouth.","longName":"VESTBULE_RSLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84CE014-244C-0B2D-E053-4EBD850AE81A","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335699","version":"1","preferredName":"Kaposi Sarcoma Related Foot Disease Assessment Indicator","preferredDefinition":"Indicator of whether or not there are any foot Kaposi Sarcoma lesions present at this evaluation.","longName":"FOOT_RSPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84BE9F2-620F-362D-E053-4EBD850A103C","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-06-17","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349755","version":"1","preferredName":"Specimen Human Herpesvirus 8 Viral Load Collection Indicator","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A gammaherpesvirus that contributes to the development of Kaposi sarcoma._The act of gathering things together; having been brought together in one place._The number of viral particles (usually HIV) in a sample of blood plasma._Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"KSPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E139B9-52E0-0573-E053-4EBD850AA5AA","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"COLLIED","dateModified":"2021-03-19","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349760","version":"1","preferredName":"Specimen Human Herpesvirus 8 Viral Load Negation Collection Reason","preferredDefinition":"Reason why the specimen for human herpesvirus 8 viral load was not collected.","longName":"KS_LBREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E94A8E-E812-0570-E053-4EBD850A8917","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349761","version":"1","preferredName":"Specimen Human Herpesvirus 8 Viral Load Negation Collection Other Specify Text","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A gammaherpesvirus that contributes to the development of Kaposi sarcoma._The act of gathering things together; having been brought together in one place._The number of viral particles (usually HIV) in a sample of blood plasma._An operation in which a term denies or inverts the meaning of another term or construction._The free text field that describes another response when other is chosen from a list of values.","longName":"OTHSP_KS_LBREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E237E2-1D1F-3A7C-E053-4EBD850A423F","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"COLLIED","dateModified":"2021-03-19","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349762","version":"1","preferredName":"Specimen Human Herpesvirus 8 Human Immunodeficiency Virus Viral Load Collection Indicator","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A gammaherpesvirus that contributes to the development of Kaposi sarcoma._The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses._The act of gathering things together; having been brought together in one place._The number of viral particles (usually HIV) in a sample of blood plasma._Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"KHPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E969D5-ADAE-2C1D-E053-4EBD850A8144","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"COLLIED","dateModified":"2021-05-12","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349763","version":"1","preferredName":"Specimen Human Herpesvirus 8 Human Immunodeficiency Virus Viral Load Negation Collection Reason","preferredDefinition":"Reason why Human Herpesvirus 8 Human Immunodeficiency Virus Viral load specimen was not collected.","longName":"KH_LBREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E97236-40EC-26DE-E053-4EBD850AA80C","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349764","version":"1","preferredName":"Specimen Human Herpesvirus 8 Human Immunodeficiency Virus Viral Load Negation Collection Other Specify Text","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A gammaherpesvirus that contributes to the development of Kaposi sarcoma._The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses._The act of gathering things together; having been brought together in one place._The number of viral particles (usually HIV) in a sample of blood plasma._An operation in which a term denies or inverts the meaning of another term or construction._The free text field that describes another response when other is chosen from a list of values.","longName":"OTHSP_KH_LBREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E7E9FB-87A6-3FEA-E053-4EBD850A33E0","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"TAYLORT","dateModified":"2020-10-19","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349770","version":"2","preferredName":"Specimen Biorepository Shipping Availability Indicator","preferredDefinition":"Indicator of whether specimen is available for shipping to biorepository.","longName":"SPEC_AVAIL_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"003A3CE9-0373-4D13-E063-731AD00AAEDF","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":"2023-07-11","createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"ZHWENDY","dateModified":"2023-07-12","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":"7/11/23_New version due to missing Rep Term in Short Name and revise definition to human readable_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349884","version":"1","preferredName":"Specimen Biorepository Shipping Negation Availability Reason","preferredDefinition":"Reason why specimen for biorepository was not available for shipping.","longName":"KSVSHP_LBREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9EF2B3C-A616-0C9E-E053-4EBD850A414A","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349886","version":"1","preferredName":"Specimen Biorepository Shipping Negation Availability Other Specify","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A storage facility of biospecimens that includes tissue samples, fluids, and molecular derivatives such as DNA, RNA, and proteins. The biorepository has stringent guidelines regarding the standardized collection, handling, storage, and documentation of biological specimens._The act or business of transporting goods._The quality of being obtainable or accessible and ready for use or service._An operation in which a term denies or inverts the meaning of another term or construction._Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"OTHSP_KSSHP_LBREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9EE5339-7DAE-0E19-E053-4EBD850A9923","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"COLLIED","dateModified":"2021-03-22","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349982","version":"1","preferredName":"Participant Homosexuality Or Bisexuality Encounter Indicator","preferredDefinition":"Indicator of whether or not the participant has had homosexual or bisexual contact.","longName":"HMBSXCT_EROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9EF2309-0811-0D55-E053-4EBD850A759F","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2022-12-19","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349986","version":"1","preferredName":"Participant Heterosexuality Encounter Indicator","preferredDefinition":"Indicator of whether or not the participant has had heterosexual contact.","longName":"HTSXCT_EROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9F252F8-0631-6B87-E053-4EBD850A6C71","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2022-12-19","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349987","version":"1","preferredName":"Person Intravenous Drug Abuse Personal Medical History Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of intravenous drug abuse.","longName":"IVU_EROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9F2A9AA-725D-6B85-E053-4EBD850A8291","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7349990","version":"1","preferredName":"Blood Transfusion Recipient Indicator","preferredDefinition":"Indicator of whether or not the participant has received a blood transfusion.","longName":"TRNSFUSN_EROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9F39AD5-87A9-6B83-E053-4EBD850A94CD","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-08","modifiedBy":"TSESU","dateModified":"2022-12-19","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350311","version":"1","preferredName":"Agent Administration Level Dose","preferredDefinition":"A description of applying, dispensing or tendering a medical product or other agent to a clinical study subject._The total quantity or strength of a substance (drug or radiation) administered at one time. (NCI)_An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._A position on a scale measuring intensity, quality, or amount._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"2715305v1.0:7350306v1.0","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9FC8CE7-07B4-4E63-E053-4EBD850A7A23","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-09","modifiedBy":"TAYLORT","dateModified":"2020-10-19","changeNote":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350333","version":"1","preferredName":"Hemophilia Disease or Disorder Indicator","preferredDefinition":"Indicator of whether or not the participant is a hemophiliac.","longName":"HEMPHLC_EROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9FC278B-5DAF-4E6B-E053-4EBD850AE6F0","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350337","version":"1","preferredName":"Participant Other Human Immunodeficiency Virus Risk Group Classification Indicator","preferredDefinition":"Indicator of whether or not the participant is in an other HIV risk group.","longName":"OTHER_EROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9FE2491-AAA3-1714-E053-4EBD850A91A0","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350340","version":"1","preferredName":"Participant Other Human Immunodeficiency Virus Risk Group Classification Specify","preferredDefinition":"Text description of the other HIV risk group not previously specified.","longName":"OTHER_ERTERM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9FB1772-465E-1533-E053-4EBD850AEF85","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350347","version":"1","preferredName":"Cancer Prior Treatment Indicator","preferredDefinition":"Indicator of whether or not the participant has has prior treatment for cancer.","longName":"PRMALIG_TRTYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9FB1772-4684-1533-E053-4EBD850AEF85","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350373","version":"1","preferredName":"Prior Chemotherapy Administered Indicator","preferredDefinition":"Indicator of whether or not prior chemotherapy was administered.","longName":"CHEMO_PRMALIG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03A16F-203E-584A-E053-4EBD850A4C28","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350374","version":"1","preferredName":"Prior Biological Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not prior biological therapy was administered.","longName":"BIORCYT_PRMALIG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9FB1772-46AA-1533-E053-4EBD850AEF85","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350375","version":"1","preferredName":"Prior Surgery Performed Indicator","preferredDefinition":"Indicator of whether or not prior surgery was performed.","longName":"SURG_PRMALIG_PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0449A4-33CD-507A-E053-4EBD850A64A2","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350376","version":"1","preferredName":"Prior Therapy Cryotherapy Administered Indicator","preferredDefinition":"Indicator of whether or not prior cryotherapy was administered.","longName":"CRYO_PRMALIG_PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03FCB7-283B-518D-E053-4EBD850AD966","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350377","version":"1","preferredName":"Prior Steroid Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not prior systemic steroid therapy was administered.","longName":"STEROID_PRMALIG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0391F2-CC4D-4D96-E053-4EBD850A6E92","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350378","version":"1","preferredName":"Prior Radiation Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not prior radiation therapy was administered.","longName":"RADIATN_PRMALIG_PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03B64E-2E5F-4823-E053-4EBD850AE6F2","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350380","version":"1","preferredName":"Prior Therapy Topical Intralesional Administered Indicator","preferredDefinition":"Indicator of whether or not prior topical/intralesional therapy was administered.","longName":"TPINTLSN_PRMALIG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03FCB7-2861-518D-E053-4EBD850AD966","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350386","version":"1","preferredName":"Prior Therapy Other Administered Indicator","preferredDefinition":"Indicator of whether or not any other prior therapy was administered.","longName":"INVEST_PRMALIG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03FCB7-2887-518D-E053-4EBD850AD966","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"2023.9.1 AQT added per ticket request CADSR0002807. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350400","version":"1","preferredName":"Prior Cancer Diagnosis Indicator","preferredDefinition":"Indicator of whether or not the participant has a prior cancer diagnosis.","longName":"OTHMALIG_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03A54A-4D2F-50A9-E053-4EBD850A104A","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"GDEEN","dateModified":"2023-05-04","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350463","version":"1","preferredName":"Antiretroviral Therapy Administration Indicator","preferredDefinition":"Indicator of whether or not antiretroviral therapy was administered.","longName":"ARV_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA06A39E-DCD7-552D-E053-4EBD850AC7A6","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7350472","version":"1","preferredName":"Antiretroviral Therapy Begin Year Value","preferredDefinition":"The year that antiretroviral therapy began in YYYY format.","longName":"ARV_CMSTYY","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA039D7A-50A6-54CB-E053-4EBD850A0301","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-09","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351173","version":"1","preferredName":"Combination Antiretroviral Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving multi-class combination agents.","longName":"MCA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA4E5D49-8547-0D77-E053-4EBD850AB42D","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351188","version":"1","preferredName":"Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving efavirenz/emtricitabine/tenofovir disoproxil fumarate.","longName":"ATRIPLA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA4E60BA-9828-0D85-E053-4EBD850AA805","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351229","version":"1","preferredName":"Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving emtricitabine/rilpivirine/tenofovir disoproxil fumarate.","longName":"COMPLRA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA547095-5C0A-7B9B-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351238","version":"1","preferredName":"Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate.","longName":"STRIBILD_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA548C76-3503-7E6C-E053-4EBD850A73A3","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351255","version":"1","preferredName":"Combination Nucleoside Reverse Transcriptase Inhibitor Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving combination nucleoside reverse transcriptase inhibitors (NRTIs).","longName":"CNRTI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA4E7DF5-D85F-1D5A-E053-4EBD850AE649","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351260","version":"1","preferredName":"Lamivudine/Zidovudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving lamivudine/zidovudine.","longName":"COMBIVIR_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA54351B-5E57-7C7D-E053-4EBD850AF35B","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351269","version":"1","preferredName":"Abacavir Sulfate/Lamivudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving abacavir sulfate/lamivudine.","longName":"EPZICOM_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA553516-A64B-6165-E053-4EBD850AB74F","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351355","version":"1","preferredName":"Abacavir Sulfate/Lamivudine/Zidovudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving abacavir sulfate/lamivudine/zidovudine.","longName":"TRIZIVIR_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA5653E4-DA56-592F-E053-4EBD850A666E","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351380","version":"1","preferredName":"Emtricitabine/Tenofovir Disoproxil Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving emtricitabine/tenofovir disoproxil fumarate.","longName":"TRUVADA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA5633EC-D3D8-2EEC-E053-4EBD850A29BA","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351412","version":"1","preferredName":"Single Agent Nucleoside Reverse Transcriptase Inhibitor Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving single-agent nucleoside reverse transcriptase inhibitors (NRTIs).","longName":"SNRTI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA5653E4-DA7C-592F-E053-4EBD850A666E","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351430","version":"1","preferredName":"Emtricitabine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving emtricitabine.","longName":"EMTRIVA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA569321-1631-3CDE-E053-4EBD850A365B","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351451","version":"1","preferredName":"Lamivudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving lamivudine.","longName":"EPIVIR_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-499D-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351457","version":"1","preferredName":"Zalcitabine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving zalcitabine.","longName":"HIVID_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA566ED7-6C98-5C48-E053-4EBD850AFC5C","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351474","version":"1","preferredName":"Zidovudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving zidovudine.","longName":"RETROVIR_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-49C3-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351501","version":"1","preferredName":"Didanosine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving didanosine.","longName":"VIDEX_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA574E0F-FDA5-5C2D-E053-4EBD850A306E","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351507","version":"1","preferredName":"Tenofovir Disoproxil Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving tenofovir disoproxil fumarate.","longName":"VIREAD_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56630B-A45C-2EE8-E053-4EBD850A1983","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-13","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351875","version":"1","preferredName":"Stavudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving stavudine.","longName":"ZERIT_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6A1CF0-1BC7-599C-E053-4EBD850A5B62","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351882","version":"1","preferredName":"Abacavir Sulfate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving abacavir sulfate.","longName":"ZIAGEN_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6A4AF9-6AA5-5D22-E053-4EBD850AC443","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351890","version":"1","preferredName":"Non-nucleoside Reverse Transcriptase Inhibitor Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving non-nucleoside reverse transcriptase inhibitors (NNRTIs).","longName":"NNRTI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA67492F-4FD2-3409-E053-4EBD850AE5D7","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351895","version":"1","preferredName":"Rilpivirine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving rilpivirine.","longName":"EDURANT_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA676828-1F4C-3915-E053-4EBD850A2C96","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7351939","version":"1","preferredName":"Etravirine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving etravirine.","longName":"INTELNCE_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6AEEE0-1D9B-2AC8-E053-4EBD850A8483","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352172","version":"1","preferredName":"Doravirine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving doravirine.","longName":"PIFELTRO_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA67492F-507E-3409-E053-4EBD850AE5D7","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352176","version":"1","preferredName":"Delavirdine Mesylate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving delavirdine mesylate.","longName":"RESCRPTR_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA69EBFD-99DB-21AE-E053-4EBD850A5FB3","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352180","version":"1","preferredName":"Efavirenz Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving efavirenz.","longName":"SUSTIVA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA67DD8A-FA4A-380E-E053-4EBD850A6F30","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352184","version":"1","preferredName":"Nevirapine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving nevirapine.","longName":"VIRMUNE_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6A136F-303D-1FB2-E053-4EBD850A90EB","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-14","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352874","version":"1","preferredName":"Protease Inhibitor Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving protease inhibitors.","longName":"PI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7AF564-06D4-1CDA-E053-4EBD850AE4D6","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352878","version":"1","preferredName":"Amprenavir Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving amprenavir.","longName":"AGNERASE_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C1A25-C011-08CB-E053-4EBD850ACC7D","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-12-16","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352883","version":"1","preferredName":"Tipranavir Disodium Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving tipranavir disodium.","longName":"APTIVUS_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C296F-7274-6240-E053-4EBD850A76CB","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352888","version":"1","preferredName":"Indinavir Sulfate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving indinavir sulfate.","longName":"CRIXIVAN_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C390F-7CAE-1A0D-E053-4EBD850A405F","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352893","version":"1","preferredName":"Saquinavir Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving saquinavir.","longName":"FORTVSE_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C47CF-D7E1-71BF-E053-4EBD850A180B","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352903","version":"1","preferredName":"Saquinavir Mesylate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving saquinavir mesylate.","longName":"INVIRASE_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C5F45-790C-242B-E053-4EBD850A6271","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352907","version":"1","preferredName":"Lopinavir/Ritonavir Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving lopinavir/ritonavir.","longName":"KALETRA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C5A58-9380-71CD-E053-4EBD850AD871","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352911","version":"1","preferredName":"Fosamprenavir Calcium Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving fosamprenavir calcium.","longName":"LEXIVA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C811A-2D56-1E1E-E053-4EBD850A3D4F","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352916","version":"1","preferredName":"Ritonavir Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving ritonavir.","longName":"NORVIR_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C5A58-93A6-71CD-E053-4EBD850AD871","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352921","version":"1","preferredName":"Darunavir Ethanolate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving darunavir ethanolate.","longName":"PREZISTA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7CB7F5-842E-1A88-E053-4EBD850A4A1E","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352925","version":"1","preferredName":"Atazanavir Sulfate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving atazanavir sulfate.","longName":"REYATAZ_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7CDC8F-A354-71C5-E053-4EBD850AE1FF","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352930","version":"1","preferredName":"Nelfinavir Mesylate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving nelfinavir mesylate.","longName":"VIRACEPT_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C1FC3-AEE3-71CB-E053-4EBD850A5F52","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352939","version":"1","preferredName":"HIV Entry Inhibitor Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving HIV entry inhibitors.","longName":"EI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C1A25-C037-08CB-E053-4EBD850ACC7D","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352943","version":"1","preferredName":"Enfuvirtide Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving enfuvirtide.","longName":"FUZEON_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7AE9FB-13A3-03B4-E053-4EBD850A2194","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7352979","version":"1","preferredName":"Maraviroc Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving maraviroc.","longName":"SELZNTRY_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7C5A58-93CC-71CD-E053-4EBD850AD871","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353015","version":"1","preferredName":"HIV Integrase Inhibitor Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving HIV integrase inhibitors.","longName":"ISTI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7E7C70-84D6-6E84-E053-4EBD850AB052","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353020","version":"1","preferredName":"Raltegravir Potassium Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving raltegravir potassium.","longName":"ISNTRSS_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7AF564-0739-1CDA-E053-4EBD850AE4D6","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353026","version":"1","preferredName":"Dolutegravir Sodium Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving dolutegravir sodium.","longName":"TIVICAY_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7E6B12-54A2-6BCB-E053-4EBD850A5149","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353030","version":"1","preferredName":"Other Antiretroviral Therapy Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving other antiretroviral agents.","longName":"OTHARV_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7E2AE2-765B-6B7B-E053-4EBD850A88E6","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353034","version":"1","preferredName":"Other Antiretroviral Therapy Administration Specify","preferredDefinition":"Text description of any antiretroviral therapy the participant is receiving, not previously specified.","longName":"OTHARV_CMTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA7CB7F5-8481-1A88-E053-4EBD850A4A1E","latestVersionIndicator":"Yes","beginDate":"2020-07-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-15","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353153","version":"1","preferredName":"Bictegravir Emtricitabine Tenofovir Alafenamide Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving bictegravir/emtricitabine/tenofovir alafenamide.","longName":"BIKTARVY_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA92967B-38B8-7074-E053-4EBD850A65A0","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353161","version":"1","preferredName":"Doravirine Lamivudine Tenofovir Disoproxil Fumarate Medication Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving doravirine/lamivudine/tenofovir disoproxil fumarate.","longName":"DLSTRGO_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA9290F0-7138-7076-E053-4EBD850A2BD8","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353166","version":"1","preferredName":"Emtricitabine/Tenofovir Alafenamide Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving emtricitabine/tenofovir alafenamide fumarate.","longName":"DESCOVY_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA931A53-19AC-401B-E053-4EBD850A2FE9","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353172","version":"1","preferredName":"Atazanavir/Cobicistat Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving atazanavir/cobicistat.","longName":"EVOTAZ_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA9290F0-715E-7076-E053-4EBD850A2BD8","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353177","version":"1","preferredName":"Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate.","longName":"GENVOYA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA877326-C41A-296A-E053-4EBD850AF0FF","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353185","version":"1","preferredName":"Dolutegravir Rilpivirine Medication Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving dolutegravir/rilpivirine.","longName":"JULUCA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA930822-5FA8-706B-E053-4EBD850A8BD6","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353191","version":"1","preferredName":"Emtricitabine/Rilpivirine/Tenofovir Alafenamide Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving emtricitabine/rilpivirine/tenofovir alafenamide fumarate.","longName":"ODEFSEY_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA938624-3EC8-6BA0-E053-4EBD850A1B90","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353205","version":"1","preferredName":"Darunavir/Cobicistat Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving darunavir/cobicistat.","longName":"PRZCOBX_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA9395C6-F65E-6B9C-E053-4EBD850A30C0","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353229","version":"1","preferredName":"Efavirenz Lamivudine Tenofovir Disoproxil Fumarate Medication Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving efavirenz/lamivudine/tenofovir disoproxil fumarate.","longName":"SYMFI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA936B1D-74BD-6BA2-E053-4EBD850A5867","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353234","version":"1","preferredName":"Abacavir/Dolutegravir/Lamivudine Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving abacavir/dolutegravir/lamivudine.","longName":"TRIUMEQ_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA938624-3F05-6BA0-E053-4EBD850A1B90","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353289","version":"1","preferredName":"Lamivudine Tenofovir Disoproxil Fumarate Medication Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving lamivudine/tenofovir disoproxil fumarate.","longName":"CIMDUO_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA936B1D-7500-6BA2-E053-4EBD850A5867","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353294","version":"1","preferredName":"Elvitegravir Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving elvitegravir.","longName":"VITEKTA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA941C68-59E0-5C10-E053-4EBD850A7640","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7353303","version":"1","preferredName":"Ibalizumab Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving ibalizumab.","longName":"TROGARZO_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA941C68-5A06-5C10-E053-4EBD850A7640","latestVersionIndicator":"Yes","beginDate":"2020-07-16","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-16","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359811","version":"1","preferredName":"Adverse Event Expected Indicator","preferredDefinition":"An indicator of whether or not the adverse event was expected.","longName":"AEEXP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE0DB97-1DB9-18B2-E053-4EBD850ABF12","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359812","version":"1","preferredName":"Adverse Event Outcome Type","preferredDefinition":"The final status of the participant related to the adverse event.","longName":"AEOUT_SPD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE14828-0962-17FC-E053-4EBD850A104D","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359815","version":"1","preferredName":"Adverse Event Dose Reduced Indicator","preferredDefinition":"An indicator of whether or not the protocol treatment dose was reduced due to the adverse event.","longName":"DOSREDUC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE15B50-1606-17B5-E053-4EBD850A65AC","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359816","version":"1","preferredName":"Adverse Event Dose Interruption Indicator","preferredDefinition":"An indicator of whether or not the protocol treatment was interrupted due to the adverse event.","longName":"DOSDELAY","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE16854-DB9B-1857-E053-4EBD850A6991","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359817","version":"1","preferredName":"Adverse Event Dose Withdraw Indicator","preferredDefinition":"An indicator of whether or not the protocol treatment was withdrawn due to the adverse event.","longName":"DOSDISC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE04974-5E9E-6EFF-E053-4EBD850A3FAE","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359822","version":"1","preferredName":"Adverse Event Prescription Administration Indicator","preferredDefinition":"An indicator of whether or not a prescription medication was given as a result of the adverse event.","longName":"AETRTRX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE1837E-5C82-6EF9-E053-4EBD850A9B88","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7359823","version":"1","preferredName":"Adverse Event Over the Counter Product Administration Indicator","preferredDefinition":"An indicator of whether or not an over the counter medication was given as a result of the adverse event.","longName":"AETRTOTC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE19328-9075-1710-E053-4EBD850A1D26","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-20","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7365500","version":"1","preferredName":"Dolutegravir Lamivudine Medication Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving dolutegravir/lamivudine.","longName":"DOVATO_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB06C1C0-8D68-3D7E-E053-4EBD850A2906","latestVersionIndicator":"Yes","beginDate":"2020-07-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-22","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366305","version":"1","preferredName":"Darunavir Ethanolate/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate Administration Indicator","preferredDefinition":"Indicator of whether or not the participant is receiving darunavir ethanolate/cobicistat/emtricitabine/tenofovir alafenamide fumarate.","longName":"SYMTUZA_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1F3795-3F87-5080-E053-4EBD850A76DE","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-23","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366377","version":"1.1","preferredName":"Kaposi Sarcoma Related Edema Present Indicator","preferredDefinition":"information relating to the presence of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues)._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"KS_R/T_ED_PRES_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB72A103-3B10-4297-E053-4EBD850A790F","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-27","modifiedBy":"ALAIS","dateModified":"2020-07-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366445","version":"1","preferredName":"Concomitant Medication Domain Concomitant Medication Dose Unit Other Specify","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._The unit of measure for the concomitant medication dose._Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"OTHSP_CMDOSFRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB214814-0FA9-17B7-E053-4EBD850A40D1","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-23","modifiedBy":"ALAIS","dateModified":"2020-07-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366896","version":"1","preferredName":"First Disease Response Observed Indicator","preferredDefinition":"Information related to first the pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"RSORRES_FOBS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB31AD3F-B419-703D-E053-4EBD850AD306","latestVersionIndicator":"Yes","beginDate":"2020-07-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-24","modifiedBy":"ALAIS","dateModified":"2020-07-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366897","version":"1","preferredName":"First Disease Response Observed Date","preferredDefinition":"Information related to first pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._The date on which an observation was made or an event occurred.","longName":"RSDAT_FOBS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB32D7C3-9CDF-2495-E053-4EBD850A33CB","latestVersionIndicator":"Yes","beginDate":"2020-07-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-24","modifiedBy":"CLOHNES","dateModified":"2023-03-08","changeNote":null,"administrativeNotes":"3/8/23 added 1 alt OID for CCTG ticket request CADSR0002117 cjl; 2/23/23 added alt name, alt OID for CCTG ticket number CADSR0002081 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366901","version":"1","preferredName":"Disease Response Confirmation Date","preferredDefinition":"A domain for disease response evaluations._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Having been established or verified._The date on which an observation was made or an event occurred.","longName":"CONFIRM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB30FBAD-921C-7039-E053-4EBD850AA531","latestVersionIndicator":"Yes","beginDate":"2020-07-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-24","modifiedBy":"ALAIS","dateModified":"2020-07-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366902","version":"1","preferredName":"Disease Response Confirmation Indicator","preferredDefinition":"A domain for disease response evaluations._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Having been established or verified._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"CONFIRM_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB335736-AB49-23FA-E053-4EBD850A878B","latestVersionIndicator":"Yes","beginDate":"2020-07-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-24","modifiedBy":"ALAIS","dateModified":"2020-07-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7366916","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Disease Marker Anatomic Location Type","preferredDefinition":"information relating to the position or site on the body where a disease marker (specific characteristics that may simplify the diagnostic process or help track disease progression) malignant neoplasm of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) is present._Named locations of or within the body._Something distinguishable as an identifiable class based on common qualities.","longName":"PROGTYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AB335154-C9C1-23D7-E053-4EBD850A47D7","latestVersionIndicator":"Yes","beginDate":"2020-07-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-24","modifiedBy":"ALAIS","dateModified":"2020-07-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372115","version":"1","preferredName":"Kaposi Sarcoma Related Visceral Disease Assessment Indicator","preferredDefinition":"Indicator of whether or not an evaluation of visceral Kaposi sarcoma was performed.","longName":"QSYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB8224B8-89A2-5363-E053-4EBD850A543F","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372137","version":"1","preferredName":"Diagnostic Imaging Radiology Endoscopic Procedure Gastrointestinal Tract Evaluation Indicator","preferredDefinition":"Indicator of whether or not a diagnostic evaluation of the gastrointestinal tract was performed.","longName":"QSYN_GIEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB8224B8-8A97-5363-E053-4EBD850A543F","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372163","version":"1","preferredName":"Gastrointestinal Lesion Evaluation Status","preferredDefinition":"Text term(s) that represents the status of the gastrointestinal lesion evaluation.","longName":"QSORRES_GIEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB82B85A-CC92-300C-E053-4EBD850A7C82","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372178","version":"1","preferredName":"Radiology Evaluation Indicator","preferredDefinition":"Indicator of whether or not a radiological evaluation was performed.","longName":"RADIOL_GIEVAL_QSMETHOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB82DE54-E38E-5B28-E053-4EBD850AAEB6","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372190","version":"1","preferredName":"Endoscopic Procedure Evaluation Indicator","preferredDefinition":"Indicator of whether or not an endoscopic evaluation was performed.","longName":"ENDOSCPY_QSMETHOD_GIEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB829A82-0382-3149-E053-4EBD850A56B5","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372195","version":"1","preferredName":"Colonoscopy Evaluation Indicator","preferredDefinition":"Indicator of whether or not a colonoscopy evaluation was performed.","longName":"COLNSCPY_GIEVAL_QSMETHOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB8331A8-ED04-10D0-E053-4EBD850AA4B0","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372198","version":"1","preferredName":"Sigmoidoscopy Evaluation Indicator","preferredDefinition":"Indicator of whether or not a sigmoidoscopy evaluation was performed.","longName":"SGMDSCPY_GIEVAL_QSMETHOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB82A7DE-4B66-34D1-E053-4EBD850A48C9","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372206","version":"1","preferredName":"Gastrointestinal Evaluation Performed Indicator","preferredDefinition":"Indicator of whether or not a gastrointestinal evaluation was performed.","longName":"QSPERF_GIEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81F7D3-9D4E-2F79-E053-4EBD850A1FC4","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372390","version":"1","preferredName":"Gastrointestinal Lesion Confirmation Indicator","preferredDefinition":"An indicator of whether or not any gastrointestinal (GI) lesions were confirmed present.","longName":"QSPERF_CONF_GI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB82EBDA-8988-3460-E053-4EBD850A1FCF","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372436","version":"1","preferredName":"Diagnostic Imaging Radiology Pulmonary Evaluation Indicator","preferredDefinition":"Indicator of whether or not a diagnostic pulmonary evaluation was performed.","longName":"QSYN_PULEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB838C3F-DBF2-5B62-E053-4EBD850A7136","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372445","version":"1","preferredName":"Pulmonary Lesion Evaluation Status","preferredDefinition":"Text term(s) that represents the status of the pulmonary lesion evaluation.","longName":"QSORRES_PULEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB826125-0AF7-1106-E053-4EBD850AEB1E","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372448","version":"1","preferredName":"Chest Radiography Evaluation Indicator","preferredDefinition":"An indicator of whether or not a chest x-ray was performed.","longName":"QSMETHOD_XRAY","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB8434B6-ED5F-0D93-E053-4EBD850ABC0D","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372451","version":"1","preferredName":"Pleural Effusion Evaluation Indicator","preferredDefinition":"Indicator of whether or not a pleural effusion evaluation was performed.","longName":"QSMETHOD_PLEUREFF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB826125-0B1D-1106-E053-4EBD850AEB1E","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372454","version":"1","preferredName":"Computed Tomography Evaluation Indicator","preferredDefinition":"Indicator of whether or not a Computed Tomography (CT) scan evaluation was performed.","longName":"QSMETHOD_CT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB830DC9-AB83-32B6-E053-4EBD850A09BC","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372457","version":"1","preferredName":"Bronchoscopy Evaluation Indicator","preferredDefinition":"Indicator of whether or not a bronchoscopy evaluation was performed.","longName":"QSMETHOD_BRONCH","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB82978B-C14D-2F5C-E053-4EBD850AAE92","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372467","version":"1","preferredName":"Other Diagnostic Imaging Evaluation Indicator","preferredDefinition":"Indicator of whether or not another type of diagnostic imaging evaluation, not previously specified, was performed.","longName":"QSMETHOD_OTH","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB82EBDA-89CD-3460-E053-4EBD850A1FCF","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372478","version":"1","preferredName":"Other Diagnostic Imaging Evaluation Specify","preferredDefinition":"Text description of the other diagnostic imaging evaluation performed, not previously specified.","longName":"QSMETHOD_OTHSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB866789-A44D-207D-E053-4EBD850A0AB9","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"TSESU","dateModified":"2023-08-08","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/8/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372482","version":"1","preferredName":"Pulmonary Evaluation Performed Indicator","preferredDefinition":"Indicator of whether or not a pulmonary evaluation was performed.","longName":"QSPERF_PULEVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB838C3F-DC57-5B62-E053-4EBD850A7136","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372485","version":"1","preferredName":"Kaposi Sarcoma Lesion Assessment Count","preferredDefinition":"Numeric value used to describe the number of Kaposi sarcoma lesions.","longName":"TRORRES_TOTAL1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB86B82C-191C-26D4-E053-4EBD850ACE36","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7372492","version":"1","preferredName":"Kaposi Sarcoma Lesion Last Patient Visit Change Count","preferredDefinition":"Numeric value used to describe the number of new Kaposi sarcoma lesions compared to the last study visit.","longName":"TRORRES_NUMNEW1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB838C3F-DC7D-5B62-E053-4EBD850A7136","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373690","version":"1","preferredName":"Diagnostic Imaging Radiology Visceral Kaposi Sarcoma Evaluation Indicator","preferredDefinition":"Indicator of whether or not a diagnostic evaluation of visceral Kaposi sarcoma was performed.","longName":"QPERF_OTH","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB9638A6-7188-5999-E053-4EBD850A614A","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373698","version":"1","preferredName":"Visceral Kaposi Sarcoma Lesion Confirmation Indicator","preferredDefinition":"Indicator of whether or not visceral Kaposi sarcoma lesions were confirmed.","longName":"QSPERF_OTH_CONF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB95D502-D9FD-5993-E053-4EBD850AF047","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373703","version":"1","preferredName":"Visceral Kaposi Sarcoma Lesion Anatomic Location Specify","preferredDefinition":"Text description of the visceral Kaposi sarcoma lesion anatomic location.","longName":"QSLOC1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB95D502-DA23-5993-E053-4EBD850AF047","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373709","version":"1","preferredName":"Visceral Kaposi Sarcoma Lesion Evaluation Status","preferredDefinition":"Text term(s) that represents the status of the visceral Kaposi sarcoma lesion evaluation.","longName":"QSSORES_QSLOC1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB95D502-DA49-5993-E053-4EBD850AF047","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373842","version":"1","preferredName":"Tumor Largest Dimension Measurement","preferredDefinition":"Numeric value used to describe the largest tumor dimension measurement in millimeters.","longName":"DIMENSION1_TRORRES1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB990288-FFBE-4901-E053-4EBD850A42BB","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"SHEIKHM","dateModified":"2021-08-11","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373843","version":"1","preferredName":"Tumor Second Dimension Measurement","preferredDefinition":"Numeric value used to describe the tumor second dimension measurement in millimeters.","longName":"DIMENSION2_TRORRES1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB990DE6-2FE0-552D-E053-4EBD850A8599","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7373888","version":"1","preferredName":"Lesion Shape Change Indicator","preferredDefinition":"Indicator of whether or not the lesion has changed shape.","longName":"TUSPLFUS1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB9918BD-1223-6913-E053-4EBD850AB3CF","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374302","version":"1","preferredName":"Lesion Shape Change Type","preferredDefinition":"Text term that represents the type of lesion shape change.","longName":"TUCHANGE_SPEC1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB9C1942-2AD6-34DC-E053-4EBD850A797C","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374304","version":"1","preferredName":"Patient Photograph Malignant Neoplasm Assessment Indicator","preferredDefinition":"Indicator of whether or not photos were taken of the malignant neoplasm.","longName":"PHOTO_TUYN1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABA8A8D0-A54A-2C94-E053-4EBD850A9A75","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374710","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Cutaneous Assessment Indicator","preferredDefinition":"Indicator of whether or not an assessment of cutaneous Kaposi sarcoma malignant neoplasms was performed.","longName":"TUPERF_CUTLES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABADE1DE-FDD1-73AD-E053-4EBD850A3E00","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374760","version":"1","preferredName":"Kaposi Sarcoma Lesion Additional Information Specify","preferredDefinition":"Text description of additional information related to the Kaposi sarcoma lesion.","longName":"TUCHANGE_SPEC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABADD26C-7746-5F24-E053-4EBD850A9260","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374764","version":"1","preferredName":"New Kaposi Sarcoma Lesion Assessment Indicator","preferredDefinition":"Indicator of whether or not new Kaposi sarcoma lesions are identified during evaluation.","longName":"TUCHANGE_NEWLESION","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABAF197B-BABE-2D18-E053-4EBD850A0E33","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374765","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm New Count","preferredDefinition":"Number of new Kaposi sarcoma malignant neoplasms.","longName":"TRORRES_CHGNEW","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABAE91AE-6788-6DF6-E053-4EBD850A2CFB","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"COLLIED","dateModified":"2020-08-28","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374766","version":"1","preferredName":"Confirmed Response Observed Indicator","preferredDefinition":"Indicator of whether or not the participant had a confirmed response observed.","longName":"RESP_CRPR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABAF42BA-A430-585A-E053-4EBD850A8368","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374767","version":"1","preferredName":"Disease New Progression Indicator","preferredDefinition":"Indicator of whether or not the participant's disease has progressed since the previous assessment.","longName":"RESP_CRPR_CONF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABADA73C-61AA-5E5F-E053-4EBD850A4BE3","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-30","modifiedBy":"SHEIKHM","dateModified":"2021-01-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7378917","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Elevated Count","preferredDefinition":"Number of raised Kaposi sarcoma malignant neoplasms.","longName":"TRORRES_TOTRAISED1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC128F68-E788-5AE4-E053-4EBD850A585D","latestVersionIndicator":"Yes","beginDate":"2020-08-04","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-04","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7378925","version":"1","preferredName":"Kaposi Sarcoma Skin Plaque Or Nodule Lesion Percentage Change Value","preferredDefinition":"Numeric value that represents the percentage change of raised Kaposi sarcoma lesions.","longName":"TRORRES_PCHG1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC126D57-D51E-5AD8-E053-4EBD850A896F","latestVersionIndicator":"Yes","beginDate":"2020-08-04","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-04","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7378926","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Flat Quantity Lesion Count","preferredDefinition":"Number of flat Kaposi sarcoma malignant neoplasms.","longName":"TRORRES_NUMFLAT1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC12B449-6C15-28F6-E053-4EBD850A8794","latestVersionIndicator":"Yes","beginDate":"2020-08-04","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-04","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7378938","version":"1","preferredName":"Kaposi Sarcoma Negation Skin Plaque Or Nodule Lesion Percentage Change Percentage Value","preferredDefinition":"Numeric value that represents the percentage change in flat Kaposi sarcoma lesions.","longName":"TRORRES_PCHGFLAT1","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC12ED08-53A2-52B9-E053-4EBD850A6F5C","latestVersionIndicator":"Yes","beginDate":"2020-08-04","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-04","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7382376","version":"1","preferredName":"Kaposi Sarcoma Lesion Assessment Count","preferredDefinition":"Number of Kaposi sarcoma lesions.","longName":"NUMLES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC49F47C-7993-0715-E053-4EBD850A259D","latestVersionIndicator":"Yes","beginDate":"2020-08-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-07","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7382377","version":"1","preferredName":"Kaposi Sarcoma Lesion Last Patient Visit Change Count","preferredDefinition":"Number of new Kaposi sarcoma lesions since the last study visit.","longName":"TOTLNSLV","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC49FFC6-8817-0713-E053-4EBD850A06C5","latestVersionIndicator":"Yes","beginDate":"2020-08-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-07","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7385081","version":"1","preferredName":"Capsule Agent Taken Cycle Count","preferredDefinition":"information related to a pill in the form of a small rounded soluble container with medicine or an active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect having been taken._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence._Determining the number or amount of something.","longName":"ECDOSFRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AC7B3ED7-8410-2478-E053-4EBD850A2BA8","latestVersionIndicator":"Yes","beginDate":"2020-08-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-08-09","modifiedBy":"ALAIS","dateModified":"2020-08-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7385084","version":"1","preferredName":"Exposure as Collected Reduced Dose","preferredDefinition":"This interventions domain model reflects protocol-specified study treatment administrations, as collected._The amount of substance that the patient or test subject was exposed to at one time, or the total quantity administered._information related to reduced dose of treatments.","longName":"ECDOSE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AC7B5529-6BE1-29A0-E053-4EBD850AC1D8","latestVersionIndicator":"Yes","beginDate":"2020-08-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-08-09","modifiedBy":"ALAIS","dateModified":"2020-08-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7385516","version":"1","preferredName":"Clinical Events Domain Clinical Events Occurrence Indicator","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to clinical events._An indication or description of a clinical event occurrence._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"CEOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAF885C-76DB-10CB-E053-4EBD850A388A","latestVersionIndicator":"Yes","beginDate":"2020-08-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-08-12","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7404672","version":"1.1","preferredName":"Agent Day Administered Cycle Day Count","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._The act of having given something (e.g., a medication or test)._An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._Determining the number or amount of something.","longName":"ECDOSDY","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AF991B74-A486-1E42-E053-4EBD850A1B49","latestVersionIndicator":"Yes","beginDate":"2020-08-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-09-18","modifiedBy":"KUMMEROA","dateModified":"2023-02-03","changeNote":null,"administrativeNotes":"2023.2.3 AQT, Alt SN added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421334","version":"1","preferredName":"Negation Able to Remember Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not the participant forgot was the reason the visit was missed.","longName":"FORGOT_ REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5D77A4-656D-431B-E053-4EBD850A783F","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421335","version":"1","preferredName":"Health Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not health reasons were the reason the visit was missed.","longName":"HEALTH_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5D8444-9D6F-427A-E053-4EBD850A9634","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421337","version":"1","preferredName":"Occupation Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not occupation reasons were the reason the visit was missed.","longName":"WORK_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF4F3DA1-DBAB-4BDB-E053-4EBD850AAB44","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421338","version":"1","preferredName":"Transportation Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not transportation reasons were the reason the visit was missed.","longName":"TRANSPRT_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5D8BD4-9F9B-1953-E053-4EBD850AAE02","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421339","version":"1","preferredName":"Unhappy With Schedule Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not the participant being unhappy with the visit schedule was the reason the visit was missed.","longName":"FRQVISIT_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5D8444-9D96-427A-E053-4EBD850A9634","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421340","version":"1","preferredName":"Schedule Difficulty Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not scheduling difficulties were the reason the visit was missed.","longName":"DIFSCHED_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5D8444-9DBD-427A-E053-4EBD850A9634","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421341","version":"1","preferredName":"Discontinue Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not study discontinuation was the reason the visit was missed.","longName":"DISCON_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF4F4E70-D44B-4A7B-E053-4EBD850AA10C","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421344","version":"1","preferredName":"Adverse Event Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not an adverse event was the reason the visit was missed.","longName":"AE_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF4F4E70-D472-4A7B-E053-4EBD850AA10C","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421346","version":"1","preferredName":"Other Reason Participant Absent Visit Indicator","preferredDefinition":"An indicator of whether or not other reason(s) were the reason the visit was missed.","longName":"OTH_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5D5E06-BF58-05C6-E053-4EBD850A8702","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421347","version":"1","preferredName":"Patient Schedule Next Visit Indicator","preferredDefinition":"An indicator of whether or not the next visit has been scheduled.","longName":"VISTSCHD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF5CE79A-F344-7324-E053-4EBD850A2BA8","latestVersionIndicator":"Yes","beginDate":"2020-09-15","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-09-15","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507168","version":"1","preferredName":"Patient Current Sex Behavior Assessment Not Sexually Active Indicator","preferredDefinition":"information related to the patient's assessment of satisfaction with current sexual activity._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"PT_CSCB_ASS_NSA_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B45D6AEF-5FD3-0F85-E053-4EBD850AD7D5","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-18","modifiedBy":"COLLIED","dateModified":"2021-01-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507325","version":"1","preferredName":"Kaposi Sarcoma Related Periorbital Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues)._Occurring in, or located in the area around the orbit of the eye._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_PO_ED_ASSES_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B474716A-8E87-3897-E053-4EBD850AA152","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507326","version":"1","preferredName":"Kaposi Sarcoma Related Genitalia Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related genitalia (the external sex organs) edema (pathological transudate within one or more tissues)._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_GE_ED_ASS_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46A7FE3-5834-1B5B-E053-4EBD850A0C72","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507327","version":"1","preferredName":"Kaposi Sarcoma Related Genitalia Edema Assessment Findings Text","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related genitalia (the external sex organs) edema (pathological transudate within one or more tissues)._Descriptive text used to enumerate additional non-coded pathologic observations._The words of something written.","longName":"KS_R/T_GE_ED_ASS_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B47503D9-B5D8-4411-E053-4EBD850A1787","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507328","version":"1","preferredName":"Kaposi Sarcoma Related Periorbital Edema Assessment Findings Text","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues)._Occurring in, or located in the area around the orbit of the eye._Descriptive text used to enumerate additional non-coded pathologic observations._The words of something written.","longName":"KS_R/T_PO_ED_ASSES_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B4750763-E189-40B1-E053-4EBD850AFBFA","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507362","version":"1","preferredName":"Kaposi Sarcoma Related Limb Ankle Joint Left Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI)_Being or located on or directed toward the side of the body to the west when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_AL_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B465E6E8-DC31-0328-E053-4EBD850A758C","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507363","version":"1","preferredName":"Kaposi Sarcoma Related Limb Ankle Joint Right Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus._Being or located on or directed toward the side of the body to the east when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_AR_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46B5F7D-5E8F-4312-E053-4EBD850A5ED7","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507364","version":"1","preferredName":"Kaposi Sarcoma Related Limb Calf Left Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI)_Being or located on or directed toward the side of the body to the west when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_CL_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46AA827-3946-1B5D-E053-4EBD850A31EF","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507365","version":"1","preferredName":"Kaposi Sarcoma Related Limb Calf Right Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI)_Being or located on or directed toward the side of the body to the east when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_CR_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46B40C0-3CD8-4395-E053-4EBD850AF2F2","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507366","version":"1","preferredName":"Kaposi Sarcoma Related Limb Foot Left Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The entire structure distal to the ankle joint/tarsus, which includes the metatarsus and digit(s)._Being or located on or directed toward the side of the body to the west when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_FL_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B474F7A1-32DB-3D66-E053-4EBD850AE643","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507367","version":"1","preferredName":"Kaposi Sarcoma Related Limb Foot Right Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The entire structure distal to the ankle joint/tarsus, which includes the metatarsus and digit(s)._Being or located on or directed toward the side of the body to the east when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_FR_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46A7FE3-5880-1B5B-E053-4EBD850A0C72","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507368","version":"1","preferredName":"Kaposi Sarcoma Related Limb Arm Left Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The portion of the upper extremity between the shoulder and the elbow._Being or located on or directed toward the side of the body to the west when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_ARL_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46A7FE3-58A1-1B5B-E053-4EBD850A0C72","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507369","version":"1","preferredName":"Kaposi Sarcoma Relationship Limb Arm Right Edema Assessment Yes No Indicator","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A state of connectedness between people, objects, or events; to be associated or connected with something._A body region referring to an upper or lower extremity._The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb._Accumulation of an excessive amount of fluid in cells or intercellular tissues._The final result of a determination of the value, significance, or extent of._Being or located on or directed toward the side of the body to the east when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_ARR_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B474716A-8EAC-3897-E053-4EBD850AA152","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507370","version":"1","preferredName":"Kaposi Sarcoma Related Limb Hand Left Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI)_Being or located on or directed toward the side of the body to the west when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_HL_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46B5C80-DB1F-44F7-E053-4EBD850AC19A","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507371","version":"1","preferredName":"Kaposi Sarcoma Related Limb Hand Right Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI)_Being or located on or directed toward the side of the body to the east when facing north._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_HR_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B47503D9-B5FC-4411-E053-4EBD850A1787","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507372","version":"1","preferredName":"Kaposi Sarcoma Related Limb Other Edema Assessment Yes No Indicator","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._Different than the one(s) previously specified or mentioned. (NCI)_The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"KS_R/T_L_O_ED_ASE_IND2","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B47503D9-B61D-4411-E053-4EBD850A1787","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507373","version":"1","preferredName":"Kaposi Sarcoma Related Limb Other Edema Assessment Specify","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._Different than the one(s) previously specified or mentioned. (NCI)_Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"KS_R/T_L_O_ED_ASE_SPEC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46AA827-3967-1B5D-E053-4EBD850A31EF","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507374","version":"1","preferredName":"Kaposi Sarcoma Related Limb Ankle Joint Left Edema Assessment Circumference Value","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI)_Being or located on or directed toward the side of the body to the west when facing north._The length of the closed curve of a circle; the size of something as given by the distance around it._A numerical quantity measured or assigned or computed.","longName":"KS_R/T_L_AL_ED_ASE_CIR_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B474F7A1-32FC-3D66-E053-4EBD850AE643","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507375","version":"1","preferredName":"Kaposi Sarcoma Related Limb Ankle Joint Right Edema Assessment Circumference Value","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus._Being or located on or directed toward the side of the body to the east when facing north._The length of the closed curve of a circle; the size of something as given by the distance around it._A numerical quantity measured or assigned or computed.","longName":"KS_R/T_L_AR_ED_ASE_CIR_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46AA827-3988-1B5D-E053-4EBD850A31EF","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507376","version":"1","preferredName":"Kaposi Sarcoma Related Limb Calf Left Edema Assessment Circumference Value","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI)_Being or located on or directed toward the side of the body to the west when facing north._The length of the closed curve of a circle; the size of something as given by the distance around it._A numerical quantity measured or assigned or computed.","longName":"KS_R/T_L_CL_ED_ASE_CIR_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46B40C0-3CF9-4395-E053-4EBD850AF2F2","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507377","version":"1","preferredName":"Kaposi Sarcoma Related Limb Calf Right Edema Assessment Circumference Value","preferredDefinition":"information relating to an assessment of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related limb (a body region referring to an upper or lower extremity) edema (pathological transudate within one or more tissues)._The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI)_Being or located on or directed toward the side of the body to the east when facing north._The length of the closed curve of a circle; the size of something as given by the distance around it._A numerical quantity measured or assigned or computed.","longName":"KS_R/T_L_CR_ED_ASE_CIR_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B46AA827-39A9-1B5D-E053-4EBD850A31EF","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-11-19","modifiedBy":"ALAIS","dateModified":"2020-11-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7524704","version":"1","preferredName":"Complete Response First Observed Indicator","preferredDefinition":"Indicator of whether or not a complete response was first observed.","longName":"CR_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B593A328-A10F-0894-E053-4EBD850A1F1A","latestVersionIndicator":"Yes","beginDate":"2020-12-04","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-12-04","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544966","version":"1","preferredName":"Partial Response First Observed Indicator","preferredDefinition":"Indicator of whether or not a partial response was first observed.","longName":"PR_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B84276FE-6360-7C68-E053-4EBD850A34AC","latestVersionIndicator":"Yes","beginDate":"2021-01-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-06","modifiedBy":"SHEIKHM","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7545080","version":"1","preferredName":"Central Nervous System Progression Indicator","preferredDefinition":"Indicator of whether or not there has been central nervous system progression","longName":"CNSPROG_CEOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8567C56-5607-29DD-E053-4EBD850A3A8E","latestVersionIndicator":"Yes","beginDate":"2021-01-07","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-07","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7545082","version":"1","preferredName":"Leptomeninges CNS Involved Indicator","preferredDefinition":"Indicator of whether or not there has been progression into the leptomeninges","longName":"LEPTO_CNSPROG_CEOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8569AE5-021F-584B-E053-4EBD850AAFB4","latestVersionIndicator":"Yes","beginDate":"2021-01-07","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-07","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7545083","version":"1","preferredName":"Brain Parenchyma Involved Indicator","preferredDefinition":"Indicator of whether or not there has been progression into the parenchyma","longName":"PAREN_CNSPROG_CEOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8555E6B-51CD-7686-E053-4EBD850AEE62","latestVersionIndicator":"Yes","beginDate":"2021-01-07","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-07","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7551858","version":"1","preferredName":"Measurable Disease Present Indicator","preferredDefinition":"Indicator of whether or not measurable disease is present.","longName":"MEASDS_TUYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B95989AC-73A3-3A42-E053-4EBD850ADA3B","latestVersionIndicator":"Yes","beginDate":"2021-01-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-20","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7551859","version":"1","preferredName":"Target Lesion Identification Follow-up Assessment Indicator","preferredDefinition":"Indicator of whether or not the target lesion was assessed at a follow-up visit.","longName":"TUPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9587223-85DD-5FEA-E053-4EBD850A59AF","latestVersionIndicator":"Yes","beginDate":"2021-01-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-20","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7551864","version":"1","preferredName":"Target Lesion Present Indicator","preferredDefinition":"Indicator of whether or not target lesion/s are present.","longName":"IDENT_TUYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B95A0828-7615-3671-E053-4EBD850AEF3D","latestVersionIndicator":"Yes","beginDate":"2021-01-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-20","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7551870","version":"1","preferredName":"Malignant Neoplasm Complete Remission Observed Indicator","preferredDefinition":"An indicator of whether or not a complete remission of the malignant neoplasm was observed.","longName":"RESOL_TUYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9590FBB-DD69-63E5-E053-4EBD850AA122","latestVersionIndicator":"Yes","beginDate":"2021-01-20","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-20","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552131","version":"1","preferredName":"Positron Emission Tomography Diagnostic Imaging Assessment Indicator","preferredDefinition":"Indicator of whether or not a Positron Emission Tomography (PET) diagnostic imaging assessment was performed.","longName":"PET_PRPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96C07D4-F12D-5BAB-E053-4EBD850A44EA","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curate for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552142","version":"1","preferredName":"Nontarget Lesion Present Indicator","preferredDefinition":"Indicator of whether or not a nontarget lesion is present.","longName":"NTARGET_TUMIDENT_TUORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96B9AB4-3636-57CF-E053-4EBD850A4958","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"KUMMEROA","dateModified":"2023-08-11","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":"2023.8.11 AQTs added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552171","version":"1","preferredName":"New Non-Target Lesion Present Indicator","preferredDefinition":"Indicator of whether or not new nontarget lesion/s are present.","longName":"LESIDENT_TUORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96DB94D-2DE4-463C-E053-4EBD850A7875","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552187","version":"1","preferredName":"Organ Enlargement Present Indicator","preferredDefinition":"Indicator of whether or not organ enlargement is present.","longName":"ORSTATE_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96EE2FC-E508-4D7B-E053-4EBD850A4D5B","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552197","version":"1","preferredName":"Organ Enlargement Present Anatomic Site","preferredDefinition":"Text term (or description) that represents the anatomic site of organ enlargement.","longName":"ORSTATE_ORGIDENT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96DB94D-2E8E-463C-E053-4EBD850A7875","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552203","version":"1","preferredName":"Organ Enlargement Present Anatomic Site Specify","preferredDefinition":"Text description of the anatomic site, not previously specified, where organ enlargement is present.","longName":"OTHSP_ORSTATE_ORGIDENT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96F5AD5-CB4C-47A2-E053-4EBD850AD8D8","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552209","version":"1","preferredName":"Baseline Splenomegaly Present Indicator","preferredDefinition":"Indicator of whether or not spleen enlargement is present.","longName":"BSL_SPLEEN_ORSTATE_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96F7692-D887-46FB-E053-4EBD850A94C5","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552223","version":"1","preferredName":"Splenomegaly Change Category","preferredDefinition":"Text term that represents the spleen enlargement change category.","longName":"BSL_SPLEEN_ACHBSL_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96FA24B-769D-4AF5-E053-4EBD850AAFF3","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-21","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7553270","version":"1","preferredName":"Splenomegaly Present Indicator","preferredDefinition":"Indicator of whether or not spleen enlargement was observed.","longName":"VISIT_SPLEEN_ORSTATE_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97E0372-20C5-49B4-E053-4EBD850A59AD","latestVersionIndicator":"Yes","beginDate":"2021-01-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-22","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7553274","version":"1","preferredName":"Baseline Splenomegaly Increase Indicator","preferredDefinition":"An indicator of whether or not spleen enlargement has increased since baseline.","longName":"7553273v1.0:6343337v1.0","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B98346B9-C872-5DFC-E053-4EBD850AAE2B","latestVersionIndicator":"Yes","beginDate":"2021-01-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":"2023.8.31 Alt Name added per ticket request CADSR0002801. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7553284","version":"1","preferredName":"Baseline Hepatomegaly Present Indicator","preferredDefinition":"Indicator of whether or not liver enlargement was observed at baseline.","longName":"BSL_LIVER_ORSTATE_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9841900-DA5C-5A88-E053-4EBD850A0641","latestVersionIndicator":"Yes","beginDate":"2021-01-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-22","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7553744","version":"1","preferredName":"Excision Surgical Procedure Referral Indicator","preferredDefinition":"Indicator of whether or not the participant was referred for surgical excision","longName":"SURGRFR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97E9F27-3F9A-5E39-E053-4EBD850AB8CC","latestVersionIndicator":"Yes","beginDate":"2021-01-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-22","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7553745","version":"1","preferredName":"Surgical Procedure Complete Excision Performed Indicator","preferredDefinition":"Indicator of whether or not a complete excision was performed","longName":"LESNRMV","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97FF912-8756-5D8F-E053-4EBD850AD8F9","latestVersionIndicator":"Yes","beginDate":"2021-01-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-22","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7556990","version":"1","preferredName":"Hepatomegaly Change Category","preferredDefinition":"Text term that represents the organ change category.","longName":"BSL_LIVER_ACHBSL_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2E8AA-1B2C-57AD-E053-4EBD850A6145","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-26","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7556991","version":"1","preferredName":"Liver Enlargement Present Indicator","preferredDefinition":"Indicator of whether or not liver enlargement was observed.","longName":"VISIT_LIVER_ORSTATE_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2F5D8-AE9C-401F-E053-4EBD850ADCEA","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-26","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7556995","version":"1","preferredName":"Baseline Hepatomegaly Increase Indicator","preferredDefinition":"An indicator of whether or not liver enlargement has occurred since baseline.","longName":"NBSL_LIVER_ACHBSL_TRORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D308C4-B3D5-51C8-E053-4EBD850ACE8A","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-26","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7556996","version":"1","preferredName":"Bone Marrow Biopsy Indicator","preferredDefinition":"Indicator of whether or not a bone marrow biopsy was performed.","longName":"BMBX_PRPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D31365-A90E-4D92-E053-4EBD850A7D02","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-26","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7556998","version":"1","preferredName":"Lymphomatous Involvement of Extranodal Site Bone Marrow Present Indicator","preferredDefinition":"Indicator of whether or not the participant had lymphomatous involvement of the bone marrow.","longName":"MARROW_TUMIDENT_TUORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D31FCC-8EEB-53FB-E053-4EBD850A93A6","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-01-26","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7557192","version":"1","preferredName":"Procedure Biopsy Not Done Reason Type","preferredDefinition":"The explanation given as to why a biopsy was not completed.","longName":"REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D39EFD-B20E-4E02-E053-4EBD850A7ADB","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-26","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7559804","version":"1","preferredName":"Anal Biopsy Performed Count","preferredDefinition":"Numeric value used to describe the number of anal biopsies performed","longName":"BXNUM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9E63053-A380-6D3C-E053-4EBD850A5982","latestVersionIndicator":"Yes","beginDate":"2021-01-27","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-01-27","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7574302","version":"1","preferredName":"Lesion Malignant Neoplasm Indicator","preferredDefinition":"Indicator of whether or not any lesions were suspicious of cancer","longName":"CNCRYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA5E07B7-B0EF-324D-E053-4EBD850A4AC9","latestVersionIndicator":"Yes","beginDate":"2021-02-02","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-02","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576154","version":"1","preferredName":"Digital Rectal Examination Normal Assessment Indicator","preferredDefinition":"Indicator of whether or not a digital rectal examination had normal or standard results","longName":"DARENRML","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAE9D8A3-B67D-0696-E053-4EBD850A4B39","latestVersionIndicator":"Yes","beginDate":"2021-02-09","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-09","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576479","version":"1","preferredName":"Anal Endoscopy Diagnostic Procedure Physical Examination Indicator","preferredDefinition":"Indicator of whether or not an assessment or evaluation to diagnose disease through an anal endoscopic examination was performed","longName":"PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB01BBEE-C3B1-64B9-E053-4EBD850AAA1A","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576492","version":"1","preferredName":"Patient Negation Anal Endoscopic Procedure Not Done Reason","preferredDefinition":"Reason why an anal endoscopic procedure was not performed.","longName":"RESHRAND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB025557-D2C6-401E-E053-4EBD850AFDE1","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576493","version":"1","preferredName":"Anus Papilla Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not the existence of anal papilla was an abnormal finding","longName":"ANPAP_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB028240-1554-49DD-E053-4EBD850AD6F9","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576497","version":"1","preferredName":"Anal Condyloma Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not an anal condyloma is an abnormal finding","longName":"WRTNOD_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB02B5EC-77A5-60C2-E053-4EBD850AF652","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576502","version":"1","preferredName":"Cellular Granularity Present Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not the presence of cellular granularity in a tissue sample is an abnormal finding","longName":"GRANUL_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB02CDDF-AE83-5056-E053-4EBD850A58B4","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576506","version":"1","preferredName":"Increase Thickness Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not the presence of increased thickness is an abnormal finding","longName":"THICKEN_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB02E324-A196-43A3-E053-4EBD850ADFC8","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576510","version":"1","preferredName":"Induration Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not the presence of induration is an abnormal finding","longName":"INDUR_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB02C0C3-235A-47BD-E053-4EBD850AE19F","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576513","version":"1","preferredName":"Ulcer Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not the presence of an ulcer is an abnormal finding","longName":"ULCER_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB015899-06F9-62CE-E053-4EBD850A2BB3","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576517","version":"1","preferredName":"Hard Mass Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not a hard mass is an abnormal finding","longName":"MASS_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB02D888-EC0E-3DF2-E053-4EBD850A0946","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576520","version":"1","preferredName":"Other Abnormal Finding Indicator","preferredDefinition":"Indicator of whether or not there is another abnormal finding","longName":"OTH_PEORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB02C0C3-239D-47BD-E053-4EBD850AE19F","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-02-10","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7580727","version":"1","preferredName":"Patient Skin Tissue Donor Consent Indicator","preferredDefinition":"Indicator of whether or not the patient consented to donation of skin tissue.","longName":"FTRUSBX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ED567-8E48-695A-E053-4EBD850A1CE9","latestVersionIndicator":"Yes","beginDate":"2021-02-18","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-18","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582635","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Diagnosis Indicator","preferredDefinition":"An indicator of whether or not the participant was diagnosed with Acquired Immunodeficiency Syndrome (AIDS).","longName":"AIDS_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF0179D-BF6E-06C4-E053-4EBD850A1453","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582644","version":"1","preferredName":"Prior Systemic Chemotherapy Or Radiation Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not prior systemic chemotherapy or radiation therapy was administered.","longName":"CHEMRAD_TRTYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF16E5C-C356-7FBE-E053-4EBD850A5B68","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582649","version":"1","preferredName":"Anus High Grade Squamous Intraepithelial Neoplasia Diagnosis Date","preferredDefinition":"The date on which an anal high-grade squamous intraepithelial lesion (HSIL) was diagnosed.","longName":"AHSIL_MHSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF189AC-B7A1-235A-E053-4EBD850ABB50","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582652","version":"1","preferredName":"Anus High Grade Squamous Intraepithelial Neoplasia Prior Therapeutic Procedure Indicator","preferredDefinition":"Indicator of whether or not prior therapy for anal high-grade squamous intraepithelial lesions was received.","longName":"AHSIL_TRTYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF1CC8B-7C2F-7B92-E053-4EBD850A0823","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582656","version":"1","preferredName":"Prior Randomization Therapeutic Procedure Month Number","preferredDefinition":"Number of months the therapeutic procedure occurred prior to randomization.","longName":"AHSIL_TRTVINTX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF1E691-DE3A-2CA7-E053-4EBD850A07A3","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"TSESU","dateModified":"2021-09-10","changeNote":"Curated for AMC-112 protocol DC; 9/10/2021 - revised special character \" to display properly in caDSR. smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582657","version":"1","preferredName":"Anus High Grade Squamous Intraepithelial Neoplasia Prior Therapeutic Procedure Number","preferredDefinition":"Number of prior therapeutic procedures for anal high-grade squamous intraepithelial lesions (HSIL) the participant has received.","longName":"AHSIL_TRTNUM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF1E691-DE61-2CA7-E053-4EBD850A07A3","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"TSESU","dateModified":"2021-09-10","changeNote":"Curated for AMC-112 protocol DC;  9/10/2021 - revised special character \" to display properly in caDSR. smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582661","version":"1","preferredName":"Prior Anus Cytology Performed Indicator","preferredDefinition":"Indicator of whether or not prior anal cytology was performed.","longName":"CYTOL_MIPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF1CC8B-7C56-7B92-E053-4EBD850A0823","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582665","version":"1","preferredName":"Prior Anus Or Perianal Region Biopsy Performed Indicator","preferredDefinition":"Indicator of whether or not a prior anal or perianal biopsy was performed.","longName":"PRPERF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF26F4E-AA44-61B8-E053-4EBD850A93D6","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7582680","version":"1","preferredName":"Laboratory Test Result Documented Type","preferredDefinition":"Text term that represents the document type used to report the laboratory test results.","longName":"LBSRC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF30891-9EC8-1A4E-E053-4EBD850A845D","latestVersionIndicator":"Yes","beginDate":"2021-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-22","modifiedBy":"TSESU","dateModified":"2023-08-09","changeNote":"Curated for AMC-112 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7584369","version":"1","preferredName":"Protocol Treatment Course Start Date","preferredDefinition":"The date on which the protocol treatment course began.","longName":"CYCSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC046E9F-A167-5553-E053-4EBD850A66B3","latestVersionIndicator":"Yes","beginDate":"2021-02-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-23","modifiedBy":"COLLIED","dateModified":"2021-06-10","changeNote":"Curated for AMC-108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7584372","version":"1","preferredName":"Protocol Treatment Course End Date","preferredDefinition":"The date on which the protocol treatment course ended.","longName":"CYCENDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC04352F-EEF2-7947-E053-4EBD850A8067","latestVersionIndicator":"Yes","beginDate":"2021-02-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-02-23","modifiedBy":"COLLIED","dateModified":"2021-06-10","changeNote":"Curated for AMC-108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601842","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma Morphology Other Specify","preferredDefinition":"Text description of other information relating to the morphology of diffuse large B-cell lymphoma.","longName":"OTHSP_DLBCL_MORPHTYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDABBD9C-8986-7C38-E053-4EBD850A07E1","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-16","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604171","version":"1","preferredName":"International Prognostic Index Patient Age Assessment Indicator","preferredDefinition":"Indicator of whether or not a participant is above 60 years of age, used in calculating the International Prognostic Index (a list of five factors that help doctors assess how a non-Hodgkins lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy).","longName":"AGE_IPI_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAC5877-CF37-0DE6-E053-4EBD850A7F9A","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-16","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604638","version":"1","preferredName":"International Prognostic Index Patient Stage Assessment Indicator","preferredDefinition":"Indicator of whether or not a patient is at a certain disease stage, used in calculating the International Prognostic Index (a list of five factors that help doctors assess how a non-Hodgkins lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy).","longName":"STAGE_IPI_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBE1D4A-7616-3F43-E053-4EBD850A5FEF","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604642","version":"1","preferredName":"International Prognostic Index Patient Lactate Dehydrogenase Assessment Indicator","preferredDefinition":"Indicator of whether or not a patient's serum LDG is elevated, used in calculating the International Prognostic Index (a list of five factors that help doctors assess how a non-Hodgkins lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy).","longName":"LDH_IPI_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBFE4E7-4FBE-73E5-E053-4EBD850A9E8D","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604643","version":"1","preferredName":"International Prognostic Index Patient Performance Status 2-4 Assessment Indicator","preferredDefinition":"Indicator of whether or not a patient's assessment of ECOG performance status, used in calculating the International Prognostic Index (a list of five factors that help doctors assess how a non-Hodgkins lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy) is between 2-4.","longName":"ECOG_IPI_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDC07DDE-FB4F-07DE-E053-4EBD850AF5B8","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604664","version":"1","preferredName":"International Prognostic Index Patient Extranodal Disease Assessment Indicator","preferredDefinition":"Indicator of whether or not a patient has two or more extranodal disease sites, used in calculating the International Prognostic Index (a list of five factors that help doctors assess how a non-Hodgkins lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy).","longName":"DSSITE_IPI_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDC1E584-65DC-21BC-E053-4EBD850AD1E5","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604669","version":"1","preferredName":"Lymphomatous Involvement of Extranodal Site Testis Present Indicator","preferredDefinition":"Indicator of whether or not there is extranodal lymphomatous spread to the testes.","longName":"TESTES_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDC24474-8C5E-6070-E053-4EBD850A470E","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604674","version":"1","preferredName":"Lymphomatous Involvement of Extranodal Site Paranasal Sinus Present Indicator","preferredDefinition":"Indicator of whether or not there is extranodal lymphomatous spread to the paranasal sinuses.","longName":"SINUS_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDC261D5-C150-5EDF-E053-4EBD850A10C8","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604675","version":"1","preferredName":"Lymphomatous Involvement of Extranodal Site Multiple Site Present Indicator","preferredDefinition":"Indicator of whether or not there is extranodal lymphomatous spread to two or more extranodal sites.","longName":"EXTRNODL_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDC26D3C-28B1-6306-E053-4EBD850ADD1D","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604676","version":"1","preferredName":"Lymphomatous Involvement of Extranodal Site Epidural Spinal Canal Space Present Indicator","preferredDefinition":"Indicator of whether or not there is extranodal lymphomatous spread to the epidural space.","longName":"EPIDURAL_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDC26D3C-28D8-6306-E053-4EBD850ADD1D","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-17","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607315","version":"1","preferredName":"Lymphoma Sweating Symptom Indicator","preferredDefinition":"The indicator related to whether or not a participant experiences the lymphoma symptom of sweating.","longName":"SWEAT_OCCUR_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDD66CD5-1522-1208-E053-4EBD850A3022","latestVersionIndicator":"Yes","beginDate":"2021-03-18","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-18","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607316","version":"1","preferredName":"Lymphoma Fever Symptom Indicator","preferredDefinition":"The indicator related whether or not a participant experiences the lymphoma symptom of fever.","longName":"FEVER_OCCUR_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDD67649-C344-39BE-E053-4EBD850A205D","latestVersionIndicator":"Yes","beginDate":"2021-03-18","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-18","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607317","version":"1","preferredName":"Lymphoma Weight Loss Indicator","preferredDefinition":"The indicator related to whether or not a patient with lymphoma has experienced weight loss.","longName":"WGHTLOSS_OCCUR_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDD68016-4FD4-106E-E053-4EBD850AEB8B","latestVersionIndicator":"Yes","beginDate":"2021-03-18","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-18","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607413","version":"1","preferredName":"Specimen KSHV Inflammatory Cytokine Syndrome Assay Collection Indicator","preferredDefinition":"Indicator of whether or not a specimen was collected for Kaposi Sarcoma-Associated Herpesvirus (KSHV) assay.","longName":"PRETRT_CYTOKINE_COLYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDE45D26-1F10-4FD8-E053-4EBD850AE7B4","latestVersionIndicator":"Yes","beginDate":"2021-03-19","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-19","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607425","version":"1","preferredName":"Specimen KSHV Inflammatory Cytokine Syndrome Assay Negation Collection Reason","preferredDefinition":"Text used to describe the reason why a specimen was not collected for Kaposi Sarcoma-Associated Herpesvirus (KSHV) assay.","longName":"PRETRT_CYTOKINE_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDE4AFF4-928A-5113-E053-4EBD850AC7D3","latestVersionIndicator":"Yes","beginDate":"2021-03-19","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-19","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607426","version":"1","preferredName":"Specimen KSHV Inflammatory Cytokine Syndrome Assay Negation Collection Other Specify Text","preferredDefinition":"Text term that describes the other reason a specimen was not collected for Kaposi Sarcoma-Associated Herpesvirus (KSHV) assay.","longName":"OTHSP_PRETRT_CYTOKINE_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDE45D26-1F37-4FD8-E053-4EBD850AE7B4","latestVersionIndicator":"Yes","beginDate":"2021-03-19","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-19","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607427","version":"1","preferredName":"Burkitt's Lymphoma Morphology Diagnosis Specify","preferredDefinition":"Text description of morphological type of Burkitt's lymphoma/leukemia not previously specified.","longName":"OTHSP_BL_MORPHTYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBFFF3B-9993-1400-E053-4EBD850AE34C","latestVersionIndicator":"Yes","beginDate":"2021-03-19","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-19","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607677","version":"2","preferredName":"Specimen Neoplasm Microarray Analysis Collection Indicator","preferredDefinition":"Indicator of whether or not a specimen was collected for neoplasm microarray analysis.","longName":"NEOP_MICATTY_CLLCT_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"00396E99-1D86-2FBB-E063-731AD00AC501","latestVersionIndicator":"Yes","beginDate":"2021-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"TSESU","dateModified":"2023-07-14","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607678","version":"1","preferredName":"Specimen Neoplasm Microarray Analysis Negation Collection Reason","preferredDefinition":"Text used to describe the reason why a specimen was not collected for neoplasm microarray analysis.","longName":"PRETRT_TUMARRY_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE22B628-BF09-037F-E053-4EBD850A6B1B","latestVersionIndicator":"Yes","beginDate":"2021-03-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7607732","version":"1","preferredName":"Specimen Neoplasm Microarray Analysis Negation Collection Other Specify Text","preferredDefinition":"Text term that describes the other reason why a specimen was not collected for neoplasm microarray analysis.","longName":"OTHSP_PRETRT_TUMARRY_REASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE220ACF-B2FF-40C3-E053-4EBD850A6DF5","latestVersionIndicator":"Yes","beginDate":"2021-03-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-22","modifiedBy":"LEEW","dateModified":"2021-12-03","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619460","version":"1","preferredName":"Neprilysin Biomarker Analysis Laboratory Finding Result","preferredDefinition":"The laboratory testing result for the CD10 biomarker","longName":"CD10_MIORRES&nbsp;","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB0BB54-DBD3-13EF-E053-4EBD850A8B07","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619467","version":"1","preferredName":"B-Cell Lymphoma 6 Protein Biomarker Analysis Laboratory Finding Result","preferredDefinition":"The laboratory testing result for the B-cell lymphoma 6 protein biomarker","longName":"BCL6_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB0FC18-4DCA-1CE4-E053-4EBD850A1DFA","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for protocol 112 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619502","version":"1","preferredName":"Interferon Regulatory Factor 4 Biomarker Analysis Laboratory Finding Result","preferredDefinition":"The laboratory testing result for interferon regulatory factor 4, encoded by the human IRF4 gene","longName":"MUM1_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB1EBEE-0DD7-3378-E053-4EBD850A8152","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619503","version":"1","preferredName":"FOXP1 Gene Laboratory Biomarker Analysis Laboratory Finding Result","preferredDefinition":"The laboratory testing result for the FOXP1 gene, which is involved in transcriptional modulation","longName":"FOXP1_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB1DBDD-5204-214F-E053-4EBD850AB9BD","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619504","version":"1","preferredName":"SERPINA9 Gene Biomarker Analysis Laboratory Finding Result","preferredDefinition":"The laboratory testing result for the SERPINA9 gene, which is involved in trypsin activity regulation","longName":"GCET1_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB2025C-8686-6462-E053-4EBD850AE72C","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619505","version":"1","preferredName":"B-Lymphocyte Antigen CD20 Biomarker Analysis Laboratory Finding Result","preferredDefinition":"The laboratory testing result for the B-lymphocyte antigen CD20, which is encoded by the human MS4A1 gene","longName":"CD20_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB2025C-86AF-6462-E053-4EBD850AE72C","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619670","version":"1","preferredName":"Lymph Node Progression Criteria Assessment Indicator","preferredDefinition":"Indicator of whether or not there has been progression based on lymph node criteria","longName":"LYMINVLV_OCCUR_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEB1DBDD-5234-214F-E053-4EBD850AB9BD","latestVersionIndicator":"Yes","beginDate":"2021-03-29","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-29","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7619729","version":"1","preferredName":"Lymphoma Lymph Node Large Diameter Lymph Node Diameter Large Indicator","preferredDefinition":"information related to the lymphoma lymph nodes having bulky diameter._A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection._The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference._Of considerable or relatively great size, extent, or capacity._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"BULKDIS_OCCUR_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEC468BB-79F1-59C5-E053-4EBD850A6DA4","latestVersionIndicator":"Yes","beginDate":"2021-03-30","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-03-30","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7627367","version":"1","preferredName":"Clinical Complete Response Confirmed Indicator","preferredDefinition":"Indicator of whether or not a complete response was confirmed","longName":"CR_CNFRMYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF68E53D-2AAF-2162-E053-4EBD850ACA4B","latestVersionIndicator":"Yes","beginDate":"2021-04-07","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-07","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7627376","version":"1","preferredName":"Partial Response Confirmed Indicator","preferredDefinition":"Indicator of whether or not a partial response was confirmed","longName":"PR_CNFRMYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF762790-645F-70A2-E053-4EBD850A7C7E","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-08","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7627492","version":"1","preferredName":"Clinical Complete Response Assessment Method Type","preferredDefinition":"Text term that represents the assessment method used to evaluate a complete response to treatment","longName":"CR_RSMETHOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF775EB2-F958-15BE-E053-4EBD850AB1BE","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-08","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7627820","version":"1","preferredName":"Global Partial Response Assessment Method Type","preferredDefinition":"Text term that represents the assessment method used to evaluate a global partial response to treatment","longName":"PR_RSMETHOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7A24CB-3EE2-786D-E053-4EBD850AB80F","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-08","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7627905","version":"1","preferredName":"Recurrent Disease Progressive Disease Patient Diagnosis Indicator","preferredDefinition":"The indicator of whether or not the patient has been diagnosed with recurrent or progressive disease","longName":"PDYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7AA7E6-E2ED-020C-E053-4EBD850A7509","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-08","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7629257","version":"1","preferredName":"First Observed Unconfirmed Progressive Disease Indicator","preferredDefinition":"The indicator of whether or not the unconfirmed progressive disease is first observed","longName":"UNCNFM_PD_OBSVYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF8EB756-B47C-3B5C-E053-4EBD850AB6B0","latestVersionIndicator":"Yes","beginDate":"2021-04-09","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-09","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7629588","version":"1","preferredName":"First Observed Unconfirmed Progressive Disease Date","preferredDefinition":"The date on which unconfirmed progressive disease was first observed","longName":"UNCNFM_PD_RSDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF8FCA2A-6B9B-7769-E053-4EBD850A674F","latestVersionIndicator":"Yes","beginDate":"2021-04-09","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-09","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7629816","version":"1","preferredName":"Progression First Observed Indicator","preferredDefinition":"Indicator of whether or not the progressive disease was first observed","longName":"CNFM_PD_OBSVYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF90C59A-A14A-63C8-E053-4EBD850AF832","latestVersionIndicator":"Yes","beginDate":"2021-04-09","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-04-09","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC 112 protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7653757","version":"1","preferredName":"Smoking History Time Interval Type","preferredDefinition":"The time interval since the person stopped smoking.","longName":"BSHS101A_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2263A9B-5A45-2ECE-E053-4EBD850A9281","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-05-12","modifiedBy":"TSESU","dateModified":"2022-05-04","changeNote":"Curated for AMC protocol 111 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7656692","version":"1","preferredName":"Temporary Smoking Cessation Status Indicator","preferredDefinition":"Indicator of whether or not the participant temporarily stopped smoking","longName":"BSHS102D_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2268BBA-AC3B-7871-E053-4EBD850AEA05","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-05-12","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC protocol 111 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7656702","version":"1","preferredName":"Temporary Smoking Cessation Duration Year Number","preferredDefinition":"Number of years the participant temporarily stopped smoking","longName":"BSHS102E_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C226DD20-E840-209E-E053-4EBD850A7F81","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-05-12","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC protocol 111 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7656765","version":"1","preferredName":"Person Cigarette Smoking Pack Year History Number","preferredDefinition":"Number of pack-years a person has smoked (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year. Number with 3 places before the decimal and one place after the decimal point.","longName":"BSHS102F_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C228A183-876A-1D40-E053-4EBD850A1069","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-05-12","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":"Curated for AMC protocol 111 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7669668","version":"1","preferredName":"Cigarette Average Daily Smoked Count","preferredDefinition":"Number representing how many cigarettes a person typically smokes in a day.","longName":"CIG_DAILY_CT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2DE2923-0258-5B66-E053-4EBD850AA0AF","latestVersionIndicator":"Yes","beginDate":"2021-05-21","endDate":null,"createdBy":"TSESU","dateCreated":"2021-05-21","modifiedBy":"COLLIED","dateModified":"2021-05-24","changeNote":"Curated for AMC-111 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7715471","version":"1","preferredName":"Nivolumab Administered Start Date","preferredDefinition":"The date on which nivolumab was administered.","longName":"NIVOLUMAB_ECSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C59D17D2-CB16-6B1C-E053-4EBD850A6555","latestVersionIndicator":"Yes","beginDate":"2021-06-25","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-06-25","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC 110 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7716037","version":"1","preferredName":"Capecitabine Chemotherapy Agent Administration Daily Dose","preferredDefinition":"Daily dose of Capecitabine, an anticancer drug that belongs to the family of drugs called antimetabolites.","longName":"CAPECITABINE_ECDOSTOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5FF540D-FFA3-3E35-E053-4EBD850AFFFF","latestVersionIndicator":"Yes","beginDate":"2021-06-30","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-06-30","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7716038","version":"1","preferredName":"Capecitabine Chemotherapy Agent Administration Total Dose","preferredDefinition":"The total dose of Capecitabine, an anticancer drug that belongs to the family of drugs called antimetabolites.","longName":"CAPECITABINE_ECDOSE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5FEA3BB-30C4-0ADB-E053-4EBD850ADC90","latestVersionIndicator":"Yes","beginDate":"2021-06-30","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-06-30","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736182","version":"1","preferredName":"Frequency Any Tobacco Use Quantity Year Count","preferredDefinition":"A person's stated response about the number of years they have been or were a pipe or cigar smoker.","longName":"AZSS111_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6B9D0E8-DE9D-237A-E053-4EBD850AF080","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736184","version":"1","preferredName":"Arizona Tobacco Survey Usually Inhale Tobacco Smoke Only to Mouth Indicator","preferredDefinition":"A person's stated response about whether they usually inhale tobacco smoke to only their mouth.","longName":"AZSS104A_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BA646A-3B04-3F29-E053-4EBD850AFC0A","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-07-28","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736186","version":"1","preferredName":"Arizona Tobacco Survey Usually Inhale Tobacco Smoke to Chest Indicator","preferredDefinition":"A person's stated response about whether they usually inhale tobacco smoke to their chest.","longName":"AZSS104B_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BA823A-38A3-34D4-E053-4EBD850A5E1A","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-07-28","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736188","version":"1","preferredName":"Arizona Tobacco Survey Amount of Cigarette Smoked","preferredDefinition":"A person's stated response about how much of a cigarette they smoked.","longName":"AZSS105_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BAB98C-638D-3E20-E053-4EBD850A57AD","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736190","version":"1","preferredName":"Smoked Cigarettes Past 3 Days Quantity Count","preferredDefinition":"A person's response about how many cigarettes they smoke over the past 3 days.","longName":"AZSS106_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BAD514-7633-79DD-E053-4EBD850A9329","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736191","version":"1","preferredName":"Primary Brand Smoked Cigarettes Text","preferredDefinition":"A person's stated response about the brand of cigarettes they smoked the most.","longName":"AZSS107_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BAE7BA-6381-1685-E053-4EBD850AC43A","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736192","version":"1","preferredName":"Menthol Type Cigarette Smoked Indicator","preferredDefinition":"A person's stated response about whether the cigarette type they smoke most often is menthol.","longName":"AZSS107A_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BAF208-55F7-585E-E053-4EBD850AA5D7","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736193","version":"1","preferredName":"Filter Device on Smoked Cigarettes Indicator","preferredDefinition":"A person's stated response about whether the cigarette brand they smoke has a filter.","longName":"AZSS107B_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BAF99D-B56B-179B-E053-4EBD850A6B23","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736197","version":"1","preferredName":"Prior to Age Twenty Smoked Cigarettes Daily Average Scale","preferredDefinition":"A person's stated response about the average number of cigarettes they smoked before the age of twenty.","longName":"AZSS108_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BB2503-1F81-6408-E053-4EBD850A666E","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736198","version":"1","preferredName":"More than One Smoked Cigarettes Per Day Average Count","preferredDefinition":"A person's stated response about the number of cigarettes they smoked, if more than 1 per day.","longName":"AZSS108A_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BB325C-0989-33E1-E053-4EBD850A4ECD","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736199","version":"1","preferredName":"Arizona Tobacco Survey Smoked Pipe or Cigar at Least Twenty Times in Lifetime Indicator","preferredDefinition":"A person's stated response about whether they smoked a pipe or cigar at least twenty times in their life.","longName":"AZSS109_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6B8BF0E-78C2-1C89-E053-4EBD850A5A8B","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736397","version":"1","preferredName":"Arizona Tobacco Survey Smoked Pipe or Cigar at Least Twenty Times in Lifetime Tobacco Delivery Type","preferredDefinition":"A person's stated response about whether, if they smoked a pipe or cigar at least twenty times in their life, which delivery method was used.","longName":"AZSS109A_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BA646A-3B2A-3F29-E053-4EBD850AFC0A","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736401","version":"1","preferredName":"Currently Smoke Cigar And Or Pipe Indicator","preferredDefinition":"A person's stated response about whether they currently smoke a pipe and/or cigar.","longName":"AZSS112_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BB916C-3C19-3044-E053-4EBD850ACCE9","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736402","version":"1","preferredName":"Tobacco Use Cessation Attempt Indicator","preferredDefinition":"A person's stated response about whether they have ever attempted to quit any form of tobacco use.","longName":"AZSS113_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BB8CBE-C359-6A74-E053-4EBD850A532F","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736403","version":"1","preferredName":"Tobacco Use Cessation Attempt Count","preferredDefinition":"A person's stated response about whether, if they have quit any form of tobacco use, how many times they have quit for at least one day.","longName":"AZSS114_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BA74CF-3D49-74AD-E053-4EBD850A5C7C","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736404","version":"1","preferredName":"Arizona Tobacco Survey Mother Smoked Cigarettes While Pregnant with You Indicator","preferredDefinition":"A person's stated response about whether their mother smoked cigarettes when she was pregnant with them.","longName":"AZSS115_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BBB1FC-63E8-5857-E053-4EBD850A854B","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736408","version":"1","preferredName":"Primary Caregiver Cigarette Smoker Indicator","preferredDefinition":"A person's stated response of whether their primary caregiver when they were a child smoked.","longName":"AZSS116_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BBDB1F-9103-7628-E053-4EBD850AF946","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Created for AMC Arizona Smoking Survey","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7736409","version":"1","preferredName":"Cigarette Smoke Exposure Past 30 Days Daily Quantity Hour Count","preferredDefinition":"A person's stated response about how many hours per day they have been exposed to other people's cigarette smoke in an enclosed location.","longName":"AZSS117_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BBCE16-022F-5ED2-E053-4EBD850AFAEA","latestVersionIndicator":"Yes","beginDate":"2021-07-09","endDate":null,"createdBy":"TSESU","dateCreated":"2021-07-09","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Created for AMC Arizona Tobacco Survey","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7742833","version":"1","preferredName":"Patient Eligibility Indicator","preferredDefinition":"Information that identifies whether eligibility criteria have been met for the patient to participate in the clinical study.","longName":"ELIGIBLE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C74315B6-4D4C-7769-E053-4EBD850A17C3","latestVersionIndicator":"Yes","beginDate":"2021-07-16","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-07-16","modifiedBy":"TSESU","dateModified":"2022-08-16","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7742844","version":"1","preferredName":"Tumor Clinical T Stage","preferredDefinition":"The clinical T stage for a tumor.","longName":"AJCC101_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C743EC17-B81B-4DF4-E053-4EBD850AAA92","latestVersionIndicator":"Yes","beginDate":"2021-07-16","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-07-16","modifiedBy":"TSESU","dateModified":"2023-01-04","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7742845","version":"1","preferredName":"Disease Lymph Node Stage Code","preferredDefinition":"Stage of disease based on the nodes present (N stage).","longName":"AJCC102_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7445713-B7E1-0679-E053-4EBD850A6000","latestVersionIndicator":"Yes","beginDate":"2021-07-16","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-07-16","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7742846","version":"1","preferredName":"Disease Metastasis Stage Code","preferredDefinition":"Stage of disease based on the metastases present (M stage).","longName":"AJCC103_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7445713-B809-0679-E053-4EBD850A6000","latestVersionIndicator":"Yes","beginDate":"2021-07-16","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-07-16","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7752373","version":"1","preferredName":"Arizona Tobacco Survey Times Smoked Pipe or Cigar per Week Usage Category","preferredDefinition":"Text term that represents the category of weekly pipe or cigar usage.","longName":"AZSS110_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8461E67-979E-4A23-E053-4EBD850A9928","latestVersionIndicator":"Yes","beginDate":"2021-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-07-29","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Curated for AMC 111 protocol DC","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7752374","version":"1","preferredName":"Arizona Tobacco Survey Greater Than One Pipe Or Cigar Weekly Average Count","preferredDefinition":"Number of pipes or cigars smoked in a weekly average if greater than one.","longName":"AZSS110A_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C845E7AC-4F8B-4A26-E053-4EBD850AD5C3","latestVersionIndicator":"Yes","beginDate":"2021-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-07-29","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC 111 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7757300","version":"1","preferredName":"Non Nodal Target Lesion Present Indicator","preferredDefinition":"Indicator of whether or not non nodal (any bulge or swelling of an anatomical structure or part) of an area of abnormal tissue change is present","longName":"NNDLTIND_TUORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8A795D4-A207-17BE-E053-4EBD850A0B05","latestVersionIndicator":"Yes","beginDate":"2021-08-03","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-03","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7757301","version":"1","preferredName":"Nodal Lesion Present Indicator","preferredDefinition":"The indicator of whether or not a nodal (pertaining to a node, any bulge or swelling of an anatomical structure or part) is present.","longName":"NDLTIND_TUORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8A795D4-A22F-17BE-E053-4EBD850A0B05","latestVersionIndicator":"Yes","beginDate":"2021-08-03","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-03","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7760139","version":"1","preferredName":"Last Treatment Occurrence Indicator","preferredDefinition":"Indicator of whether or not the last treatment occurred.","longName":"SUPPPR_LASTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8E81CC6-8282-63CF-E053-4EBD850AB00C","latestVersionIndicator":"Yes","beginDate":"2021-08-06","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-08-06","modifiedBy":"COLLIED","dateModified":"2021-09-23","changeNote":"Curated for AMC-110 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7764288","version":"1","preferredName":"Tumor Sequence Number Identifier","preferredDefinition":"A number identifying the sequence of related tumor records.","longName":"TU_TULNKID","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C94DFE4A-86A0-4561-E053-4EBD850A8D56","latestVersionIndicator":"Yes","beginDate":"2021-08-11","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-11","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7764925","version":"1","preferredName":"Procedure Radiation Therapy Total Dose","preferredDefinition":"The total dose of radiation therapy administered measured in Gy (gray) unit of measure.","longName":"PRDSTXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C94EF5BD-B2D3-410E-E053-4EBD850AE358","latestVersionIndicator":"Yes","beginDate":"2021-08-11","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-11","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765089","version":"1","preferredName":"Patient Concurrent Enrollment Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response that indicates the patient meets the eligibility requirements for participation in a clinical trial with regards to enrollment in a concurrent clinical trial.","longName":"CONCPROT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C96051B6-A4BE-5F02-E053-4EBD850A2876","latestVersionIndicator":"Yes","beginDate":"2021-08-12","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-08-12","modifiedBy":"COLLIED","dateModified":"2021-09-03","changeNote":"Curated for AMC-S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765133","version":"1","preferredName":"Baseline Neoplasm Non-Measurable Tumor Type","preferredDefinition":"The type of tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured.","longName":"TR_TRORRES_NMEASTYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C971497E-CE01-341E-E053-4EBD850A1B30","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765136","version":"1","preferredName":"Baseline Neoplasm Measurable Lesion Type","preferredDefinition":"Type of measurable lesion","longName":"TR_TRORRES_MEASTYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C971D2AF-E866-046C-E053-4EBD850A48B0","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765137","version":"1","preferredName":"Baseline Neoplasm Measurable Other Lesion Specify","preferredDefinition":"Other type of baseline measurable lesion","longName":"TR_TRORRES_MEASTYPO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C97201CF-27E9-3976-E053-4EBD850AC2B7","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765138","version":"1","preferredName":"Baseline Neoplasm Non-Measurable Other Lesion Specify","preferredDefinition":"Other type of non-measurable lesion","longName":"TR_TRORRES_NMEASTYPO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C971497E-CE29-341E-E053-4EBD850A1B30","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765152","version":"1","preferredName":"Tumor Anatomic Site","preferredDefinition":"The anatomic site of the tumor.","longName":"TU_TULOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C972F262-689D-4E0F-E053-4EBD850A807F","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-02","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":"2023.2.3 AQT, Alt SN added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765153","version":"1","preferredName":"Tumor Location Other Specify","preferredDefinition":"Other location of the tumor","longName":"TU_TULOCO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9732902-6ED4-0A5B-E053-4EBD850AB56B","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":"2023.11.3 Added Alt SNs per ticket request CADSR0003042. ak 2023.10.18 Alt SN added per ticket request CADSR0002981. ak 2023.8.1 AQTs added per ticket request CADSR0002677. ak 2023.2.3 AQT, Alt SN added per ticket request CADSR0002006/ CADSR0002214 and CADSR0002164. ak 2023.1.20 Alt SN added per ticket request CADSR0001943. ak 1/17/2023: added alt short name per cadrs0001921.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7765154","version":"1","preferredName":"Tumor Assessment Method Type","preferredDefinition":"The technique used to administer the tumor identification assessment.","longName":"TU_TUMETHOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C97335DE-7AE0-692E-E053-4EBD850A4883","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeNote":"Curated for AMC protocol MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784424","version":"1","preferredName":"Patient Questionnaire Administered Method Type","preferredDefinition":"Method used to complete the patient questionnaire.","longName":"AFQ11_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0A67F1-770D-4586-E053-4EBD850AD322","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-15","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784434","version":"1","preferredName":"Patient Questionnaire Administered Method Other Specify Text","preferredDefinition":"Text description that represents the other method that a patient questionnaire was administered.","longName":"AFQ11_OTHER_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC09921E-8ABE-665F-E053-4EBD850AE9F8","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-15","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784475","version":"1","preferredName":"Patient Questionnaire Reason Not Done Type","preferredDefinition":"Text term that represents the reason why the patient questionnaire was not completed.","longName":"AFQ11A _QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0F596F-7C4F-5743-E053-4EBD850A76B9","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-15","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":"11/17/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784813","version":"1","preferredName":"Missed Dose Past Day Count","preferredDefinition":"Number of doses missed the day before.","longName":"AFQ1A6_1_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC32489C-417D-736D-E053-4EBD850A358F","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-17","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784838","version":"1","preferredName":"Missed Dose Past Two Days Count","preferredDefinition":"The number of doses missed two days ago.","longName":"AFQ1A7_1_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC329E39-108A-6512-E053-4EBD850AF6D6","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-17","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784855","version":"1","preferredName":"Missed Dose Past Three Days Count","preferredDefinition":"The number of doses missed three days ago.","longName":"AFQ1A8_1_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC32E908-0645-344C-E053-4EBD850AFA80","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-17","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784859","version":"1","preferredName":"Missed Dose Past Four Days Count","preferredDefinition":"The number of doses missed four days ago.","longName":"AFQ1A9_1_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC313938-80D0-76C8-E053-4EBD850AA120","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-17","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784908","version":"1","preferredName":"Missed Dose During Four Days Number Type","preferredDefinition":"Text term that represents the number of medication doses missed over four days.","longName":"AFQ1B_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC37453D-05EF-46E8-E053-4EBD850A6DC2","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-17","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786821","version":"1","preferredName":"Agent Consumption Patient Compliance Temporal Frequency","preferredDefinition":"Text term that represents the category for how often the patient follows their medication schedule.","longName":"AFQ1C_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72BCF2-1A9B-091A-E053-4EBD850A801C","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-20","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786830","version":"1","preferredName":"Medication Special Instructions Indicator","preferredDefinition":"Indicator of whether or not there are special instructions for a medication","longName":"AFQ1D_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC73B51D-844F-1ABD-E053-4EBD850A9204","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-20","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786831","version":"1","preferredName":"Medication Special Instructions Patient Compliance Temporal Frequency","preferredDefinition":"Text term that represents the category for how often the patient followed their medication's special instructions.","longName":"AFQ1D1_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC723E3B-5947-3A51-E053-4EBD850A422F","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7787595","version":"1","preferredName":"Missed Dose Past Weekend Indicator","preferredDefinition":"Indicator of whether or not the participant missed any of their medicine doses the past weekend.","longName":"AFQ1E_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC81E423-EB9B-7A6E-E053-4EBD850A0087","latestVersionIndicator":"Yes","beginDate":"2021-09-21","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-21","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7787665","version":"1","preferredName":"Missed Dose Last Time Interval","preferredDefinition":"The time interval that represents the last time the participant missed their medicine dose.","longName":"AFQ1F_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC813785-1B08-6961-E053-4EBD850A7549","latestVersionIndicator":"Yes","beginDate":"2021-09-21","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-21","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7787666","version":"1","preferredName":"How Often Missed Dose Due To Away from Home Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to being away from home.","longName":"AFQ1G1_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC8424B1-E01A-1D23-E053-4EBD850AB937","latestVersionIndicator":"Yes","beginDate":"2021-09-21","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-21","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788395","version":"1","preferredName":"How Often Missed Dose Due To Busy Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to being too busy.","longName":"AFQ1G2_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9B5BE4-43CD-664C-E053-4EBD850A7982","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788396","version":"1","preferredName":"How Often Missed Dose Due To Forgot to Take Medication Scale","preferredDefinition":"Scale related to how often the patient missed their medication dose due to forgetting.","longName":"AFQ1G3_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9B5BE4-43F5-664C-E053-4EBD850A7982","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788397","version":"1","preferredName":"How Often Missed Dose Due To Excessive Medication Quantity Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to having too many pills to take.","longName":"AFQ1G4_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9B5BE4-441D-664C-E053-4EBD850A7982","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788398","version":"1","preferredName":"How Often Missed Dose Due To Avoidance Side Effect Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to wanting to avoid side effects.","longName":"AFQ1G5_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9B5BE4-4445-664C-E053-4EBD850A7982","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788399","version":"1","preferredName":"How Often Missed Dose Due To Change Daily Routine Scale","preferredDefinition":"Scale related to how often the patient missed their medication dose due to a change in their daily routine.","longName":"AFQ1G7_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9B5BE4-446D-664C-E053-4EBD850A7982","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788400","version":"1","preferredName":"How Often Missed Dose Because Was Asleep Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to being asleep.","longName":"AFQ1G9_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9B5BE4-4495-664C-E053-4EBD850A7982","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788401","version":"1","preferredName":"How Often Missed Dose Because Feeling Too Sick Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to being too sick.","longName":"AFQ1G10_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9C3538-EAEC-39E3-E053-4EBD850A4C35","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788414","version":"1","preferredName":"Missed Dose Because Did Not Want Others See Medications Scale","preferredDefinition":"Scale related to how often the patient has missed their medication dose due to not wanting others to see them taking medication.","longName":"AFQ1G6_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9ACF5B-A487-664A-E053-4EBD850A6F1C","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788418","version":"1","preferredName":"How Often Missed Dose Due To Afraid Treatment May Harm Body Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to a feeling that the drug was harmful.","longName":"AFQ1G8_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC994D03-7920-48F4-E053-4EBD850AA7AE","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-22","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788456","version":"1","preferredName":"How Often Missed Dose Due To Feel Depressed Scale","preferredDefinition":"Scale related to how often the patient has missed their medication dose due to feeling depressed.","longName":"AFQ1G11_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCACE750-4F26-3E68-E053-4EBD850A8BDF","latestVersionIndicator":"Yes","beginDate":"2021-09-23","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-23","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788462","version":"1","preferredName":"How Often Missed Dose Due To Difficulty Follow Dose Regimen Timing Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to being unable to follow the dose timings.","longName":"AFQ1G12_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCAD2E6B-CF9D-369B-E053-4EBD850AB37D","latestVersionIndicator":"Yes","beginDate":"2021-09-23","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-23","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788477","version":"1","preferredName":"How Often Missed Dose Because Medication Ran Out Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to running out of pills.","longName":"AFQ1G13_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCAEB403-BCFB-3B4F-E053-4EBD850AEE2E","latestVersionIndicator":"Yes","beginDate":"2021-09-23","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-09-23","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7794865","version":"1","preferredName":"How Often Missed Dose Due To Feel Healthy Scale","preferredDefinition":"Scale related to how often the patient missed their medicine dose due to feeling healthy.","longName":"AFQ1G14_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDA0D69C-4A41-7AC3-E053-4EBD850A095E","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-10-05","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7800906","version":"1","preferredName":"Lesion Sum of Diameters Short Axis Value","preferredDefinition":"Sum of the diameters of lesion short axes","longName":"TR_TRORRES_SUMLPERP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF46A9CE-C0D2-3803-E053-4EBD850A8DA8","latestVersionIndicator":"Yes","beginDate":"2021-10-26","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-10-26","modifiedBy":"SHEIKHM","dateModified":"2021-12-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801083","version":"1","preferredName":"Measurable Lesions Sum of Longest Diameters Value","preferredDefinition":"The sum of the longest diameters of measurable lesions.","longName":"TR_TRORRES_SUMLDIAM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF5B6744-65B5-2D12-E053-4EBD850ABB94","latestVersionIndicator":"Yes","beginDate":"2021-10-27","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-10-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-24","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8049723","version":"1","preferredName":"Prior Third-Line Therapy Administered Agent Name","preferredDefinition":"Text term used to represent the name of the prior third-line therapy administered.","longName":"PRTX_THIRD_LN_NAM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8A0B220-4C70-79B6-E053-4EBD850A8F30","latestVersionIndicator":"Yes","beginDate":"2022-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-02-22","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8049732","version":"1","preferredName":"Prior Administered Fourth-Line Therapy Agent Name","preferredDefinition":"Text term used to represent the name of the prior fourth-line therapy administered.","longName":"PRTX_FOURTH_LN_NAM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8A11E33-EC12-79C0-E053-4EBD850A336B","latestVersionIndicator":"Yes","beginDate":"2022-02-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-02-22","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8052421","version":"1","preferredName":"Prior Administered Fifth-Line Therapy Agent Name","preferredDefinition":"Text term used to represent the name of the prior fifth-line therapy administered.","longName":"PRTX_FIFTH_LN_NAM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8B0BAB5-1589-2437-E053-4EBD850A8DB1","latestVersionIndicator":"Yes","beginDate":"2022-02-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-02-23","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8052426","version":"1","preferredName":"Laboratory Procedure CD4-Positive T-Lymphocyte Outcome Less Than One Hundred Indicator","preferredDefinition":"Indicator of whether the CD4-Positive T-Lymphocyte Count is less than one hundred or greater than or equal to one hundred.","longName":"LAB_CD4CNT_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8B234F1-42EB-0C7F-E053-4EBD850AEF78","latestVersionIndicator":"Yes","beginDate":"2022-02-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-02-23","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8052460","version":"1","preferredName":"Patient Hepatitis B Virus Antibody Positive Finding Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"Indicator of whether or not the patient is Hepatitis B antibody positive.","longName":"HBVANTI_POS_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8B09769-5A95-0C75-E053-4EBD850A2AE3","latestVersionIndicator":"Yes","beginDate":"2022-02-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-02-23","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8052461","version":"1","preferredName":"Hepatitis B Vaccine Personal Medical History Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of Hepatitis B vaccination.","longName":"HBVVACC_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8B09D98-0E55-242F-E053-4EBD850AC8C2","latestVersionIndicator":"Yes","beginDate":"2022-02-23","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-02-23","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 112 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8078557","version":"1","preferredName":"Protocol Agent Total Cycle Dose","preferredDefinition":"The total dose amount of a protocol agent administered during a protocol cycle.","longName":"CYCL_TOT_DOS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9E02398-8880-7CBE-E053-4EBD850A5F32","latestVersionIndicator":"Yes","beginDate":"2022-03-10","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-03-10","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8078616","version":"1","preferredName":"Diagnostic Imaging Central Reviewer Adjudication Assessment Indicator","preferredDefinition":"Coded indicator of whether an adjudication of disease response occurred.","longName":"CNTR_REV_ADJ_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9DE5BBC-019F-7CB5-E053-4EBD850A604B","latestVersionIndicator":"Yes","beginDate":"2022-03-10","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-03-10","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8081483","version":"1","preferredName":"Reviewer Disease Response Count","preferredDefinition":"Number of reviewers determining disease response.","longName":"NUM_RVWRS_CT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F1B308-9D9C-10F4-E053-4EBD850A75E3","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-03-11","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8081484","version":"1","preferredName":"Reviewer Consensus Disease Response Count","preferredDefinition":"Number of reviewers determining disease response that are in consensus.","longName":"REVWR_CONS_CT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F435DF-400D-1B2B-E053-4EBD850AFECE","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-03-11","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8140973","version":"1","preferredName":"Human Herpes Virus 8 Positive Negative Unknown Finding Type","preferredDefinition":"The status of the participant's KSHV infection","longName":"HHV8DNA_DET_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEB6003-AB47-262D-E053-4EBD850A501B","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8140990","version":"1","preferredName":"Human Herpes Virus 8 Viral Load Assay Value","preferredDefinition":"The participant's HHV8 viral load value.","longName":"HHV8DNA_RSLT_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEB6EDA-D747-56DD-E053-4EBD850AEFFE","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8141032","version":"1","preferredName":"Human Herpes Virus 8 Result Date","preferredDefinition":"The date of the participant's HHV8 viral load","longName":"HHV8_VIRLOAD_DT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEB9540-1A11-56DB-E053-4EBD850A8722","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8141033","version":"1","preferredName":"Epstein-Barr Virus Test Finding Type","preferredDefinition":"The results of the participant's Epstein-Barr test","longName":"EBV_RSLT_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEB9540-1A39-56DB-E053-4EBD850A8722","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8141256","version":"1","preferredName":"Cytomegalovirus Test Finding Type","preferredDefinition":"Results of the participant's CMV test.","longName":"CMV_FIND_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEBF524-03F5-29E5-E053-4EBD850A63C3","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8141262","version":"1","preferredName":"Hepatitis B Status Finding Type","preferredDefinition":"Result of the participant's HBV test.","longName":"HBV_FIND_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEBF524-041D-29E5-E053-4EBD850A63C3","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8143667","version":"1","preferredName":"Hepatitis B Viral Load Assay Value","preferredDefinition":"The value of the participant's HBV viral load.","longName":"HEPB_VIRLOAD_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEDA16B-AFDE-0A5B-E053-4EBD850AF33E","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146082","version":"1","preferredName":"Hepatitis B Infection Treated Indicator","preferredDefinition":"Coded indicator of whether the participant's hepatitis B infection has been treated.","longName":"HEPB_TX_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEBF524-044B-29E5-E053-4EBD850A63C3","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146092","version":"1","preferredName":"Hepatitis B Infection Treatment Date","preferredDefinition":"The date on which the Hepatitis B infection was treated.","longName":"HEP_B_TX_DAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBE8882D-7EC1-3E4A-E053-4EBD850A3245","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146101","version":"1","preferredName":"Hepatitis B Infection Treatment Type","preferredDefinition":"Text to describe the type of treatment received for hepatitis B infection.","longName":"HEP_B_TX_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEB6003-AB6F-262D-E053-4EBD850A501B","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146102","version":"1","preferredName":"Hepatitis B Surface Antigen Test Status","preferredDefinition":"The status of the participant's Hepatitis B surface antigen test.","longName":"HBSAG_RSLT_STA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEEB833-57D1-6E60-E053-4EBD850A4D3E","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146105","version":"1","preferredName":"Hepatitis C Status Finding Type","preferredDefinition":"Results of the participant's Hepatitis C test.","longName":"HEPC_FIND_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEEB833-57F9-6E60-E053-4EBD850A4D3E","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146108","version":"1","preferredName":"Nucleic Acid Amplification Test Hepatitis C Virus Finding Type","preferredDefinition":"Result of the participant's Hepatitis C virus nucleic acid amplification test.","longName":"NAAT_HEPC_DET _TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEF77F7-9F3F-5D21-E053-4EBD850ABDC1","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146109","version":"1","preferredName":"Hepatitis C Viral Load Value","preferredDefinition":"Viral load of the participant's Hepatitis C virus.","longName":"HEPC_VRALLD_VAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEF81FD-A03A-67C0-E053-4EBD850A52F9","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146114","version":"1","preferredName":"Hepatitis C Treatment Indicator","preferredDefinition":"Indicator code of whether or not the participant's Hepatitis C infection has been treated.","longName":"HEP_C_TX_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEFA14C-50C3-5DBA-E053-4EBD850AA516","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":"2023.3.17 AQT added per ticket request CADSR0002164. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146116","version":"1","preferredName":"Hepatitis C Treatment Date","preferredDefinition":"Participant's Hepatitis C treatment date.","longName":"HEP_C_TX_DAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEF98EA-A8A0-2D36-E053-4EBD850AFF9E","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146124","version":"1","preferredName":"Hepatitis C Treatment Type","preferredDefinition":"Text to describe the type of treatment received for Hepatitis C infection.","longName":"HEP_C_TX_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBEEC49C-408D-5BF3-E053-4EBD850A6D99","latestVersionIndicator":"Yes","beginDate":"2022-04-05","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-05","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146768","version":"1","preferredName":"Herpes Simplex Diagnosis Finding Type","preferredDefinition":"Result of the participant's Herpes simplex testing.","longName":"HSV_FIND_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFB97E2-9D22-227F-E053-4EBD850AC21C","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146773","version":"1","preferredName":"Herpes Simplex Diagnosis Type","preferredDefinition":"Herpes Simplex type","longName":"HSV_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFC7F54-8F3C-1143-E053-4EBD850A017E","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-02-22","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146775","version":"1","preferredName":"Herpes Zoster Finding Type","preferredDefinition":"The result of the participant's Herpes zoster test.","longName":"HERPZ_FIND_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFCEC5D-F566-4500-E053-4EBD850A372C","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146792","version":"1","preferredName":"Other Infection Occurrence Indicator","preferredDefinition":"Coded indicator of whether there is another infection.","longName":"OTH_INF_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD3144-9D72-2296-E053-4EBD850ACBC7","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146793","version":"1","preferredName":"Medical History Chlamydial Infection Indicator","preferredDefinition":"Coded indicator of Chlamydia infection medical history.","longName":"CHLAM_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD3DBE-29B5-1AE2-E053-4EBD850A6B04","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146794","version":"1","preferredName":"Medical History Syphilis Infection Indicator","preferredDefinition":"Coded indicator of history of Syphilis infection.","longName":"SYPH_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD45A2-39FF-1E16-E053-4EBD850AD1DF","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146795","version":"1","preferredName":"Medical History Gonorrhea Infection Indicator","preferredDefinition":"Coded indicator of history of Gonorrhea infection.","longName":"GONO_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD4E7B-4279-20A8-E053-4EBD850AB2E8","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146799","version":"1","preferredName":"Medical History Human Papillomavirus Infection Indicator","preferredDefinition":"Coded indicator of genital warts (HPV) medical history.","longName":"HPV_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD3144-9D9A-2296-E053-4EBD850ACBC7","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146800","version":"1","preferredName":"Medical History Genital Herpes Infection Indicator","preferredDefinition":"Coded indicator of history of genital herpes infection.","longName":"GEN_HRPS_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD5EB7-6FB3-63F8-E053-4EBD850A2B21","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146809","version":"1","preferredName":"Medical History Human Papillomavirus Infection Finding Type","preferredDefinition":"The status of the participant's HPV infection.","longName":"HPV_FNDNG_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFE6F83-39B0-3507-E053-4EBD850AFD1F","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146814","version":"1","preferredName":"Human Papillomavirus Specify Genotype Type","preferredDefinition":"The specific HPV genotype.","longName":"HPV_GENOTYPE_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFEED30-0E0B-34FF-E053-4EBD850AE284","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-02-22","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8146815","version":"1","preferredName":"Human Papillomavirus Vaccine Use Indicator","preferredDefinition":"Coded indicator of whether the participant has had an HPV vaccine.","longName":"HPV_VAX_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC0087AD-8B28-3505-E053-4EBD850A50B3","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-06","modifiedBy":"TSESU","dateModified":"2024-02-22","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8151630","version":"1","preferredName":"Laboratory Test Result Study Participant Recollect Or Laboratory Report Basis Indicator","preferredDefinition":"Indicator of whether or not a laboratory test result is based on study participant recollection or laboratory report.","longName":"HIVLOAD _RECALLAB","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC1588B7-A553-255A-E053-4EBD850A2412","latestVersionIndicator":"Yes","beginDate":"2022-04-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-07","modifiedBy":"COLLIED","dateModified":"2022-04-07","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8152596","version":"1","preferredName":"Antiretroviral Therapy Administration Begin Date","preferredDefinition":"The date on which antiretroviral therapy administration began.","longName":"ART_BEG_DAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC16317D-9B45-7A70-E053-4EBD850A73D5","latestVersionIndicator":"Yes","beginDate":"2022-04-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-07","modifiedBy":"TSESU","dateModified":"2024-02-22","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8152600","version":"1","preferredName":"Prior Therapy Indicator","preferredDefinition":"An indicator of whether or not prior therapy was received.","longName":"TX_PRMALIG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC1516B6-9B6E-3C5E-E053-4EBD850AF2A6","latestVersionIndicator":"Yes","beginDate":"2022-04-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-07","modifiedBy":"COLLIED","dateModified":"2022-04-07","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155750","version":"1","preferredName":"Clinical Trial Participation Name","preferredDefinition":"Text term used to represent the name of the current or planned clinical trial.","longName":"AMCPLAN_NAM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC25F827-9860-246E-E053-4EBD850A7617","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for the AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155751","version":"1","preferredName":"Protocol Agent Response Specify","preferredDefinition":"Text description of the response to the protocol agent.","longName":"RSPNS_TX_SPEC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC259634-9D18-49F6-E053-4EBD850A265A","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155752","version":"1","preferredName":"Prior Cancer Diagnosis Count","preferredDefinition":"Numeric value used to describe the number of prior cancer diagnoses.","longName":"PRMALIG_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DC25F827-9888-246E-E053-4EBD850A7617","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-08","modifiedBy":"COLLIED","dateModified":"2022-04-08","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155753","version":"1","preferredName":"Prior Cancer Diagnosis Therapy Reason Text","preferredDefinition":"Text description that represents the reason for prior cancer therapy.","longName":"HXPRMALIG_CMTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DC25F827-98B0-246E-E053-4EBD850A7617","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-08","modifiedBy":"COLLIED","dateModified":"2022-04-08","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155754","version":"1","preferredName":"Most Recent Malignant Neoplasm Diagnosis Date","preferredDefinition":"Date of most recent malignant neoplasm diagnosis.","longName":"HXPRMALIG_MHSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC25F827-98D8-246E-E053-4EBD850A7617","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-08","modifiedBy":"COLLIED","dateModified":"2022-04-25","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155853","version":"1","preferredName":"Medical History Human Papillomavirus-6 Indicator","preferredDefinition":"Coded indicator of whether HPV-6 was detected.","longName":"HPV6_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29A64B-8916-45A0-E053-4EBD850A81D5","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155854","version":"1","preferredName":"Medical History Human Papillomavirus-11 Indicator","preferredDefinition":"Coded Indicator of whether HPV-11 was detected.","longName":"HPV11_IDENT_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29AE4C-C055-458C-E053-4EBD850A0B38","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155855","version":"1","preferredName":"Medical History Human Papillomavirus-53 Indicator","preferredDefinition":"Coded indicator of whether HPV-53 was detected.","longName":"HPV53_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29B57A-8252-4590-E053-4EBD850A9B63","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155856","version":"1","preferredName":"Medical History Human Papillomavirus-66 Indicator","preferredDefinition":"Coded indicator of whether HPV-66 was detected.","longName":"HPV66_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29BDAB-B6E4-4593-E053-4EBD850A5C06","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155857","version":"1","preferredName":"Medical History Human Papillomavirus-70 Indicator","preferredDefinition":"Coded indicator of whether HPV-70 was detected.","longName":"HPV70_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC287343-BA23-03D6-E053-4EBD850A87B7","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155858","version":"1","preferredName":"Medical History Human Papillomavirus Type 16 Indicator","preferredDefinition":"Coded indicator of whether HPV-16 was detected.","longName":"HPV16_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29A64B-893E-45A0-E053-4EBD850A81D5","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155859","version":"1","preferredName":"Medical History Human Papillomavirus Type 18 Indicator","preferredDefinition":"Coded indicator of whether HPV-18 was detected.","longName":"HPV18_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC287343-BA4B-03D6-E053-4EBD850A87B7","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155860","version":"1","preferredName":"Medical History Human Papillomavirus-31 Indicator","preferredDefinition":"Coded indicator of whether HPV-31 was detected.","longName":"HPV31_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29AE4C-C07D-458C-E053-4EBD850A0B38","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155861","version":"1","preferredName":"Medical History Human Papillomavirus-33 Indicator","preferredDefinition":"Coded indicator of whether HPV-33 was detected.","longName":"HPV33_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29E196-4AEF-459E-E053-4EBD850A3D44","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155862","version":"1","preferredName":"Medical History Human Papillomavirus-35 Indicator","preferredDefinition":"Coded indicator of whether HPV-35 was detected.","longName":"HPV35_IDENT_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC287343-BA73-03D6-E053-4EBD850A87B7","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-02-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155863","version":"1","preferredName":"Medical History Human Papillomavirus-39 Indicator","preferredDefinition":"Coded indicator of whether HPV-39 was detected.","longName":"HPV39_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29EEBA-4310-459C-E053-4EBD850A377A","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155864","version":"1","preferredName":"Medical History Human Papillomavirus-45 Indicator","preferredDefinition":"Coded indicator of whether HPV-45 was detected.","longName":"HPV45_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29E84B-FC6C-4596-E053-4EBD850A6929","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155865","version":"1","preferredName":"Medical History Human Papillomavirus-51 Indicator","preferredDefinition":"Coded indicator of whether HPV-51 was detected.","longName":"HPV51_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29AE4C-C0A5-458C-E053-4EBD850A0B38","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155866","version":"1","preferredName":"Medical History Human Papillomavirus-52 Indicator","preferredDefinition":"Coded indicator of whether HPV-52 was detected.","longName":"HPV52_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC29B57A-827A-4590-E053-4EBD850A9B63","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155867","version":"1","preferredName":"Medical History Human Papillomavirus-56 Indicator","preferredDefinition":"Coded indicator of whether HPV-56 was detected.","longName":"HPV56_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC287343-BA9B-03D6-E053-4EBD850A87B7","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155868","version":"1","preferredName":"Medical History Human Papillomavirus-58 Indicator","preferredDefinition":"Coded indicator of whether HPV-58 was detected.","longName":"HPV58_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2AE030-73E3-7EE6-E053-4EBD850A7401","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155869","version":"1","preferredName":"Medical History Human Papillomavirus-59 Indicator","preferredDefinition":"Coded indicator of whether HPV-59 was detected.","longName":"HPV59_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2AE6C9-D6C2-7EDF-E053-4EBD850A9899","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8155870","version":"1","preferredName":"Medical History Human Papillomavirus-68 Indicator","preferredDefinition":"Coded indicator of whether HPV-68 was detected.","longName":"HPV68_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2AECC4-6AAC-7EE2-E053-4EBD850ACEE0","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-08","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167759","version":"1","preferredName":"Medical History Human Papillomavirus-34 Indicator","preferredDefinition":"Coded indicator of whether HPV-34 was detected.","longName":"HPV34_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA3D186-33A8-6B0F-E053-4EBD850AFC25","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167811","version":"1","preferredName":"Medical History Human Papillomavirus-40 Indicator","preferredDefinition":"Coded Indicator of whether HPV-40 was detected.","longName":"HST_HPV40_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA41B7D-A059-669A-E053-4EBD850AC899","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167815","version":"1","preferredName":"Medical History Human Papillomavirus-42 Indicator","preferredDefinition":"Coded Indicator of whether HPV-42 was detected.","longName":"HST_HPV42_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA422F2-3755-174B-E053-4EBD850A8685","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167832","version":"1","preferredName":"Medical History Human Papillomavirus-43 Indicator","preferredDefinition":"Coded Indicator of whether HPV-43 was detected.","longName":"HST_HPV43_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA3A7CA-16D1-1F5E-E053-4EBD850A8014","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167836","version":"1","preferredName":"Medical History Human Papillomavirus-44 Indicator","preferredDefinition":"Coded indicator of whether HPV-44 was detected.","longName":"HPV44_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA3B555-54BE-5304-E053-4EBD850A425D","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167846","version":"1","preferredName":"Medical History Human Papillomavirus-54 Indicator","preferredDefinition":"Coded indicator of whether HPV-54 was detected.","longName":"HPV54_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA422F2-377D-174B-E053-4EBD850A8685","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167854","version":"1","preferredName":"Medical History Human Papillomavirus-74 Indicator","preferredDefinition":"Coded indicator of whether HPV-74 was detected.","longName":"HPV74_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA42B90-72D7-2F6F-E053-4EBD850A7534","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167857","version":"1","preferredName":"Medical History Human Papillomavirus-69 Indicator","preferredDefinition":"Coded indicator of whether HPV-69 was detected.","longName":"HPV69_CODE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA42E14-2EA1-0EB4-E053-4EBD850A769A","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2022-04-14","modifiedBy":"TSESU","dateModified":"2024-01-19","changeNote":"Curated for AMC protocol S005 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177484","version":"1","preferredName":"Person Height Assessment Date","preferredDefinition":"The date on which a person's height was assessed.","longName":"HGHT_ASSMT_DAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA3EB9E-57FE-1AA4-E053-4EBD850A96ED","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177489","version":"1","preferredName":"Person Body Mass Index Date","preferredDefinition":"The date on which a person's Body Mass Index (BMI) was measured.","longName":"BMI_VSDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDA3F927-493A-01A7-E053-4EBD850A69FB","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"COLLIED","dateModified":"2022-04-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177533","version":"1","preferredName":"Malignant Neoplasm Recurrent Disease Or Progressive Disease Diagnosis Indicator","preferredDefinition":"Indicator of whether or not the participant has a recurrent or progressive malignant neoplasm.","longName":"RCRR_PROG_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA52401-02B4-07BC-E053-4EBD850A008E","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177534","version":"1","preferredName":"Malignant Neoplasm Recurrent Disease Or Progressive Disease Diagnosis Specify","preferredDefinition":"Text description of the type of recurrent or progressive malignant neoplasm.","longName":"RCRPRMAL_SPEC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA4EA39-430D-5149-E053-4EBD850A58AB","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177535","version":"1","preferredName":"Event Date Estimate Indicator","preferredDefinition":"Indicator of whether or not the event date is estimated.","longName":"STDATEST","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDA53B5D-2A49-07BA-E053-4EBD850A40DD","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"COLLIED","dateModified":"2022-04-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177536","version":"1","preferredName":"Study Subject TNM Staging System Category","preferredDefinition":"TNM Staging System category.","longName":"TNMSCORE_CAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA4AA6D-C45E-07B8-E053-4EBD850A98FA","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177537","version":"1","preferredName":"Malignant Neoplasm N Category","preferredDefinition":"Text term that represents the N Category(extent of lymph node involvement) of the TNM staging system.","longName":"NSTAGE_CAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA4B4ED-CA11-07B5-E053-4EBD850A1969","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177540","version":"1","preferredName":"Study Subject Blood Type Category","preferredDefinition":"Study participant's blood type category.","longName":"BLOOD_TYP_CAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA566DF-9C62-07BE-E053-4EBD850AF672","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-18","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177543","version":"1","preferredName":"Relative Family Cancer History Indicator","preferredDefinition":"Indicator of whether or not there is a family history of cancer.","longName":"FHXCA_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDA4EA39-4335-5149-E053-4EBD850A58AB","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"COLLIED","dateModified":"2022-04-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177545","version":"1","preferredName":"Person Other Primary Neoplasm Personal Medical History Indicator","preferredDefinition":"Indicator of whether or not there is a history of other primary cancers.","longName":"OTH_PRM_NEO_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA4AA6D-C486-07B8-E053-4EBD850A98FA","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-17","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177547","version":"1","preferredName":"Primary Neoplasm Diagnosis Date","preferredDefinition":"The date on which the primary cancer diagnosis occurred.","longName":"PRICANC_MHSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA566DF-9CBE-07BE-E053-4EBD850AF672","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2023-07-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177551","version":"1","preferredName":"Participant Personal Medical History Cerebrovascular Accident Disease or Disorder Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of cerebrovascular disease or disorder.","longName":"HXCBVD_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDA52401-02EC-07BC-E053-4EBD850A008E","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"COLLIED","dateModified":"2022-04-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177552","version":"1","preferredName":"Cardiovascular Disorder Personal Medical History Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of cardiovascular disease.","longName":"HXCVD_MHOCCUR_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA4AA6D-C4AD-07B8-E053-4EBD850A98FA","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-11","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177554","version":"1","preferredName":"Cardiovascular Disorder Personal Medical History Type","preferredDefinition":"Text term that represents the type of cardiovascular disorder.","longName":"CVD_MHTERM_TYP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA4B07D-E8D9-07C2-E053-4EBD850AD2FB","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"TSESU","dateModified":"2024-01-11","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177555","version":"1","preferredName":"Personal Medical History Type 1 Diabetes Mellitus Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of Type 1 Diabetes Mellitus.","longName":"DIABT1_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDA4AA6D-C509-07B8-E053-4EBD850A98FA","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"COLLIED","dateModified":"2022-04-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177556","version":"1","preferredName":"Personal Medical History Type 2 Diabetes Mellitus Indicator","preferredDefinition":"Indicator of whether or not the participant has a history of Type 2 Diabetes Mellitus.","longName":"DIABT2_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDA4B07D-E901-07C2-E053-4EBD850AD2FB","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"COLLIED","dateCreated":"2022-04-27","modifiedBy":"COLLIED","dateModified":"2022-04-27","changeNote":"Curated for AMC S005 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10181732","version":"1","preferredName":"Refrain from Smoking On Study Indicator","preferredDefinition":"Indicator of whether or not a participant abstained from smoking while enrolled on the study.","longName":"10181726v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED5C7E9-0AD9-2222-E053-731AD00AECE0","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-12","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10181947","version":"1","preferredName":"Laboratory Procedure Cotinine Result Value","preferredDefinition":"Value of salivary cotinine test in (ng/ml).","longName":"2435403v1.00:2183361v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-77F8-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-12","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10182328","version":"1","preferredName":"Tobacco Smoking Past Seven Days Indicator","preferredDefinition":"Indicator of whether a person smoked a cigarette, even a puff, in the past 7 days.","longName":"8018509v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED5C7E9-0F16-2222-E053-731AD00AECE0","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-12","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10182333","version":"1","preferredName":"Cigarette Smoking Consumption On Study Change Rate","preferredDefinition":"A person's response of how their cigarette consumption changed while being enrolled on the study.","longName":"10182332v1.00:10182329v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED5C7E9-0F1C-2222-E053-731AD00AECE0","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10369191","version":"1","preferredName":"Nicotine Replacement Agent Use Indicator","preferredDefinition":"Indicator of whether a person has used the prescribed nicotine replacement therapy.","longName":"10369186v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-1E6A-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-11-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10369471","version":"1","preferredName":"Primary Care Doctor Discussion Other Smoking Cessation Indicator","preferredDefinition":"Indicator of whether a person discussed other smoking cessation interventions with their primary care physician.","longName":"10369470v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18DB-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10369482","version":"1","preferredName":"Pharmacologic Substance Smoking Cessation Intervention Use Type","preferredDefinition":"A person's response about the type of pharmacological smoking cessation interventions they have used.","longName":"10369481v1.00:10369479v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18EA-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-11-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376456","version":"1","preferredName":"Assessment Result Positive Negative Not Done Category","preferredDefinition":"The result of a patient assessment/procedure/testing.","longName":"LNGCAN_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1AAA-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-05-26","modifiedBy":"MMADDINENI","dateModified":"2023-06-07","changeNote":"ISO 11179 compliance. Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":"06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380340","version":"1","preferredName":"Cigarette Average Daily Use Count","preferredDefinition":"The number of cigarettes a person smokes per day.","longName":"2593548v1.00:10376449v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"Fagerstrom Test","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-2212-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-26","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":"Modified to facilitate reuse by C3D adopters. mc 4/2/08","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10389006","version":"1","preferredName":"Nicotine Replacement Agent Most Used Type","preferredDefinition":"A person's response about which nicotine replacement agent was most used.","longName":"10369194v1.00:10369192v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-23A0-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-31","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10392287","version":"1","preferredName":"LDCT of Chest Scan Performed Indicator","preferredDefinition":"Indicator of whether a Low Dose Computed Tomography (LDCT) was performed.","longName":"LDCT_PERF_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-2465-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-31","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10392288","version":"1","preferredName":"LDCT of Chest Scan Performed Date","preferredDefinition":"The date the Low Dose Computed Tomography was performed.","longName":"LDCT_PERF_DAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-246B-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-31","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10392491","version":"1","preferredName":"Person Specimen Tissue Donate Consent Indicator","preferredDefinition":"Indicator of whether or not the participant consents to donate samples of tissue for future research.","longName":"2724572v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-A411-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-07-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10392503","version":"1","preferredName":"Person Blood Genetic Testing Consent Indicator","preferredDefinition":"Indicator of whether or a not a participant agrees to donate some of their tissue material for future research which may include genetic testing.","longName":"10392490v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-24B4-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-07-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10392504","version":"1","preferredName":"Person Specimen Genetic Testing Consent Indicator","preferredDefinition":"Indicator of whether or not the participant consents to donate samples of tissue for future research that may include genetic testing.","longName":"10392502v1.00:6343337v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-24B6-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-07-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10404356","version":"1","preferredName":"Texting Smoking Cessation Program Adherence Scale","preferredDefinition":"Description the participant's adherence level to the text-based smoking cessation program, using a 3 point scale.","longName":"TXT_SMK_CESS_AD_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-321D-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10404359","version":"1","preferredName":"Texting Smoking Cessation Program Engagement Scale","preferredDefinition":"Description the participant's engagement level to the text-based smoking cessation program, using a 3 point scale.","longName":"TXT_SMK_CESS_ENG_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3223-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10404360","version":"1","preferredName":"Low Dose Computed Tomography of the Chest Adherence Scale","preferredDefinition":"Description of the participant's adherence level to the Low Dose Computed Tomography of the chest, using a 3 point scale.","longName":"LDCT_AD_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3225-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10404821","version":"1","preferredName":"LDCT of Chest Scan Result Category","preferredDefinition":"Low Dose Computed Tomography (LDCT) result.","longName":"LDCT_RESULT_CAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-5785-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-01","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10419640","version":"1","preferredName":"Incidental Finding LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings were noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_FIND_LDCT_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-34FB-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-03","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10419641","version":"1","preferredName":"Incidental Finding Emphysematous Cholecystitis LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of emphysema were noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_EMPHYS_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-34FE-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-03","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10419642","version":"1","preferredName":"Incidental Finding Pulmonary Fibrosis LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of pulmonary fibrosis was noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_PUL_FI_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3500-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-03","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10419643","version":"1","preferredName":"Incidental Finding Pulmonary Consolidation Or Ground Glass Opacity LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of consolidation or ground glass opacity(ies) were noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_CNGGO_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3503-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-03","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422473","version":"1","preferredName":"Incidental Finding Mediastinal Or Hilar Lymphadenopathy LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of mediastinal or hilar adenopathy were noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_MEDI_HILR_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-33FF-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422474","version":"1","preferredName":"Incidental Finding Thoracic Aortic Calcification LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of thoracic aortic calcification (TAC) was noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_TAC_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3401-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422475","version":"1","preferredName":"Incidental Finding Bronchiectasis LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of Bronchiectasis was noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_BRONCH_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3403-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422476","version":"1","preferredName":"Incidental Finding Aortic Dilatation LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of aortic dilatation was noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_AOR_DIL_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3406-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422477","version":"1","preferredName":"Incidental Finding Coronary Artery Calcification LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not incidental findings of coronary artery calcification was noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_CRN_ART_CALC_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3408-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422752","version":"1","preferredName":"Incidental Finding Other LDCT of Chest Report Indicator","preferredDefinition":"Indicator of whether or not other incidental findings were noted on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_FIND_OTHR_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3467-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422753","version":"1","preferredName":"Incidental Finding Other Low Dose Computed Tomography of the Chest Report Specify Text","preferredDefinition":"Text field to describe other incidental findings on the Low Dose Computed Tomography (LDCT) of the chest report.","longName":"INC_OTHR_SPCFY_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3469-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-06","modifiedBy":"TSESU","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461880","version":"1","preferredName":"AUDIT 1 How Often Have Alcoholic Drink Score 5 Point Scale","preferredDefinition":"A person's stated response about how often they have a drink containing alcohol, using a 5 point scale.","longName":"AUDIT_1_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC85-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461881","version":"1","preferredName":"AUDIT 2 How Many Alcoholic Drinks Had on Typical Day When Drinking Score Count","preferredDefinition":"A person's stated response about how many drinks containing alcohol they have on a typical day when they are drinking, using a 5 point scale.","longName":"AUDIT_2_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC87-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461882","version":"1","preferredName":"AUDIT 3 How Often Have Six or More Drinks on One Occasion Score 5 Point Scale","preferredDefinition":"A person's stated response about how often they have 6 or more drinks on one occasion, using a 5 point scale.","longName":"AUDIT_3_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC89-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461883","version":"1","preferredName":"AUDIT 3B How Often Have Four or More Drinks on One Occasion Score 5 Point Scale","preferredDefinition":"A person's stated response about how often they have 4 or more drinks on one occasion, using a 5 point scale.","longName":"AUDIT_3B_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC8B-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461884","version":"1","preferredName":"AUDIT 4 How Often During Last Year Have You Been Unable to Stop Drinking Once Started Score 5 Point Scale","preferredDefinition":"A person's stated response about how often during the last year they found that they were not able to stop drinking once they had started, using a 5 point scale.","longName":"AUDIT_4_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC8D-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461885","version":"1","preferredName":"AUDIT 5 How Often During Last Year Failed to do what was Normally Expected Because of Drinking Score 5 Point Scale","preferredDefinition":"A person's stated response about how often during the last year they have failed to do what was normally expected from them because of drinking, using a 5 point scale.","longName":"AUDIT_5_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC8F-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461886","version":"1","preferredName":"AUDIT 6 How Often During Last Year Needed First Drink in Morning to get Going After Heavy Drinking Session Score 5 Point Scale","preferredDefinition":"A person's stated response about how often during the last year they have needed a first drink in the morning to get themselves going after a heavy drinking session, using a 5 point scale.","longName":"AUDIT_6_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC91-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461887","version":"1","preferredName":"AUDIT 7 How Often During Last Year Felt Guilt or Remorse After Drinking Score 5 Point Scale","preferredDefinition":"A person's stated response about how often during the last year they have had a feeling of guilt or remorse after drinking, using a 5 point scale.","longName":"AUDIT_7_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC94-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461891","version":"1","preferredName":"AUDIT 8 How Often During Last Year Been Unable to Remember What Happened the Night Before Because of Drinking Score 5 Point Scale","preferredDefinition":"A person's stated response about how often during the last year they have been unable to remember what happened the night before because you had been drinking, using a 5 point scale.","longName":"AUDIT_8_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC9A-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461892","version":"1","preferredName":"AUDIT 9 Have You or Someone Else Been Injured Because of Your Drinking Score Indicator","preferredDefinition":"Indicator of whether a person or someone else has been injured as a result of their drinking.","longName":"AUDIT_9_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC9C-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10461894","version":"1","preferredName":"AUDIT 10 Has Relative, Friend, Doctor, or Other Health Care Worker Been Concerned About Your Drinking or Suggested You Cut Down Score Indicator","preferredDefinition":"Indicator of whether a person's relative, friend, or a doctor, or other health care worker has been concerned about their drinking or suggested they cut down.","longName":"AUDIT_10_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-ACA1-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-10","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10465840","version":"1","preferredName":"AUDIT 3A How Often Have Five or More Drinks on One Occasion Score 5 Point Scale","preferredDefinition":"A person's stated response about how often they have 5 or more drinks on one occasion, using a 5 point scale.","longName":"AUDIT_3A_SCL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-CB5B-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-06-13","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-13","modifiedBy":"TSESU","dateModified":"2022-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525242","version":"1","preferredName":"Second Hand Smoke Exposure Indicator","preferredDefinition":"Indicator of whether or not a participant has or had second-hand smoke exposure.","longName":"SCNDHND_SMKEXP_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9A0C-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525244","version":"1","preferredName":"Radon Exposure Indicator","preferredDefinition":"Indicator of whether or not a participant has or had radon exposure.","longName":"RADON_EXP_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9A11-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525245","version":"1","preferredName":"Chest Radiation Therapy Administered Terminology Indicator","preferredDefinition":"Indicator of whether or not a participant has or had radiation therapy to the chest.","longName":"CH_RADEXP_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9A14-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525246","version":"1","preferredName":"Family History Lung Cancer Indicator","preferredDefinition":"Indicator of whether or not a participant has family history of lung cancer.","longName":"FAMHST_LNGCNCR_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9A17-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525247","version":"1","preferredName":"Other Lung Carcinoma Risk Factor Present Indicator","preferredDefinition":"Indicator of whether or not a participant has other lung cancer risk factors.","longName":"OTH_LUNGCNC_RSK_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6B1-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525248","version":"1","preferredName":"Other Lung Carcinoma Risk Factor Present Specify","preferredDefinition":"Text field to specify other lung cancer risk factors not previously listed.","longName":"OTH_LUNGCNC_RSK_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6B4-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525249","version":"1","preferredName":"COVID-19 Positive Laboratory Test Result Past 6 Months Indicator","preferredDefinition":"Indicator of whether or not participant has tested positive for COVID-19 in the last 6 months.","longName":"PSTV_COVID19_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6B8-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525250","version":"1","preferredName":"COVID-19 Medicinal Treatment Received Indicator","preferredDefinition":"Indicator of whether or not participant received medicinal treatment for COVID-19.","longName":"COVID19_TX_RCVD_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6BB-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525251","version":"1","preferredName":"COVID-19 Infection Hospitalization Indicator","preferredDefinition":"Indicator of whether or not participant was hospitalized due to COVID-19 infection.","longName":"COVID19_HSPTL_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6BE-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-08-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525252","version":"1","preferredName":"Electronic Cigarette Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not participant has used electronic cigarettes in the past 30 days?","longName":"ECIG_USE_30DAYS_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6C0-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525255","version":"1","preferredName":"Electronic Cigarette Cartridge Frequency Daily Use Count","preferredDefinition":"Number representing a participant's daily use count of e-cigarette cartridges.","longName":"ECIG_CART_DLY_CNT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6C5-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-12-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525256","version":"1","preferredName":"Chewing Tobacco Frequency Daily Use Count","preferredDefinition":"Number representing a participant's daily use count of chewing tobacco.","longName":"CHEWTOB_DLYUSE_CNT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6C8-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525257","version":"1","preferredName":"Cigarillo Or Cigar Frequency Daily Use Count","preferredDefinition":"Number representing a participant's daily use count of cigarillo(s) or cigar(s).","longName":"CIGAR_DLY_USE_CNT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6CB-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525258","version":"1","preferredName":"Hookah Frequency Daily Use Count","preferredDefinition":"Number representing a participant's daily use count of hookah.","longName":"HOOKAH_DLY_USE_CNT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6CE-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525259","version":"1","preferredName":"Chewing Tobacco Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not participant has used chewing tobacco in the past 30 days.","longName":"CHEWTOB_DLYUSE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6D1-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525260","version":"1","preferredName":"Cigarillo Or Cigar Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not participant has used cigars or cigarillos in the past 30 days.","longName":"CIGAR_DLY_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6D4-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525261","version":"1","preferredName":"Hookah Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not participant has used hookah in the past 30 days.","longName":"HOOKAH_DLY_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6D7-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10525262","version":"1","preferredName":"Alcohol Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not participant drank alcohol in the past 30 days.","longName":"ALC_P30DYS_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6DA-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528386","version":"1","preferredName":"Alcohol How Often Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they drank alcohol.","longName":"ALC_WKLY_USE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6E7-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528387","version":"1","preferredName":"Marijuana How Often Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they use marijuana.","longName":"MJ_USE_WKLY_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6E9-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528388","version":"1","preferredName":"Cocaine How Often Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they use cocaine.","longName":"COC_WKLY_USE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6ED-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528403","version":"1","preferredName":"Not Prescribed Opioid How Often Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they use opioids that were not prescribed.","longName":"NO_RX_OPI_WKUSE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B6FE-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528404","version":"1","preferredName":"Amphetamine Type Stimulant Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they used amphetamine-type stimulants.","longName":"AMPHTYP_STIM_USE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B701-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528405","version":"1","preferredName":"Methamphetamine Type Stimulant Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they used methamphetamine-type stimulants.","longName":"METHTYP_STIM_USE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B704-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528406","version":"1","preferredName":"Illicit Substance Inhalation How Often Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they used illicit inhalants.","longName":"ILLCT_INHL_USE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B707-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528407","version":"1","preferredName":"Hallucinogen How Often Use Weekly Frequency","preferredDefinition":"A participant's stated response about how often, in one week, they used hallucinogens.","longName":"HALLUC_WK_USE_FRQ","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B70A-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528408","version":"1","preferredName":"Marijuana Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not smoked marijuana in the past 30 days.","longName":"MJ_P30DYS_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B70D-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528409","version":"1","preferredName":"Cocaine Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not a participant used cocaine in the past 30 days.","longName":"COC_P30DYS_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B710-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528410","version":"1","preferredName":"Not Prescribed Opioid Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not a participant used opioids that were not prescribed to them in the past 30 days.","longName":"NO_RX_OPI_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B713-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528411","version":"1","preferredName":"Amphetamine Type Stimulant Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not a participant used amphetamine-type stimulants in the past 30 days.","longName":"AMPH_P30DY_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B716-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528412","version":"1","preferredName":"Methamphetamine Type Stimulant Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not a participant used methamphetamine-type stimulants in the past 30 days.","longName":"METH_P30DY_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B719-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528413","version":"1","preferredName":"Illicit Inhalant Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not a participant used illicit inhalants in the past 30 days.","longName":"ILLCT_INHL_P30DY_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B71C-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528414","version":"1","preferredName":"Hallucinogen Past 30 Days Use Indicator","preferredDefinition":"Indicator of whether or not a participant used hallucinogens in the past 30 days.","longName":"HALLUC_P30DY_USE_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B71F-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528415","version":"1","preferredName":"Opportunistic Infection Medical History Indicator","preferredDefinition":"Indicator of whether or not participant has history of opportunistic infections.","longName":"OI_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B722-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-12-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528416","version":"1","preferredName":"Herpesvirus Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of herpes simplex virus infections.","longName":"HERPES_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B725-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528417","version":"1","preferredName":"Salmonella Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of salmonella infections.","longName":"SALMON_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B728-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528418","version":"1","preferredName":"Candidiasis Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of candidiasis infections.","longName":"CANDID_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B72B-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-12-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528419","version":"1","preferredName":"Toxoplasmosis Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of toxoplasmosis infections.","longName":"TOXOPLAS_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B72E-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528420","version":"1","preferredName":"Pneumocystis Pneumonia Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of pneumocystis pneumonia (PCP) infections.","longName":"PCP_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B731-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528421","version":"1","preferredName":"Progressive Multifocal Leukoencephalopathy (PML) Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of progressive multifocal leukoencephalopathy (PML) infections.","longName":"PML_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B734-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-12-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528422","version":"1","preferredName":"Tuberculosis Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of tuberculosis infections.","longName":"TB_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B737-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528423","version":"1","preferredName":"Cytomegalovirus Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of cytomegalovirus (CMV) infections.","longName":"CMV_INF_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B73A-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528424","version":"1","preferredName":"Other Opportunistic Infection History Indicator","preferredDefinition":"Indicator of whether or not participant has history of other opportunistic infections.","longName":"OTH_OI_HIST_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B73D-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528425","version":"1","preferredName":"Other Opportunistic Infection History Specify","preferredDefinition":"Text field to describe a participant's history of other opportunistic infections","longName":"OTHER_OI_HIST_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B740-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10528426","version":"1","preferredName":"Comorbid Condition Present Indicator","preferredDefinition":"Indicator of whether or not participant has history of other comorbid conditions.","longName":"OTH_COMORB_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2353FEA-B743-4997-E053-731AD00A8E88","latestVersionIndicator":"Yes","beginDate":"2022-06-24","endDate":null,"createdBy":"TSESU","dateCreated":"2022-06-24","modifiedBy":"TSESU","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10803658","version":"1","preferredName":"CTC Adverse Event Secondary Malignant Neoplasm Indicator","preferredDefinition":"Indicator of whether neoplasm is a secondary malignancy.","longName":"SCNDY_MALIG_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4D29C14-54CF-707A-E053-731AD00AE76A","latestVersionIndicator":"Yes","beginDate":"2022-07-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-27","modifiedBy":"TSESU","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10803660","version":"1","preferredName":"Current Disease Second Malignant Neoplasm Assessment Indicator","preferredDefinition":"Indicator of whether neoplasm is a second malignancy.","longName":"SCND_MALIG_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4D2AB8A-4D2B-7214-E053-731AD00AF9A1","latestVersionIndicator":"Yes","beginDate":"2022-07-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-27","modifiedBy":"TSESU","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10803661","version":"1","preferredName":"Dose Limiting Toxicity Indicator","preferredDefinition":"Indicator of whether adverse event was a dose-limiting toxicity.","longName":"DOSE_LIMT_TOX_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4D2BB7E-3C60-73F5-E053-731AD00A6029","latestVersionIndicator":"Yes","beginDate":"2022-07-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-27","modifiedBy":"TSESU","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10811965","version":"1","preferredName":"Patient Personal Contact Future Research Participation Consent Indicator","preferredDefinition":"Indicator of whether the participant consents to be contacted for participation in other research in the future.","longName":"FTR_CNTCT_CNSNT_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E33573-287D-747E-E053-731AD00AE39C","latestVersionIndicator":"Yes","beginDate":"2022-07-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-28","modifiedBy":"TSESU","dateModified":"2023-08-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10811972","version":"1","preferredName":"Target Concomitant Agent Gamma Globulin Immunosuppressive Therapy Vaccination Indicator","preferredDefinition":"Indicator of whether medication is a targeted concomitant medication such as gamma globulin, immunosuppressive drug or vaccination.","longName":"GAMMAG_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E43AA0-53D4-1AFC-E053-731AD00AC12B","latestVersionIndicator":"Yes","beginDate":"2022-07-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-28","modifiedBy":"TSESU","dateModified":"2022-07-29","changeNote":null,"administrativeNotes":"7/29/22 released CDE per Sung Tse for AMC cjl; 7/29/22_revised short name per M. Sheikh_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10931188","version":"1","preferredName":"Etiology Infectious Agent Specify Text","preferredDefinition":"Text field to describe infectious etiologic agent.","longName":"MCORGIDN_MBORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E55A6614-3417-7ACD-E053-731AD00A077D","latestVersionIndicator":"Yes","beginDate":"2022-08-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-03","modifiedBy":"TSESU","dateModified":"2022-08-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10931192","version":"1","preferredName":"Adverse Event Attribution Specify Other Text","preferredDefinition":"Text field to describe other adverse event related to study treatment not previously listed.","longName":"OTHSP_AERELNST","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E55AA894-41EB-03E8-E053-731AD00AE14D","latestVersionIndicator":"Yes","beginDate":"2022-08-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-03","modifiedBy":"TSESU","dateModified":"2022-08-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10931193","version":"1","preferredName":"Bone Marrow Specimen Collection Indicator","preferredDefinition":"Indicator of whether bone marrow biopsy was collected.","longName":"BONEM_BIOPSY_MISTAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E55ADEB2-5E99-09B0-E053-731AD00AC810","latestVersionIndicator":"Yes","beginDate":"2022-08-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-03","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10936038","version":"1","preferredName":"Malignant Neoplasm Present Indicator","preferredDefinition":"Indicator of whether malignancy was present.","longName":"MALIGIND_ASPIRATE_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E55C3ED7-FCEA-3A6B-E053-731AD00A501A","latestVersionIndicator":"Yes","beginDate":"2022-08-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-03","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10936040","version":"1","preferredName":"Dysplasia Present Indicator","preferredDefinition":"Indicator of whether evidence of dysplasia was present.","longName":"DYSPSIND_ASPIRATE_MIORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E55C53FC-2202-3D0C-E053-731AD00A9FDE","latestVersionIndicator":"Yes","beginDate":"2022-08-03","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-03","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10937047","version":"2","preferredName":"Biopsy Not Performed Reason","preferredDefinition":"Response to indicate the reason that biopsy was not performed.","longName":"BIOP_NP_RSN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"003B6FC5-FB9A-03E2-E063-731AD00A049F","latestVersionIndicator":"Yes","beginDate":"2023-07-11","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"TSESU","dateModified":"2023-08-14","changeNote":null,"administrativeNotes":"7/11/23_Versioned to fix Short Name_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10937048","version":"2","preferredName":"Biopsy Not Performed Other Specify","preferredDefinition":"Response to specify other reason that biopsy was not performed than those listed previously.","longName":"OTHSP_BONEM_BIOPSY_MIREASND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"003B6B54-E4DB-0359-E063-731AD00A17A4","latestVersionIndicator":"Yes","beginDate":"2022-08-03","endDate":"2023-07-11","createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"GDEEN","dateModified":"2023-10-27","changeNote":null,"administrativeNotes":"7/11/23_Versioned to fix short name_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10938238","version":"1","preferredName":"Study Participant Lymphodepletion Therapy Conditioning Chemotherapy Eligible Indicator","preferredDefinition":"Indicator of whether study participant is eligible to start conditioning chemotherapy.","longName":"PRELIG_COND_FAYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56B7C07-5B33-1A65-E053-731AD00ADE4D","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10939365","version":"1","preferredName":"Lymphodepletion Therapy Conditioning Chemotherapy Delay Indicator","preferredDefinition":"Indicator of whether conditioning chemotherapy was delayed.","longName":"DELAY_CCHEMO_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D60F4-CC49-5808-E053-731AD00AC64D","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10939366","version":"1","preferredName":"Lymphodepletion Therapy Conditioning Chemotherapy Delay Reason","preferredDefinition":"Response indicating the reason for conditioning chemotherapy delay.","longName":"DLYREAS_CCHEMO_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D6A1A-3696-58FF-E053-731AD00AF1CC","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10939368","version":"1","preferredName":"Lymphodepletion Therapy Conditioning Chemotherapy Delay Other Specify","preferredDefinition":"Text field to specify other reason for delay of conditioning chemotherapy than those previously listed.","longName":"DLYREASO_CCHEMOFAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D805C-5452-5C09-E053-731AD00AAB98","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10939376","version":"1","preferredName":"Additional Lymphodepletion Therapy Conditioning Chemotherapy Administer Indicator","preferredDefinition":"Indicator of whether participant will receive another round of conditioning chemotherapy.","longName":"ANOTHCOND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56DEE49-E448-67FC-E053-731AD00A67B8","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10945077","version":"1","preferredName":"Chimeric Antigen Receptor T-cells Bridge Therapy Chemotherapy Administered Indicator","preferredDefinition":"Indicator of whether participant received bridge therapy chemotherapy.","longName":"BRDG_CHEMO_PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5719CB6-E853-6BC9-E053-731AD00A1BA2","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10945078","version":"1","preferredName":"Bridge Therapy Radiation Therapy Administered Indicator","preferredDefinition":"Indicator of whether participant received bridge therapy radiation?","longName":"BRDG_RAD_PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E571A3ED-1B44-6CCB-E053-731AD00AF90E","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948342","version":"1","preferredName":"Bridge Therapy Administered Reason","preferredDefinition":"Response indicating the reason that bridge therapy was administered.","longName":"BRDG_PRINDC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E571AD20-EAC7-6E38-E053-731AD00A8275","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948344","version":"1","preferredName":"Bridge Therapy Administered Other Reason Specify Text","preferredDefinition":"Text field to specify other reason that bridge therapy was administered than the ones previously listed.","longName":"OTHSP_PRINDC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E571E042-DD56-73E8-E053-731AD00A8657","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948345","version":"1","preferredName":"Bridge Therapy Administered Treatment Course Number","preferredDefinition":"The number of cycles of bridge therapy administered.","longName":"BRDG_CYCLEN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5720E28-E2B1-7918-E053-731AD00A41D9","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948350","version":"1","preferredName":"Bridge Therapy Administered Start Date","preferredDefinition":"Bridge therapy start date.","longName":"BRDG_PRSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E572527E-4355-0A8C-E053-731AD00A65F8","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948351","version":"1","preferredName":"Bridge Therapy Administered End Date","preferredDefinition":"Bridge therapy administered end date.","longName":"BRDG_PRENDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5727FA8-B430-0FF5-E053-731AD00A5C0A","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948352","version":"1","preferredName":"Bridge Therapy Disease Response Indicator","preferredDefinition":"Indicator of whether there was any response to bridge therapy.","longName":"BRDG_RESPONSE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5728D3C-AAB3-114D-E053-731AD00A5B89","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948353","version":"1","preferredName":"Second Bridge Therapy Administered Indicator","preferredDefinition":"Indicator of whether a second bridge therapy was used.","longName":"BRDG_SEC_YN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E57294A1-097E-121F-E053-731AD00A81D3","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948354","version":"1","preferredName":"Second Bridge Therapy Administered Course Number","preferredDefinition":"Number of cycles of second bridge therapy administered.","longName":"BRDG_SEC_CYCLEN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E572A17F-4232-1364-E053-731AD00AF09D","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948355","version":"1","preferredName":"Second Bridge Therapy Administered Begin Date","preferredDefinition":"The second bridge therapy start date","longName":"BRDG_SEC_PRSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E572AC5C-56A4-1481-E053-731AD00AF319","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948356","version":"1","preferredName":"Second Bridge Therapy Administered End Date","preferredDefinition":"The second bridge therapy end date.","longName":"BRDG_SEC_PRENDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E572B3A8-E7EB-1559-E053-731AD00AF0DC","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10948357","version":"1","preferredName":"Second Bridge Therapy Disease Response Indicator","preferredDefinition":"Indicator of whether there was any response to second bridge therapy.","longName":"BRDG_SEC_RESPONSE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E572BC78-5655-1631-E053-731AD00A1260","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11028488","version":"1","preferredName":"Grade 2 Neutrophil Count Decreased Chimeric Antigen Receptor T-cells Administration Indicator","preferredDefinition":"Indicator of whether participant achieved blood count recovery of neutrophils to less than or equal to grade 2 within 6 weeks of CAR-T cell administration.","longName":"NEUT_CART_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D73EFB-1954-6171-E053-731AD00ADB7D","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11028489","version":"1","preferredName":"Grade 2 Neutrophil Count Decreased Chimeric Antigen Receptor T-cells Administration Date","preferredDefinition":"Date when participant achieved blood count recovery of neutrophils to less than or equal to grade 2 within 6 weeks of CAR-T cell administration.","longName":"NEUT_CART_FADAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D74DA0-43C6-6B15-E053-731AD00A5254","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11028490","version":"1","preferredName":"Grade 2 Neutrophil Count Decreased Without Granulocyte Colony-Stimulating Factor Date","preferredDefinition":"Date when participant first achieved blood count recovery of neutrophils to less than or equal to grade 2 without the use of GCSF.","longName":"NEUTFRST_GCSFDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D75542-7882-6BDA-E053-731AD00A4D87","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11030941","version":"1","preferredName":"Laboratory Procedure Absolute Neutrophil Count Result Date","preferredDefinition":"Date that the most recent absolute neutrophil count was obtained.","longName":"NEUT_LBDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D778FE-FF42-6FB9-E053-731AD00A0B54","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11030942","version":"1","preferredName":"Grade 2 Platelets Chimeric Antigen Receptor T-cells Administration Indicator","preferredDefinition":"Indicator of whether the participant achieved blood count recovery of platelets to less than or equal to grade 2 within 6 weeks of CAR-T cell administration.","longName":"PLAT_CART_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D78A1B-7F4D-71FD-E053-731AD00AE4DF","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11043256","version":"1","preferredName":"Grade 2 Platelets Chimeric Antigen Receptor T-cells Administration Date","preferredDefinition":"Date that the participant achieved blood count recovery of platelets to less than or equal to grade 2 within 6 weeks of CAR-T cell administration.","longName":"PLAT_CART_FADAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E58AE6-DFC4-2434-E053-731AD00A919B","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11043257","version":"1","preferredName":"Platelet Transfusion Prior Grade 2 Platelets Chimeric Antigen Receptor T-cells Administration Date","preferredDefinition":"Date of last platelet transfusion prior to recovery of platelets to less than or equal to grade 2 within 6 weeks of CAR-T cell administration.","longName":"LASTPLAT_CARTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E59562-EAFE-2D5A-E053-731AD00A632D","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2023-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11043258","version":"1","preferredName":"First Greater Than or Equal To Platelet Count 50000 Recovery Occurrence Date","preferredDefinition":"Date when participant first achieved blood count recovery of platelets to less than or equal to grade 2 without transfusion:","longName":"PLAT_BLDRCVY_NTRANDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E59E04-09CF-2E44-E053-731AD00A34D2","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11043259","version":"1","preferredName":"Laboratory Procedure Platelet Result Date","preferredDefinition":"The date when most recent platelet count was obtained:","longName":"PLAT_LBDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E5B9E1-0A48-31CD-E053-731AD00AC17A","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2023-08-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11043261","version":"1","preferredName":"Laboratory Procedure Platelet Result Outcome","preferredDefinition":"The most recent platelet count outcome.","longName":"PLAT_LBORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E5C9FD-FF25-3ACF-E053-731AD00A259E","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11060766","version":"1","preferredName":"Procedure Leukapheresis Performed Indicator","preferredDefinition":"Indicator of whether participant received leukapheresis.","longName":"LEUKAP_PROCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E9D83D-0B39-48FE-E053-731AD00AD8C1","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11060767","version":"1","preferredName":"Leukapheresis Eligibility Criteria Met By Subject Indicator","preferredDefinition":"Indicator of whether participant met the criteria for leukapheresis before it was initiated.","longName":"LEUKAP_CRITYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E9E1BA-CC31-4A0A-E053-731AD00A7E02","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11060768","version":"1","preferredName":"Leukapheresis Delay Indicator","preferredDefinition":"Indicator of whether leukapheresis was delayed.","longName":"DELAY_LEUKAP_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E9E8CD-4D67-4ACF-E053-731AD00A0DA1","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11060785","version":"1","preferredName":"Leukapheresis Delay Reason","preferredDefinition":"The reason that leukapheresis was delayed.","longName":"DLYREAS_LEUKAP_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA178C-C6BC-505C-E053-731AD00AA11D","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11061116","version":"1","preferredName":"Leukapheresis Delay Reason Other Specify","preferredDefinition":"Reason that leukapheresis was delayed other than those previously listed.","longName":"DLYREASO_LEUKAP_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA235C-CDF1-519B-E053-731AD00A7CCC","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11061146","version":"1","preferredName":"Leukapheresis Start Date","preferredDefinition":"The start date of leukapheresis.","longName":"LEUKAP_PRSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA34E7-3BAF-53A1-E053-731AD00A83D1","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-11","changeNote":null,"administrativeNotes":"2023.8.11 AQT added per ticket request CADSR0002726. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11061147","version":"1","preferredName":"Leukapheresis Start Time","preferredDefinition":"Start time of leukapheresis.","longName":"LEUKAP_PRSTTIM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA423C-079E-54FD-E053-731AD00A914B","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11061148","version":"1","preferredName":"Leukapheresis End Time","preferredDefinition":"The time that leukapheresis ended.","longName":"LEUKAP_PRENTIM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA4AB0-A07C-5619-E053-731AD00A7033","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11061161","version":"1","preferredName":"Peripheral Blood Mononuclear Cell Specimen Collected Count","preferredDefinition":"The total count of mononuclear cells collected.","longName":"MNC_LBORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA551E-F66A-5748-E053-731AD00A890F","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11061165","version":"1","preferredName":"Infusion Procedure Planned Date","preferredDefinition":"The proposed date of infusion procedure.","longName":"INFUSION_PROPDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5EA684C-7A3A-5A61-E053-731AD00AB4AB","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-10","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11077484","version":"1","preferredName":"Bridge Therapy Administered Name","preferredDefinition":"Text field for name of bridge therapy regimen or agent given to the participant.","longName":"BRDG_PRTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5FD111A-138E-23AD-E053-731AD00A8641","latestVersionIndicator":"Yes","beginDate":"2022-08-11","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-11","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11077503","version":"1","preferredName":"Second Bridge Therapy Administered Name","preferredDefinition":"Text field for name of second bridge therapy regimen or agent given to the participant.","longName":"BRDG_SEC_PRTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5FD22D0-C88C-2586-E053-731AD00A7813","latestVersionIndicator":"Yes","beginDate":"2022-08-11","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-11","modifiedBy":"TSESU","dateModified":"2022-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105675","version":"1","preferredName":"Cytokine Release Syndrome Occurrence Indicator","preferredDefinition":"Indicator of whether participant displays Cytokine Release Syndrome (CRS) as defined by the 2019 ASCTC harmonized system.","longName":"CRSYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6178004-60FE-6A1E-E053-731AD00A94B6","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105676","version":"1","preferredName":"Cytokine Release Syndrome Fever Attribution Indicator","preferredDefinition":"Indicator of whether participant has a fever with a temperature  38 not attributable to any other cause.","longName":"FEVNAT_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6179F15-A0E9-6DE8-E053-731AD00AEE80","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105677","version":"1","preferredName":"Antipyretic Or Anti-Cytokine Therapy Taken Indicator","preferredDefinition":"Indicator of whether participant received antipyretic or anti-cytokine therapy.","longName":"APYACYTO_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617ABF9-56EA-6F27-E053-731AD00A9951","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105678","version":"1","preferredName":"Cytokine Release Syndrome Hypotension Attribution Type","preferredDefinition":"The Cytokine Release Syndrome (CRS) description for the participant's hypotension (not attributable to any other cause).","longName":"CRSHYPOT_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617B8C4-E21D-7064-E053-731AD00AABD2","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105679","version":"1","preferredName":"Cytokine Release Syndrome Hypoxia Attribution Type","preferredDefinition":"The Cytokine Release Syndrome (CRS) description for the participant's hypoxia (not attributable to any other cause)","longName":"CRSHYPOXIA_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617C397-4B4E-7183-E053-731AD00A063F","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105680","version":"1","preferredName":"Neurotoxicity Symptom Present Indicator","preferredDefinition":"Indicator of whether the participant displays any neurotoxicity as defined by the 2019 ASCTC harmonized system.","longName":"NEUROTOX_YN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617CD43-CC0C-7269-E053-731AD00A950D","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105681","version":"1","preferredName":"Immune Effector Encephalopathy - ICE Assessment Score Range","preferredDefinition":"The participant's Immune Effector Cell-Associated Encephalopathy (ICE) score (not attributable to any other cause)","longName":"ICESCORE_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617D5CE-4C6C-7355-E053-731AD00A375C","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105682","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Depressed Level Of Consciousness Attribution Type","preferredDefinition":"The Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) description for the participant's depressed level of consciousness (not attributable to any other cause)","longName":"ICANS_DEPLCONC_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617E05E-6473-7464-E053-731AD00A171D","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105683","version":"1","preferredName":"ICANS Seizure Attribution Seizure Severity Type","preferredDefinition":"The Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) description for the participant's seizure (not attributable to any other cause).","longName":"ICANS_SEIZURE_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617EFED-0297-75D9-E053-731AD00A633A","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105684","version":"1","preferredName":"ICANS Motor Finding Attribution Type","preferredDefinition":"The Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) description for the participant's motor finding (not attributable to any other cause).","longName":"ICANS_MOTOR_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617F829-88BB-7EB4-E053-731AD00A3B93","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105685","version":"1","preferredName":"ICANS Increased Intracranial Pressure Or Cerebral Edema Attribution Type","preferredDefinition":"The Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) description for the participant's elevated ICP/cerebral edema (not attributable to any other cause).","longName":"ICANS_ICP_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E61800B1-111F-7F88-E053-731AD00A8096","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105686","version":"2","preferredName":"ICANS Grade","preferredDefinition":"The severity grade of Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS).","longName":"ICANS_GRADE_RSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0811A14B-1AFD-3FF8-E063-731AD00A987E","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-19","modifiedBy":"KUMMEROA","dateModified":"2023-10-27","changeNote":null,"administrativeNotes":"2023.10.27 Released. ak 2023.10.19 Created new version to remove and replace 2 PVs. ak 8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105687","version":"1","preferredName":"Support Therapy Administered Text","preferredDefinition":"Text field to describe supportive care measures used.","longName":"SUPMEA_COVAL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6181106-674E-038C-E053-731AD00A4854","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11105688","version":"1","preferredName":"Participant CRS or ICANS Intensive Care Unit Admission Indicator","preferredDefinition":"Indicator of whether participant was admitted to the intensive care unit (ICU) due to CRS or ICANS.","longName":"ICU_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6181C77-023A-04E8-E053-731AD00AA050","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11129578","version":"1","preferredName":"Agent Administered Indicator","preferredDefinition":"Indicator of whether participant received the study agent.","longName":"AXICIL_IV_EXYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E668CF2F-92BF-3CED-E053-731AD00A5736","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-16","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11129579","version":"1","preferredName":"Agent Delayed Administration Indicator","preferredDefinition":"Indicator of whether administration of agent was delayed.","longName":"DELAY_AXICIV_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E668E260-CF17-3F11-E053-731AD00A2B22","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-16","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11129580","version":"1","preferredName":"Agent Administration Delay Reason","preferredDefinition":"The reason for infusion delay.","longName":"DLYREAS_AXICIV_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E668EEBE-1FFD-40F5-E053-731AD00AC453","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-17","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11129581","version":"1","preferredName":"Agent Delayed Administration Other Specify","preferredDefinition":"The reason agent was delayed other than the ones previously listed.","longName":"DLYREASO_AXICIV_FAORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E66902E4-989C-6F10-E053-731AD00AF55C","latestVersionIndicator":"Yes","beginDate":"2022-08-17","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-17","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11129582","version":"1","preferredName":"Agent Administered Date","preferredDefinition":"The infusion start date.","longName":"AXICIL_IV_EXSTDAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6690B31-711F-354A-E053-731AD00A932D","latestVersionIndicator":"Yes","beginDate":"2022-08-17","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-17","modifiedBy":"TSESU","dateModified":"2023-10-03","changeNote":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11129583","version":"1","preferredName":"Agent Administered Volume Agent Dose","preferredDefinition":"The volume of the agent dose.","longName":"AGNT_ADMIN_VOL_DSE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6692D07-8987-38BC-E053-731AD00AB26C","latestVersionIndicator":"Yes","beginDate":"2022-08-17","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-17","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11131821","version":"1","preferredName":"Dose Not Administered Reason","preferredDefinition":"The reason that the agent dose was not administered.","longName":"DSE_NOT_ADMIN_RSN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6696195-CB5E-3EB8-E053-731AD00AFB38","latestVersionIndicator":"Yes","beginDate":"2022-08-17","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-17","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11131822","version":"1","preferredName":"Dose Not Administered Reason Other Specify","preferredDefinition":"Text to describe the reason dose was administered other than those previously listed.","longName":"DSE_NTADMN_OTHSP_TEXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6696D08-96BA-3FE0-E053-731AD00A0984","latestVersionIndicator":"Yes","beginDate":"2022-08-17","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-17","modifiedBy":"TSESU","dateModified":"2022-08-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11495714","version":"1","preferredName":"Patient Noncompliance Clinical Study Intervention or Procedure Indicator","preferredDefinition":"Indicator of whether a participant was noncompliant to the study intervention.","longName":"NONADH_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF3E6B3-B05D-66CA-E053-731AD00A7D87","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-26","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11495715","version":"1","preferredName":"Patient Noncompliance Clinical Study Intervention or Procedure Reason Specify","preferredDefinition":"Text field to specify the reason that participant was noncompliant to study intervention or procedure.","longName":"NONADHY_QSORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF40245-8842-69CC-E053-731AD00A0192","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-26","modifiedBy":"MMADDINENI","dateModified":"2023-09-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11517839","version":"1","preferredName":"Smoking Cessation Medication Use Indicator","preferredDefinition":"Indicator of whether participant has received any smoking cessation medications in the last five years.","longName":"SMKCESS_MHOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC5A8510-985D-7C72-E053-731AD00A74A1","latestVersionIndicator":"Yes","beginDate":"2022-10-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-31","modifiedBy":"TSESU","dateModified":"2023-02-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11517840","version":"1","preferredName":"Smoking Cessation Medication Use Begin Date","preferredDefinition":"The start date of smoking cessation medication use.","longName":"SMKCESS_MHSTDTC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC5A969C-ACDA-7E53-E053-731AD00A781F","latestVersionIndicator":"Yes","beginDate":"2022-10-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-31","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11517841","version":"1","preferredName":"Smoking Cessation Medication Use Text","preferredDefinition":"Text field to indicate the agents used in the participant's previous smoking cessation regimen within the last five years.","longName":"SMKCESS_CMTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC5AA2C0-E079-7F68-E053-731AD00ACE62","latestVersionIndicator":"Yes","beginDate":"2022-10-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-31","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11517851","version":"1","preferredName":"Bupropion Received Indicator","preferredDefinition":"Indicator of whether Bupropion was received.","longName":"BUPROP_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC5ACBA4-3A29-05F2-E053-731AD00AC345","latestVersionIndicator":"Yes","beginDate":"2022-10-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-31","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11517852","version":"1","preferredName":"Varenicline Received Indicator","preferredDefinition":"Indicator of whether Varenicline was received.","longName":"VARENI_CMOCCUR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC5AD578-A37A-06DA-E053-731AD00A3992","latestVersionIndicator":"Yes","beginDate":"2022-10-31","endDate":null,"createdBy":"TSESU","dateCreated":"2022-10-31","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11727674","version":"1","preferredName":"Peripheral Blood Smear Platelet Count Value","preferredDefinition":"The absolute peripheral blood smear platelet count value (in 1000/mcL).","longName":"PERIPLAT_LBORRES","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED0EF274-B29B-14E2-E053-731AD00AF8A6","latestVersionIndicator":"Yes","beginDate":"2022-11-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-11-09","modifiedBy":"TSESU","dateModified":"2022-11-10","changeNote":"12/7/10 Added comment for TCGA by request of T.Lichtenberg. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12126752","version":"1","preferredName":"Study Participant Gender Self-Report Description Gender Type","preferredDefinition":"The self-reported description of a study participant's gender.","longName":"EC115ASELF","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF2FBA87-0F4B-034B-E053-731AD00ACC5C","latestVersionIndicator":"Yes","beginDate":"2022-12-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-06","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12127872","version":"1","preferredName":"AMC Clinical Trial Site Receive Treatment Indicator","preferredDefinition":"Yes/No indicator of whether participant is or will be treated at an AIDS Malignancy Consortium (AMC) clinical trial site for care or research.","longName":"EC115AAMC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF31376B-96C9-419F-E053-731AD00AC763","latestVersionIndicator":"Yes","beginDate":"2022-12-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-06","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12131799","version":"1","preferredName":"Participant HIV Infection Documentation Present Indicator","preferredDefinition":"Yes/No indicator of whether participant has met HIV-1 infection documentation criteria.","longName":"EC115BHIV","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF47AEC9-6F1F-5602-E053-731AD00AE418","latestVersionIndicator":"Yes","beginDate":"2022-12-07","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-07","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12131804","version":"1","preferredName":"Cancer Diagnosis Status","preferredDefinition":"Question asking the current status of participant's cancer diagnosis.","longName":"EC115BSTAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF47ECBE-A61C-5C89-E053-731AD00AFF86","latestVersionIndicator":"Yes","beginDate":"2022-12-07","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-07","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12173262","version":"1","preferredName":"Risk HIV Classification Unknown Indicator","preferredDefinition":"Indicator of whether the risk of HIV Classification is unknown.","longName":"HHSUNKN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0332DC5-569E-40DB-E053-731AD00AAD69","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12173263","version":"1","preferredName":"Risk HIV Classification Other Indicator","preferredDefinition":"Indicator of whether the risk of HIV classification is other than those previously mentioned.","longName":"HHSRSKOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F03367F7-6B00-49A9-E053-731AD00A2A49","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12175288","version":"1","preferredName":"HIV Treatment Receive Indicator","preferredDefinition":"Indicator of whether patient is receiving HIV treatment.","longName":"HHSHIVTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0355BAD-461C-11AF-E053-731AD00A2D2E","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12175342","version":"1","preferredName":"HIV Western Blot Performed Indicator","preferredDefinition":"Indicator of whether HIV Western Blot was performed.","longName":"HHSWESTR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0359C9D-6174-1B91-E053-731AD00A42BB","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12175598","version":"1","preferredName":"HIV Multispot Antibody Measurement Assay Performed Indicator","preferredDefinition":"Indicator of whether HIV Rapid Multispot (HIV-1/HIV-2) Antibody Differentiation Assay was performed.","longName":"HHSRAPMT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F035B806-75EE-1E8E-E053-731AD00A8B5E","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12175838","version":"1","preferredName":"ELISA Performed Indicator","preferredDefinition":"Indicator of whether ELISA (Enzyme-linked Immunosorbent Assay) was performed.","longName":"HHSELISA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F035D21A-5460-21C0-E053-731AD00A3D06","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12176165","version":"1","preferredName":"Received Medication Reporting Period Indicator","preferredDefinition":"Indicator of whether participant is receiving medication this reporting period.","longName":"HHSANTI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0362051-F939-2FFC-E053-731AD00A11A2","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12177459","version":"1","preferredName":"Antifungal Agent Administered Indicator","preferredDefinition":"Indicator of whether antifungal agent has been administered.","longName":"HHSAFUNG","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F036408E-C141-37D1-E053-731AD00AC728","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"KUMMEROA","dateModified":"2023-11-17","changeNote":null,"administrativeNotes":"2023.11.17 AQT added per ticket request CADSR0003092. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12177536","version":"1","preferredName":"Tuberculosis Medication Administered Indicator","preferredDefinition":"Indicator of whether Tuberculosis medication was administered.","longName":"HHSTB","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0366BED-82BA-3C2A-E053-731AD00A7247","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12177541","version":"1","preferredName":"Personal Medical History Candida Esophagitis Infection Indicator","preferredDefinition":"Indicator of whether participant has Esophageal Candidiasis infection.","longName":"HHSPESOPH","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F036C6A8-8894-480B-E053-731AD00A00F1","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-19","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12182619","version":"1","preferredName":"Life Expectancy of Patient Greater Than or Equal To Twelve Weeks Indicator","preferredDefinition":"Indicator of whether the patient's life expectancy is greater than or equal to twelve (12) weeks.","longName":"HHSELEXP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0447ED0-C78A-73DA-E053-731AD00AB5CC","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186053","version":"1","preferredName":"AIDS Diagnosis Date","preferredDefinition":"Date of the AIDS diagnosis.","longName":"HHSAIDSDT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0454729-EE4E-1A3E-E053-731AD00A25E1","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186057","version":"1","preferredName":"Assay Result Greater Than Thousand RNA Copies per Ml Indicator","preferredDefinition":"Indicator of whether assay result is greater than one thousand RNA copies per milliliter.","longName":"HHSRNAAS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0455C90-09A2-1CA3-E053-731AD00A5E67","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186058","version":"1","preferredName":"Personal Medical History Invasive Cervical Carcinoma Indicator","preferredDefinition":"Indicator of whether participant has invasive cervical cancer.","longName":"HHSPCERVI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0456B9C-912F-1E67-E053-731AD00A6FF8","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186059","version":"1","preferredName":"Personal Medical History Extrapulmonary Or Disseminate Coccidioidomycosis Indicator","preferredDefinition":"Indicator of whether patient has disseminated or extrapulmonary Coccidioidomycosis.","longName":"HHSPCOCCI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F04572C4-49BC-1F0E-E053-731AD00A1063","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186060","version":"1","preferredName":"Personal Medical History Extrapulmonary Cryptococcosis Indicator","preferredDefinition":"Indicator of whether patient has Extrapulmonary Cryptococcosis.","longName":"HHSPCRYEX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0457936-91EF-1FC6-E053-731AD00A6E79","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186061","version":"1","preferredName":"Personal Medical History Chronic Intestinal Cryptosporidiosis Duration Greater Than One Month Indicator","preferredDefinition":"Indicator of whether patient has history of chronic Intestinal Cryptosporidiosis of longer than one month duration.","longName":"HHSPCRYIN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0457FF9-5DC9-203E-E053-731AD00A8AB3","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186062","version":"1","preferredName":"Personal Medical History Cytomegaloviral Retinitis With Loss of Vision Indicator","preferredDefinition":"Indicator of whether patient has history of Cytomegaloviral Retinitis with loss of vision.","longName":"HHSPCMVRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0458ADB-982B-21C9-E053-731AD00AEF93","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186065","version":"1","preferredName":"Personal Medical History HIV-Related Encephalopathy Indicator","preferredDefinition":"Indicator of whether patient has medical history of HIV-related Encephalopathy.","longName":"HHSPENCEP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0459581-21CE-237E-E053-731AD00A35BF","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186066","version":"1","preferredName":"Personal Medical History Bronchitis Pneumonitis Esophagitis Herpes Simplex Virus Infection Onset Or Duration Greater Than One Month Indicator","preferredDefinition":"Indicator of whether patient has medical history of Herpes Simplex with Bronchitis, Pneumonitis or Esophagitis with onset or duration greater than one month..","longName":"HHSPHERPS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0459E68-0399-2779-E053-731AD00A6633","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186067","version":"1","preferredName":"Personal Medical History Extrapulmonary Or Disseminate Histoplasmosis Indicator","preferredDefinition":"Indicator of whether patient has medical history of extrapulmonary or disseminate Histoplasmosis.","longName":"HHSPHISTO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045AB80-88B3-2900-E053-731AD00AC2F1","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186068","version":"1","preferredName":"Personal Medical History Chronic Isosporiasis Duration Greater Than One Month Indicator","preferredDefinition":"Indicator of whether patient has medical history of chronic Isosporiasis.","longName":"HHSPISOPO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045B4F4-4B25-29CF-E053-731AD00AE65E","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186069","version":"1","preferredName":"Personal Medical History Extrapulmonary or Disseminate Mycobacterium avium complex or Mycobacterium kansasii Indicator","preferredDefinition":"Indicator of whether patient has medical history of extrapulmonary or disseminate Mycobacterium avium complex or Mycobacterium kansasii.","longName":"HHSPMAVIU","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045C47B-C431-2BDC-E053-731AD00AB453","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186070","version":"1","preferredName":"Personal Medical History Extrapulmonary Pulmonary or Disseminate Mycobacterium tuberculosis Indicator","preferredDefinition":"Indicator of whether patient has medical history of extrapulmonary, pulmonary or disseminate Mycobacterium tuberculosis.","longName":"HHSPMTB","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045CF83-395D-2D0C-E053-731AD00A5A5D","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186072","version":"1","preferredName":"Personal Medical History Extrapulmonary or Disseminate Other Mycobacterium Indicator","preferredDefinition":"Indicator of whether patient has medical history of other species or unidentified species, disseminated or extrapulmonary Mycobacterium.","longName":"HHSPMOTHE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045DCDF-A153-2E72-E053-731AD00ACCA7","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12186073","version":"1","preferredName":"Personal Medical History Pneumocystis jirovecii Pneumonia Indicator","preferredDefinition":"Indicator of whether patient has medical history of Pneumocystis jirovecii pneumonia.","longName":"HHSPPJIRO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045E489-C81D-2F51-E053-731AD00A83F0","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187517","version":"1","preferredName":"Personal Medical History Recurrent Pneumonia Indicator","preferredDefinition":"Indicator of whether patient has medical history of recurrent Pneumonia.","longName":"HHSPPRECU","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045EDA1-5A9F-302C-E053-731AD00AD71F","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187518","version":"1","preferredName":"Personal Medical History Recurrent Salmonella Septicemia Indicator","preferredDefinition":"Indicator of whether patient has medical history of recurrent Salmonella Septicemia.","longName":"HHSPSALMO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F045F532-D1B3-311F-E053-731AD00A4C03","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187519","version":"1","preferredName":"Personal Medical History Brain Toxoplasmosis Age Started Greater Than One Month Indicator","preferredDefinition":"Indicator of whether patient has medical history of Brain Toxoplasmosis with onset age greater than one month.","longName":"HHSPTOXOP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F04604BA-3F19-336F-E053-731AD00A5447","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187521","version":"1","preferredName":"Personal Medical History Wasting Syndrome Due To Human Immunodeficiency Virus Indicator","preferredDefinition":"Indicator of whether patient has medical history of Wasting Syndrome due to Human Immunodeficiency Virus (HIV).","longName":"HHSPWASTI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046563E-A61D-46B4-E053-731AD00A8BEC","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187522","version":"1","preferredName":"Current Medical Status Opportunistic Infection Indicator","preferredDefinition":"Indicator of whether participant has any current opportunistic infection(s).","longName":"HHSCOPPOR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F04667D2-705D-4927-E053-731AD00A3536","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187523","version":"1","preferredName":"Current Medical Status Candidiasis Indicator","preferredDefinition":"Indicator of whether patient has Candidiasis.","longName":"HHSCBRINC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F04674C5-88A2-4A3A-E053-731AD00A6940","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187525","version":"1","preferredName":"Current Medical Status Candida Esophagitis Infection Indicator","preferredDefinition":"Indicator of whether participant currently has Candida Esophagitis Infection.","longName":"HHSCESOPH","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046AD21-ED37-53B3-E053-731AD00AA182","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187526","version":"1","preferredName":"Current Medical Status Invasive Cervical Carcinoma Indicator","preferredDefinition":"Indicator of whether participant currently has invasive cervical cancer.","longName":"HHSCCERVI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046C8A4-A013-5669-E053-731AD00A9A0E","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187527","version":"1","preferredName":"Current Medical Status Extrapulmonary Or Disseminate Coccidioidomycosis Indicator","preferredDefinition":"Indicator of whether participant currently has extrapulmonary or disseminate Coccidioidomycosis.","longName":"HHSCCOCCI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046D0AA-F93D-57C5-E053-731AD00ACA4D","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187528","version":"1","preferredName":"Current Medical Status Extrapulmonary Cryptococcosis Indicator","preferredDefinition":"Indicator of whether participant currently has extrapulmonary Cryptococcosis.","longName":"HHSCCRYEX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046D618-B6E8-5864-E053-731AD00AB091","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187534","version":"1","preferredName":"Current Medical Status Chronic Intestinal Cryptosporidiosis Duration Greater Than One Month Indicator","preferredDefinition":"Indicator of whether participant currently has chronic, intestinal Cryptosporidiosis.","longName":"HHSCCRYIN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046E8A1-C79B-5A62-E053-731AD00A06AE","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187536","version":"1","preferredName":"Current Medical Status HIV-Related Encephalopathy Indicator","preferredDefinition":"Indicator of whether participant currently has HIV-related Encephalopathy.","longName":"HHSCENCEP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0474895-4F26-67C0-E053-731AD00A0DB3","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187542","version":"1","preferredName":"Current Medical Status Extrapulmonary Or Disseminate Histoplasmosis Indicator","preferredDefinition":"Indicator of whether participant currently has extrapulmonary or disseminate Histoplasmosis.","longName":"HHSCHISTO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F04772FF-6F7B-6F1B-E053-731AD00A7C9C","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187543","version":"1","preferredName":"Current Medical Status Extrapulmonary Disseminate Mycobacterium avium complex or Mycobacterium kansasii Indicator","preferredDefinition":"Indicator of whether participant currently has extrapulmonary or disseminate Mycobacterium avium complex or Mycobacterium kansasii.","longName":"HHSCMAVIU","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0478406-27DB-7137-E053-731AD00A65E7","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187544","version":"1","preferredName":"Current Medical Status Extrapulmonary Pulmonary Disseminate Mycobacterium tuberculosis Indicator","preferredDefinition":"Indicator of whether participant currently has extrapulmonary, pulmonary or disseminate Mycobacterium tuberculosis.","longName":"HHSCMTB","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0478BA9-C7CA-721F-E053-731AD00A29AF","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187545","version":"1","preferredName":"Current Medical Status Extrapulmonary Disseminate Other Mycobacterium Indicator","preferredDefinition":"Indicator of whether participant currently has extrapulmonary or disseminate Mycobacterium or other species.","longName":"HHSCMOTHE","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0479821-0270-736C-E053-731AD00ACA96","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187546","version":"1","preferredName":"Current Medical Status Pneumocystis jirovecii Pneumonia Indicator","preferredDefinition":"Indicator of whether participant currently has Pneumocystis jirovecii Pneumonia.","longName":"HHSCPJIRO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0479EEE-2EAA-7424-E053-731AD00A7D03","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"HARTLEYG","dateModified":"2023-07-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187547","version":"1","preferredName":"Current Medical Status Recurrent Pneumonia Indicator","preferredDefinition":"Indicator of whether participant currently has recurrent Pneumonia.","longName":"HHSCPRECU","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F047A497-C283-74E1-E053-731AD00A7FE4","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187549","version":"1","preferredName":"Current Medical Status Progressive Multifocal Leukoencephalopathy Indicator","preferredDefinition":"Indicator of whether participant currently has progressive Multifocal Leukoencephalopathy.","longName":"HHSCLEUKO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F047C0D9-C976-7855-E053-731AD00A28FF","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187550","version":"1","preferredName":"Current Medical Status Recurrent Salmonella Septicemia Indicator","preferredDefinition":"Indicator of whether participant currently has recurrent Salmonella Septicemia.","longName":"HHSCSALMO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F047CD5E-889F-7C8B-E053-731AD00ABE2C","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187551","version":"1","preferredName":"Current Medical Status Wasting Syndrome due to HIV Indicator","preferredDefinition":"Indicator of whether participant currently has Wasting Syndrome due to HIV.","longName":"HHSCWASTI","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F047E3C5-FE02-08D2-E053-731AD00AD56A","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-20","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12197718","version":"1","preferredName":"ECOC Performance Status Assessment Date","preferredDefinition":"The date of ECOG performance assessment.","longName":"HHSECGDT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0589826-496F-46AC-E053-731AD00AC9D6","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12201086","version":"1","preferredName":"Current Medical Status Cytomegaloviral Retinitis With Loss of Vision Indicator","preferredDefinition":"Indicator of whether participant currently has Cytomegaloviral Retinitis with loss of vision.","longName":"HHSCCMVRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F059D60A-90D5-0140-E053-731AD00A8F33","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12201089","version":"1","preferredName":"Current Medical Status Bronchitis Pneumonitis Esophagitis Herpes Simplex Virus Infection Onset Or Duration Greater Than One Month Indicator","preferredDefinition":"Indicator of whether participant currently has Herpes Simplex with chronic ulcers of greater than 1-month duration or bronchitis, pneumonitis or esophagitis with onset greater than 1 month.","longName":"HHSCHERPS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F059FD32-26E0-05EF-E053-731AD00AF8A7","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12201093","version":"1","preferredName":"Current Medical Status Chronic Isosporiasis Duration Greater Than One Month Indicator","preferredDefinition":"Response indicating whether participant currently has chronic Isosporiasis greater than duration of one-month.","longName":"HHSCISOPO","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05A1548-AE69-08A6-E053-731AD00AF42C","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12201095","version":"1","preferredName":"Current Medical Status Brain Toxoplasmosis Onset Age Greater Than One Month Indicator","preferredDefinition":"Response indicating whether participant currently has brain toxoplasmosis with age of onset greater than one month.","longName":"HHSCTOXOP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05A2A1B-BBFF-0B9D-E053-731AD00A380E","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208229","version":"1","preferredName":"Additional Therapy Cancer Therapeutic Procedure Planned Indicator","preferredDefinition":"Response indicating whether additional cancer treatment is planned.","longName":"CCTNTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05C5764-ABDF-69C5-E053-731AD00AFBC6","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208230","version":"1","preferredName":"Study Participant No Therapy Planned Reason","preferredDefinition":"The reason that no treatment is planned.","longName":"CCTNTRTN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05C6613-C952-6B6D-E053-731AD00A88C1","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208231","version":"1","preferredName":"Study Participant No Therapy Planned Other Specify Text","preferredDefinition":"Text describing the reason(s) that no therapy is planned other than previously listed.","longName":"CCTNTRTNSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05C87EF-1DCB-71E8-E053-731AD00A2269","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208234","version":"1","preferredName":"Planned Chemotherapy Agent Text","preferredDefinition":"Text describing agents to be used for planned chemotherapy.","longName":"CCTNCHEMSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05C9A81-9A87-7414-E053-731AD00A663B","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208235","version":"1","preferredName":"Antiretroviral Therapy Planned Indicator","preferredDefinition":"Response indicating whether antiretroviral therapy is planned.","longName":"CCTNART","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05CFFBD-740B-02D8-E053-731AD00A5B11","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208236","version":"1","preferredName":"Other Therapy Planned Indicator","preferredDefinition":"Response indicating whether other therapy is planned.","longName":"CCTNTRTOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05D06CB-163C-0473-E053-731AD00A7791","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208237","version":"1","preferredName":"Other Planned Therapy Specify Text","preferredDefinition":"Text describing other planned therapy.","longName":"CCTNTRTSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05D10A0-18EF-0592-E053-731AD00ABC0F","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208242","version":"1","preferredName":"Planned Therapeutic Procedure At AIDS Malignancy Consortium Site Indicator","preferredDefinition":"Response indicating whether planned treatment is at AIDS Malignancy Consortium enrolling site.","longName":"CCTNLOC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05D2DAA-0959-08A5-E053-731AD00AA83B","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12208246","version":"1","preferredName":"Person Receive Cancer Treatment At Time of Study Enrollment Indicator","preferredDefinition":"Response indicating whether participant was receiving cancer treatment at the time of study enrollment.","longName":"CCTCRNTRT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F05D8E02-E4CC-1F3D-E053-731AD00A02DD","latestVersionIndicator":"Yes","beginDate":"2022-12-21","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-21","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12216527","version":"1","preferredName":"Study Participant Previous Clinical Trial Enrollment Indicator","preferredDefinition":"Response indicating whether study participant has previously enrolled in a clinical trial.","longName":"BASENRCT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F072F8B6-C8BA-3743-E053-731AD00AFE1E","latestVersionIndicator":"Yes","beginDate":"2022-12-22","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-22","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12216528","version":"1","preferredName":"Study Participant Prior AIDS Malignancy Consortium Clinical Trial Enrollment Indicator","preferredDefinition":"Response indicating whether study participant has previously enrolled in an AIDS Malignancy Consortium clinical trial.","longName":"BASENRAMCYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F07312D2-166A-3CF0-E053-731AD00AF2B7","latestVersionIndicator":"Yes","beginDate":"2022-12-22","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-22","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12216529","version":"1","preferredName":"Study Participant Malignant Neoplasm Diagnosis Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"Response indicating whether study participant is currently eligible for an AIDS Malignancy Consortium (AMC) clinical trial that is open at this site based on cancer diagnosis including stage and histology, age range, and indication for the study intervention.","longName":"BASELIGAMCYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F075292B-6364-0F13-E053-731AD00A2B0D","latestVersionIndicator":"Yes","beginDate":"2022-12-22","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-22","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12216533","version":"1","preferredName":"Participant Study Enrollment Status","preferredDefinition":"Response indicating the enrollment status of the study participant.","longName":"BASELIGAMCSTAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F075595B-F0B9-1791-E053-731AD00AA38A","latestVersionIndicator":"Yes","beginDate":"2022-12-22","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12216534","version":"1","preferredName":"Study Participant Homeless History Indicator","preferredDefinition":"Response indicating whether study participant has been homeless.","longName":"BASHMLSSYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F075A431-3CBB-226F-E053-731AD00A2829","latestVersionIndicator":"Yes","beginDate":"2022-12-22","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-22","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12216535","version":"1","preferredName":"Study Participant How Often Previous 60 Days Homeless Response","preferredDefinition":"Response of how often in the past 60 days the study participant has been homeless.","longName":"BASHMLSS60","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F075AC2E-299B-2342-E053-731AD00AEC2B","latestVersionIndicator":"Yes","beginDate":"2022-12-22","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-22","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217172","version":"1","preferredName":"Chewing Tobacco Use Indicator","preferredDefinition":"Response indicating the history of chewing tobacco use.","longName":"BASCHEW","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D37BBE-8A5A-338B-E053-731AD00A77F8","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217173","version":"1","preferredName":"Chewing Tobacco Use Year Count","preferredDefinition":"Number of years of chewing tobacco use.","longName":"BASCHEWYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D3839C-CEA7-346F-E053-731AD00A17B3","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217174","version":"1","preferredName":"Cigar Use Indicator","preferredDefinition":"Response indicating the status of cigar use.","longName":"BASCIGAR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D38B41-D222-353B-E053-731AD00A74F8","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217175","version":"1","preferredName":"Cigar Use Year Count","preferredDefinition":"Number of years of cigar use.","longName":"BASCIGARYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D3937C-DC02-360D-E053-731AD00ADF02","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217176","version":"1","preferredName":"Electronic Cigarette Use Indicator","preferredDefinition":"Response indicating the history of electronic cigarettes (e-cigarettes).","longName":"BASECIG","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D39D97-1D4E-372D-E053-731AD00A9FCA","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217177","version":"1","preferredName":"Electronic Cigarette Use Year Count","preferredDefinition":"Number of years of electronic cigarettes (e-cigarettes) use.","longName":"BASECIGYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D3A6D5-68B1-3896-E053-731AD00AA4E9","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217178","version":"1","preferredName":"Other Tobacco Use Indicator","preferredDefinition":"Response indicating the use history of other tobacco than the others previously mentioned.","longName":"BASTBCOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D3B49A-956E-3A01-E053-731AD00A0295","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217179","version":"1","preferredName":"Other Tobacco Use Year Count","preferredDefinition":"Number of years of other tobacco use.","longName":"BASTBCOTYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D3C2EA-A0FD-3B6E-E053-731AD00A1020","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217180","version":"1","preferredName":"Marijuana Use Indicator","preferredDefinition":"Response Indicating whether cannabis was used.","longName":"BASCNBS","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D4025F-A0D6-44C6-E053-731AD00A9A45","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217218","version":"1","preferredName":"Person Household Income Category","preferredDefinition":"Response indicating the household income category.","longName":"BASINCM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5A3A6-29CE-068C-E053-731AD00AA01A","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217219","version":"1","preferredName":"Cocaine Use Indicator","preferredDefinition":"Response indicating whether cocaine was used.","longName":"BASCOCN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5B61E-8B10-091F-E053-731AD00AD15D","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217220","version":"1","preferredName":"Cocaine Use Year Count","preferredDefinition":"Number of years of cocaine use.","longName":"BASCOCNYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5BCF8-F6FF-0A37-E053-731AD00A78C9","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217221","version":"1","preferredName":"Amphetamine Type CNS Stimulant Use Indicator","preferredDefinition":"Response indicating whether amphetamine-type stimulants were used.","longName":"BASSTIM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5C512-DDF2-0B37-E053-731AD00A30BB","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217222","version":"1","preferredName":"Amphetamine Type CNS Stimulant Use Year Count","preferredDefinition":"Number of years of amphetamine-type CNS stimulant use.","longName":"BASSTIMYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5CF28-5CE0-0C35-E053-731AD00AE817","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217225","version":"1","preferredName":"Illicit Substance Inhalation Use Year Count","preferredDefinition":"Number of years of illicit substance inhalants (nitrous oxide, glue, petrol, paint thinner, etc.) use.","longName":"BASINHLYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5E46D-3D3E-0F02-E053-731AD00A6C71","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217227","version":"1","preferredName":"Illicit Substance Inhalants Use Indicator","preferredDefinition":"Response indicating whether illicit substance inhalants (nitrous oxide, glue, petrol, paint thinner, etc.) was used.","longName":"BASINHL","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D5EE9F-073A-1034-E053-731AD00AF859","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217228","version":"1","preferredName":"Illicit Substance Sedative Hypnotic Use Indicator","preferredDefinition":"Response indicating whether illicit sedative-hypnotic substances (Valium, Serapax, Rohypnol, etc.) were used.","longName":"BASSEDIT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D607C4-59E0-15E5-E053-731AD00A16B3","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217232","version":"1","preferredName":"Illicit Substance Sedative and Hypnotic Use Year Count","preferredDefinition":"Number of years of illicit sedatives and/or hypnotic substance use.","longName":"BASSEDITYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D65B7D-2D5A-2704-E053-731AD00A6B0B","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217233","version":"1","preferredName":"Hallucinogen Use Indicator","preferredDefinition":"Response indicating whether hallucinogens were used.","longName":"BASHALLGN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D67539-4AD9-2C7F-E053-731AD00ADF89","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217234","version":"1","preferredName":"Hallucinogen Use Year Count","preferredDefinition":"Number of years of hallucinogen use.","longName":"BASHALLGNYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D67E4F-B372-2D7C-E053-731AD00A875A","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217235","version":"1","preferredName":"Opioid Use Indicator","preferredDefinition":"Response indicating whether opioids (heroin, morphine, methadone, codeine, etc.) were used.","longName":"BASOPIOD","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D6896E-9F4C-2EC6-E053-731AD00AB07C","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217236","version":"1","preferredName":"Opioid Use Year Count","preferredDefinition":"Number of years of opioids (heroin, morphine, methadone, codeine, etc.) use.","longName":"BASOPIODYR","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D69617-8816-3073-E053-731AD00A6161","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217237","version":"1","preferredName":"Other Illicit Substance Use Indicator","preferredDefinition":"Response indicating whether other illicit substances were used.","longName":"BASDRUGOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D69DC7-6EA9-3133-E053-731AD00AE209","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217238","version":"1","preferredName":"Other Illicit Substance Use Year Count","preferredDefinition":"Number of years of other illicit drug(s) use.","longName":"BASDRUGOTSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D6A877-37F6-31EB-E053-731AD00A6A57","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217239","version":"1","preferredName":"Hepatitis B Infection Present Indicator","preferredDefinition":"Response indicating whether Hepatitis B infection is present.","longName":"BASHEPB","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D6B11F-4689-333F-E053-731AD00AE711","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217240","version":"1","preferredName":"Hepatitis C Infection Present Indicator","preferredDefinition":"Response indicating whether Hepatitis C is present.","longName":"BASHEPC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D6BCD2-85B8-346E-E053-731AD00A07B8","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217242","version":"1","preferredName":"Malignant Neoplasm Unrelated Lung Disorder Present Indicator","preferredDefinition":"Response indicating whether non-cancer related pulmonary conditions are present.","longName":"BASPULM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D6F6FE-0EA3-3D81-E053-731AD00A1097","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217243","version":"1","preferredName":"Malignant Neoplasm Unrelated Lung Disorder Present Specify Text","preferredDefinition":"Text describing the type of non-cancer related pulmonary condition.","longName":"BASPULMSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"NHLBI FBPP:Family Blood Pressure Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D703EF-4032-3F38-E053-731AD00A0A27","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"2/10/12 - Retired as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).  1/30/07-CDE created reusing existing DEC from CDE 5227 but with a coded response for the value domain.","administrativeNotes":"12/27/22.smt.Unretired for reuse by AMC.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217244","version":"1","preferredName":"Study Participant EORTC QLC-C30 QoL Submission Indicator","preferredDefinition":"Response indicating whether study participant submitted EORTC QLC-C30 Quality of Life questionnaire.","longName":"BASC30","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D7340C-7D03-442C-E053-731AD00A1AA4","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"10.16.20 TL changed WFS from RETIRED DELETED to RETIRED ARCHIVED in preparation of OneData.; 3/11/2020: CM retired deleted, created in error","administrativeNotes":"12.27.22_Unretired to reuse for AMC_smt; 07.05.22_Set RS to Retired to reflect WFS of Retired_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12217245","version":"1","preferredName":"Study Participant SCNS-SF35 Submission Indicator","preferredDefinition":"Response indicating whether study participant submitted the Supportive Care Needs Survey-Short Form 34 (SCNS-SF35).","longName":"BASSF34","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0D753EE-A774-4A87-E053-731AD00A4D2F","latestVersionIndicator":"Yes","beginDate":"2022-12-27","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-27","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"10.16.20 TL changed WFS from RETIRED DELETED to RETIRED ARCHIVED in preparation of OneData.; 3/11/2020: CM retired deleted, created in error","administrativeNotes":"12.27.22_Unretired to reuse for AMC_smt; 07.05.22_Set RS to Retired to reflect WFS of Retired_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12220011","version":"1","preferredName":"Baseline Planned Treatment Status","preferredDefinition":"Status of baseline planned treatment.","longName":"FUATRTPLN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0E7A3EA-1F79-7EA5-E053-731AD00AE503","latestVersionIndicator":"Yes","beginDate":"2022-12-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-28","modifiedBy":"TSESU","dateModified":"2023-08-16","changeNote":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12220013","version":"1","preferredName":"Planned Start Date Change Indicator","preferredDefinition":"Response indicating whether there was a change in the planned initiation date.","longName":"FUANCHNG","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0E7C3C3-7FF0-0425-E053-731AD00AB09B","latestVersionIndicator":"Yes","beginDate":"2022-12-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-28","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12220015","version":"1","preferredName":"Treatment Projected Begin Category","preferredDefinition":"Response indicating the projected initiation timeframe of treatment.","longName":"FUANCTIME","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0E7DD29-3A42-0A66-E053-731AD00A30ED","latestVersionIndicator":"Yes","beginDate":"2022-12-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-28","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12221356","version":"1","preferredName":"Treatment Not Begin Reason","preferredDefinition":"Response indicating the reason(s) that treatment will not be initiated.","longName":"FUADRSN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0E7E5CE-0A42-0B61-E053-731AD00A8492","latestVersionIndicator":"Yes","beginDate":"2022-12-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-28","modifiedBy":"TSESU","dateModified":"2023-01-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12221357","version":"1","preferredName":"Treatment Delayed Reason","preferredDefinition":"Reason(s) that treatment was delayed.","longName":"FUAIDLYRSN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0E7F958-2314-0DC5-E053-731AD00A4566","latestVersionIndicator":"Yes","beginDate":"2022-12-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-28","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12221358","version":"1","preferredName":"Off Treatment Reason","preferredDefinition":"Reason(s) for ending treatment prematurely.","longName":"FUAIEND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0E852DE-8505-1AED-E053-731AD00AA2E7","latestVersionIndicator":"Yes","beginDate":"2022-12-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-28","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12245391","version":"1","preferredName":"Other Cancer Treatment Administered Indicator","preferredDefinition":"Response indicating whether other cancer treatment was administered that was not previously listed.","longName":"FUADOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0F9C1F5-7CEC-7F97-E053-731AD00A0364","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12245395","version":"1","preferredName":"Treatment Status","preferredDefinition":"Response indicating the status of treatment.","longName":"FUAISTAT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FA08F8-70D5-0998-E053-731AD00AA91D","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12253686","version":"1","preferredName":"Cancer Diagnosis Status","preferredDefinition":"Response indicating the status of cancer diagnosis.","longName":"CHSCANDX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FD57D3-7D32-1D79-E053-731AD00AC63D","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12253687","version":"1","preferredName":"New Cancer Diagnosis Type","preferredDefinition":"Response indicating the diagnosis type of new cancer.","longName":"CHSINIDX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FD66EE-1372-1F2F-E053-731AD00A2101","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12253694","version":"1","preferredName":"Neoplasm Staging Procedure Date Available Indicator","preferredDefinition":"Response indicating whether date of staging is available.","longName":"CHSINIDX_STGDTNA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FDC96B-3242-2D29-E053-731AD00A6C47","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12253706","version":"1","preferredName":"Histopathology Report Date Availability Indicator","preferredDefinition":"Response indicating whether the date of histopathology report is available.","longName":"CHSINIDX_HISTDTNA","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FED40C-4ABD-58F4-E053-731AD00A64FE","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12253707","version":"1","preferredName":"Laboratory Finding Report Date","preferredDefinition":"Date of histology report.","longName":"CHSINIDX_HISTDT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FEDDCD-6EAB-5CE0-E053-731AD00A3773","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12253708","version":"1","preferredName":"Clinical Assessment Performed Indicator","preferredDefinition":"Response indicating whether clinical assessment was performed.","longName":"CHSINIDX_CLNC","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FEE468-DACE-5D86-E053-731AD00AC772","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12256237","version":"1","preferredName":"Prior Therapy Known Indicator","preferredDefinition":"Response indicating whether prior therapy is known.","longName":"CHSPRTXYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FF9CBA-71FE-74C0-E053-731AD00A7C33","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12256238","version":"1","preferredName":"Treatment Method Type","preferredDefinition":"Response indicating the type of treatment.","longName":"CHSPRTX","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FFAAFB-3FE6-76BD-E053-731AD00A029C","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12256239","version":"1","preferredName":"Treatment Method Other Specify Text","preferredDefinition":"Text describing the treatment method other than the ones previously specified.","longName":"CHSPRTXSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FFB50F-A6FA-77BC-E053-731AD00ADF63","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12256240","version":"1","preferredName":"Response Assessment Type","preferredDefinition":"Response indicating the type of post-treatment assessment.","longName":"CHSSURV","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FFD077-E89B-7D9D-E053-731AD00A3753","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12256241","version":"1","preferredName":"Follow-up Visit Schedule Other Specify Text","preferredDefinition":"Text describing other follow-up schedule different from the ones previously specified.","longName":"CHSSCHESP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1002C1C-2EE7-15E2-E053-731AD00AE2B3","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12256318","version":"1","preferredName":"Prior Cancer Diagnosis Specify Text","preferredDefinition":"Text describing the prior cancer diagnosis.","longName":"CHSGE1CANSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1027FE3-0FD4-688B-E053-731AD00ABEE3","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12264818","version":"1","preferredName":"Psychiatric Disorder Personal Medical History Specify Text","preferredDefinition":"Text describing the participant's psychiatric disorder type(s).","longName":"BASPSYCSP","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10E2B39-ADE9-6B8F-E053-731AD00A2D12","latestVersionIndicator":"Yes","beginDate":"2022-12-30","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-30","modifiedBy":"TSESU","dateModified":"2023-01-05","changeNote":"Replaced VD Chronic Disease Ind-3 (2018845v1) with VD Yes No Unknown Indicator (3506034v1) - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12291550","version":"1","preferredName":"Clinical Trial Eligibility Criteria Central Review Confirmation Indicator","preferredDefinition":"Response indicating whether the participant's clinical trial eligibility has been confirmed by central review.","longName":"DSLWRKYN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F17837F6-4056-60AC-E053-731AD00A82DB","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-06-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12291752","version":"1","preferredName":"Other Cytomegalovirus Occurrence CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"Response indicating whether cytomegalovirus other than liver, spleen or nodes occurred.","longName":"HHSCCMVOT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F178BA1B-268C-72FD-E053-731AD00ADD1F","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-06-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12432551","version":"1","preferredName":"Therapeutic Procedure Year Begin Status Indicator","preferredDefinition":"The response indicating whether the year the therapeutic procedure started is known or an estimate.","longName":"ART_CMSTEST","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2F470D2-478D-2B97-E053-731AD00A72D4","latestVersionIndicator":"Yes","beginDate":"2023-01-23","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-23","modifiedBy":"TSESU","dateModified":"2023-06-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14007914","version":"1","preferredName":"Tobacco Smoking Survey First Cigarette Minute Elapse Time","preferredDefinition":"The elapsed minutes from when a person wakes to smoking their first cigarette.","longName":"FRST_CIG_ELPS_TM","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF373BA0-F924-3137-E053-731AD00A59B9","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-06-28","modifiedBy":"TSESU","dateModified":"2023-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14056141","version":"1","preferredName":"Punch Biopsy RNA Sequencing Bio-specimen Collection Indicator","preferredDefinition":"Indicator of whether punch biopsy bio-specimen for RNA sequencing was collected.","longName":"PNCHBIO_RNA_SEQ_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"003B38BE-34E6-7B95-E063-731AD00A5561","latestVersionIndicator":"Yes","beginDate":"2023-07-11","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"TSESU","dateModified":"2024-01-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14056142","version":"1","preferredName":"Specimen Not Collected Reason","preferredDefinition":"The reason why specimen was not collected.","longName":"SPEC_NOT_COLLCT_RSN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"003C27CC-FE0B-2882-E063-731AD00A0179","latestVersionIndicator":"Yes","beginDate":"2023-07-11","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"TSESU","dateModified":"2023-07-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14056143","version":"1","preferredName":"Specimen Not Collected Other Specify Text","preferredDefinition":"Text field to describe the reason specimen was not collected other than previously described.","longName":"SPEC_NOTCLLT_OTH_RSN_TXT","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"003D12EA-E3B7-48A8-E063-731AD00A4EB8","latestVersionIndicator":"Yes","beginDate":"2023-07-11","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-11","modifiedBy":"TSESU","dateModified":"2023-07-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14056246","version":"1","preferredName":"Biospecimen Future Research Collection Indicator","preferredDefinition":"Indicator of whether bio-specimen was collected for future research.","longName":"BIOSP_CLLCT_FUTR_RSRCH_IND","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"004BAC57-8E1E-08C6-E063-731AD00A76FA","latestVersionIndicator":"Yes","beginDate":"2023-07-12","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-12","modifiedBy":"FINCHAMB","dateModified":"2023-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14072992","version":"1","preferredName":"Specimen Not Collected Reason","preferredDefinition":"The reason specimen was not collected.","longName":"SPCMN_NOTCLLT_RSN","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"00756D2B-AA31-470A-E063-731AD00A2BE4","latestVersionIndicator":"Yes","beginDate":"2023-07-14","endDate":null,"createdBy":"TSESU","dateCreated":"2023-07-14","modifiedBy":"TSESU","dateModified":"2023-07-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429697","version":"1","preferredName":"Cell of Origin Lymphoma Subtype","preferredDefinition":"The cell of origin (COO) lymphoma subtype.","longName":"14429691v1.00:14429694v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CA9DDF-7871-4A20-E063-731AD00A61A8","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429704","version":"1","preferredName":"Person Lymphoma MYC And BCL2 Gene Rearrangement And/Or BCL6 Gene Rearrangement Indicator","preferredDefinition":"Indicator of whether a person's lymphoma is MYC and BCL2 gene rearrangement and/or BCL5 gene rearrangement(s).","longName":"14429575v1.00:14429700v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CAF3E9-99C4-605C-E063-731AD00A9215","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429707","version":"1","preferredName":"Target Disease or Disorder Anatomic Site","preferredDefinition":"The anatomical site of the target disease.","longName":"14429706v1.00:2018671v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CB130F-3B09-66BE-E063-731AD00A7192","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429711","version":"1","preferredName":"London Deauville Criteria Point Scale Highest Score Scale","preferredDefinition":"Numerical value representing the highest score on the London Deauville Criteria Point Scale.","longName":"14429709v1.00:7429298v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CB5AA0-8F00-6EBB-E063-731AD00AFA89","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429714","version":"1","preferredName":"Recurrent Disease From Complete Remission Yes No Indicator","preferredDefinition":"Yes/No indicator of whether disease has relapsed from previously complete remission.","longName":"14429579v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBAEB6-7B74-7A84-E063-731AD00A968E","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429715","version":"1","preferredName":"Refractory Disease First-Line Therapy Chemoimmunotherapy Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether disease is refractory to first-line chemoimmunotherapy.","longName":"14429581v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBB9CB-5DE9-7BBC-E063-731AD00A2992","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429716","version":"1","preferredName":"Recurrent Disease Within 12 Months of First-Line Chemoimmunotherapy Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether disease is recurrent within 12 months of first-line chemoimmunotherapy.","longName":"14429582v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBB9CB-5DEB-7BBC-E063-731AD00A2992","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429717","version":"1","preferredName":"Candidiasis Esophagus Bronchus Trachea or Lung Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether candidiasis of esophagus, bronchus, trachea or lung is present.","longName":"14429585v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBC25B-E3AE-7D4F-E063-731AD00A9785","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429718","version":"1","preferredName":"Disseminate Or Extrapulmonary Coccidioidomycosis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether disseminate or extrapulmonary coccidioidomycosis is present.","longName":"14429588v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBC50A-3638-7D9F-E063-731AD00A3A11","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429719","version":"1","preferredName":"Extrapulmonary Cryptococcosis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether extrapulmonary cryptococcosis is present.","longName":"14429591v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBC7E8-5012-7DED-E063-731AD00A4DFE","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429720","version":"1","preferredName":"Chronic Intestinal Cryptosporidiosis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether chronic intestinal cryptosporidiosis is present.","longName":"14429594v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBCBBD-800D-7E6D-E063-731AD00AEE22","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429721","version":"1","preferredName":"Cytomegalovirus Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether cytomegalovirus is present","longName":"14429595v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBCF2A-F421-7EC8-E063-731AD00A7FED","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429722","version":"1","preferredName":"HIV-Related Encephalopathy Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether HIV-related encephalopathy is present.","longName":"14429597v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBD457-E9EE-7F65-E063-731AD00ACA12","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429723","version":"1","preferredName":"Chronic Ulcer Herpes Simplex Virus Infection Or Bronchitis Or Pneumonitis Or Esophagitis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether chronic ulcer herpes simplex virus infection, bronchitis, pneumonitis or esophagitis is present.","longName":"14429600v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBD858-D6B2-01C5-E063-731AD00A1E8E","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429724","version":"1","preferredName":"Disseminate or Extrapulmonary Histoplasmosis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether disseminate or extrapulmonary histoplasmosis is present.","longName":"14429604v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBDB12-CA3B-0200-E063-731AD00AA98A","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429725","version":"1","preferredName":"Chronic Intestinal Isosporiasis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether chronic intestinal isosporiasis is present.","longName":"14429606v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBDE92-390B-0277-E063-731AD00A868B","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429726","version":"1","preferredName":"Burkitt Lymphoma Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether Burkitt Lymphoma is present.","longName":"14429609v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CBF880-AAD4-08AC-E063-731AD00AAE20","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429727","version":"1","preferredName":"Immunoblastic Lymphoma Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether immunoblastic lymphoma is present.","longName":"14429611v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CC0142-15F1-09C6-E063-731AD00AD57F","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429728","version":"1","preferredName":"Cerebral Lymphoma Diagnosis Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether cerebral lymphoma is present.","longName":"14429613v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CC08C6-A8C7-0AB1-E063-731AD00ADF8A","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429729","version":"1","preferredName":"Other Or Unknown Mycobacterium Disseminate Or Extrapulmonary Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether other or unknown mycobacterium, disseminate or extrapulmonary is present.","longName":"14429615v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CC0F9E-7771-0BE0-E063-731AD00ACF3A","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429730","version":"1","preferredName":"Disseminate Or Extrapulmonary Mycobacterium Avium Complex or Mycobacterium kansasii Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether disseminated or extrapulmonary mycobacterium avium complex or mycobacterium kansasii is present.","longName":"14429621v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CC1C7D-97B1-0D4C-E063-731AD00A1183","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429731","version":"1","preferredName":"Pulmonary or Extrapulmonary Mycobacterium tuberculosis Any Anatomic Site Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether pulmonary or extrapulmonary mycobacterium tuberculosis at any anatomic site is present.","longName":"14429618v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CC2894-D36B-0EB2-E063-731AD00AE615","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14429732","version":"1","preferredName":"Brain Toxoplasmosis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether brain toxoplasmosis is present.","longName":"14429632v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CC42E9-EA67-1166-E063-731AD00AB370","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14434093","version":"1","preferredName":"Therapeutic Procedure Begin Year Estimate Yes No Indicator","preferredDefinition":"Yes/No indicator of whether the year that treatment was started an estimate.","longName":"14429688v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03FEF39E-5B51-2C15-E063-731AD00AE8BD","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14434094","version":"1","preferredName":"MYC Greater Than Or Equal to Forty Percent Indicator","preferredDefinition":"Indicator of whether MYC expression is greater than or equal to forty percent.","longName":"14429571v1.00:7339794v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03FF5511-FECC-3A50-E063-731AD00A78BD","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14434095","version":"1","preferredName":"BCL2 Greater Than Or Equal to Fifty Percent Indicator","preferredDefinition":"Indicator of whether BCL2 expression is greater than or equal to fifty percent.","longName":"14429574v1.00:7339794v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03FFB7B9-D354-519F-E063-731AD00A936D","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14435684","version":"1","preferredName":"Adverse Event Domain Multi-agent Therapeutic Regimens Relationship Type","preferredDefinition":"The type of adverse event-related multi-agent therapy.","longName":"7190126v1.00:14429712v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0400EF38-6278-7EAE-E063-731AD00AA0AD","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14435689","version":"1","preferredName":"Personal Medical History AIDS Defining Illness Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether person has medical history of AIDS-defining illness(s).","longName":"14435686v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"04012198-87F1-0F58-E063-731AD00A493C","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14435697","version":"1","preferredName":"Cytomegaloviral Retinitis Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether cytomegaloviral retinitis is present.","longName":"14435696v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0401C2C6-441C-299B-E063-731AD00A7A32","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14435983","version":"1","preferredName":"Systemic B-Symptoms Present Yes No Indicator","preferredDefinition":"Yes/No Indicator of whether systemic B-symptoms are present present.","longName":"14429626v1.00:3506068v1.00","contextName":"AMC","contextVersion":"1","dataElementConceptPublicId":"5043687","dataElementConceptVersion":"1","valueDomainPublicId":"2015603","valueDomainVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0403C0D7-C25C-01A3-E063-731AD00AF910","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeNote":null,"administrativeNotes":"2023.9.1 Alt Name added per ticket request CADSR0002807. ak","unresolvedIssues":null,"deletedIndicator":"No"}]}